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SUMMARY 
 
 
Despite a paucity of experimental evidence, clinical opinion remains that 
though LTrPs allow pain-free movement, they are primarily associated with 
motor effects and occur commonly in ‘healthy’ muscles. In contrast, evidence 
exists to support the fact that ATrPs are prevalent and a common cause of 
pain in patients with musculoskeletal pain and have significant effects, 
including augmentation or inhibition of sensation and because of pain, 
movement adaptations. The primary aim of this study was to investigate the 
effects of LTrPs on the muscle activation patterns (MAPs) of key shoulder 
girdle muscles during scapular plane elevation of the arm, the results of 
which were presented in Chapters four and five. In connection with the main 
aim, a preliminary study was carried out to examine the frequency with which 
LTrPs occur in the scapular positioning muscles in a group of normal 
subjects.  
 
To investigate the occurrence of LTrPs in the scapular positioning muscles of 
healthy subjects, a LTrP examination process was tested for intra-examiner 
reliability (see Appendix C). Subsequently, 154 healthy subjects volunteered 
to be screened for normal shoulder girdle function and then undergo a 
physical examination for the presence of LTrPs in the trapezius, rhomboids, 
levator scapulae, serratus anterior and the pectoralis minor muscles 
bilaterally. Of these subjects, 89.8% had at least one LTrP in the scapular 
positioning muscles (mean=10.65 ± 6.8, range=1-27), with serratus anterior 
and upper trapezius harbouring the most LTrPs on average (2.46 ± 1.8 and 
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2.36 ± 1.3 respectively). Consistent with clinical opinion, this study found that 
LTrPs occur commonly in the scapular positioning muscles. Having 
established this, the clinical significance of their presence and the question of 
whether they have motor effects was investigated, forming the remainder of 
the thesis. 
 
To establish whether LTrPs in the scapular rotator muscles affected the 
timing of muscle activation of this muscle group, surface electromyography 
(sEMG) was employed during elevation of the arm in the plane of the scapula 
during conditions that occur commonly (unloaded, loaded and fatigued 
movement). Furthermore, sEMG was also used to measure the muscle 
activation of functionally related shoulder girdle muscles (infraspinatus as a 
representative of the rotator cuff group that acts on the humeral head to 
optimally position it during arm movements and the middle deltoid, an 
abductor of the arm) during the test movement. These studies found that 
LTrPs housed in the scapular upward rotator muscles affected the timing of 
activation and increased the variability of those activation times of this 
muscle group and were also associated with altered timing of activation in the 
functionally related infraspinatus and middle deltoid. Compared with the 
control group (LTrP-free), the MAPs of the LTrP group appeared to be sub-
optimal, particularly in relation to preserving the subacromial space and the 
loading of the rotator cuff muscles. After the initial sEMG evaluations, the 
LTrP subjects were randomly assigned to one of two interventions: superficial 
dry needling (SDN) followed by post-isometric relaxation (PIR) stretching to 
remove the clinical signs of LTrPs or sham ultrasound, to act as a placebo 
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treatment where LTrPs remained. A subsequent sEMG evaluation found 
MAPs to be similar to the control group in most of the experimental 
conditions investigated. Of particular note, when LTrPs had been treated and 
the subjects repeated the fatiguing protocol, the resultant MAP showed no 
significant difference with that of the control group in the rested state, 
suggesting treating LTrPs was associated with an improved response to 
fatigue induced by repetitive overhead movements. 
 
 
In conclusion, the findings of the current work were that LTrPs commonly 
occur in scapular positioning muscles and have deleterious effects of MAPs 
employed to perform elevation of the arm in the scapular plane during a 
number of experimental conditions (unloaded, loaded, and fatigued 
movement) and thus affect motor control mechanisms. Treating LTrPs with 
SDN and PIR stretching increases PPTs and removes associated taut bands 
and at least transiently (no follow up was performed) optimises the MAP 
during scapular plane elevation in commonly occurring conditions. 
Discussion includes possible neuromuscular pathophysiology that might 
explain these results. 
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CHAPTER 1 
 
INTRODUCTION 
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1.1 Thesis Overview 
 
The primary aim of this study was to investigate the effects of latent 
myofascial trigger points (LTrPs) on the muscle activation patterns (MAPs) of 
key shoulder girdle muscles during scapular plane elevation of the arm. In 
connection with the main aim, a preliminary study was carried out to examine 
the frequency with which LTrPs occur in the scapular rotator muscles in a 
group of normal subjects. The thesis is set out in the following manner: 
 
Chapter 1 provides a brief introduction and rationale for the investigations, 
followed by the main aims. Chapter 2 provides a review of the relevant 
literature, which in the interests of clarity, has been divided into three 
sections. The first part (Sections 2.1, page 14) focuses on myofascial trigger 
points (TrPs) and reviews what is known of the problem that they represent, 
their clinical characteristics, the underpinning pathophysiology, how they are 
identified and the reliability of these techniques, and the treatment modalities 
available. It also presents the most recent description of the evolving 
“Integrated TrP Hypothesis” and discusses the nature of the active (ATrPs) 
and latent (LTrPs) forms. Second (Section 2.2, page 81) provides a 
discussion of elevation of the arm in the plane of the scapula, including 
kinematics, muscle activation and the upper extremity kinetic chain during 
optimal function. This is followed by a discussion of how these aspects may 
be altered by dysfunction, with particular emphasis on the relationships 
between scapular dyskinesis, rotator cuff overuse or dysfunction and 
subacromial impingement syndrome. Finally (Sections 2.3, page 105) muscle 
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activation patterns (MAPs) as one aspect of motor control are introduced and 
the effects of pain on MAPs outlined. The Chapter concludes with the 
presentation of the research questions that the experimental work was 
designed to answer. 
 
Chapter three describes the investigations carried out to establish a protocol 
to identify the presence or absence of LTrPs in the scapular rotator muscles 
and includes a discussion on the reliability of this protocol. In addition, the 
results of a study to measure how commonly LTrPs occur in the scapular 
rotator muscles in a healthy sample are reported and discussed. 
 
Chapter four reports on experimental work into the effects of LTrPs present in 
the scapular rotator muscles on MAPs during scapular plane elevation. The 
chapter includes the methodology employed and discusses the resultant 
MAPs under a variety of experimental conditions including unloaded, loaded 
and fatigued states. 
 
Chapter 5 describes the outcomes of an experiment in which subjects with 
LTrPs performed scapular plane elevation, (under the same conditions as 
discussed in Chapter four) after undergoing either a clinical LTrP treatment or 
placebo intervention in order to investigate the effects of removing LTrPs on 
MAPs. 
 7 
Chapter 6 summarises the findings and conclusions drawn as well as 
discussing the limitations of the work and provides suggestions for further 
study in the area.  
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1.2 Introduction to the Research Problem 
 
Myofascial TrPs are a common source of pain and disability considered 
clinically important by various health professionals including general 
practitioners (McClaflin 1994), dentists (Jaeger 1994), chronic pain 
specialists (Roth, Horowitz & Backman 1998), gynaecologists (Reiter & 
Gambone 1991), neurologists (Gerwin, RD 1991), paediatricians (Fine 1987), 
rheumatologists (Fricton 1994), physiotherapists (Hanten, W. P. et al. 2000), 
chiropractors (Cohen & Gibbons 1998), osteopaths (McPartland 2004), 
acupuncturists (Itoh, Katsumi & Kitakoji 2004) and myotherapists or massage 
therapists (Delaney et al. 2002). Myofascial TrPs produce a well described 
set of signs and symptoms (Simons, D. G. 2004a) and produce varying 
degrees of neuromuscular dysfunction (Huguenin, LK 2004) and have been 
categorised as either ‘Active’ (ATrPs) or ‘Latent’ (LTrPs). Active TrPs give 
rise to pain at rest or upon movement or compression of the affected muscle 
while, LTrPs have been described as neuromuscular lesions eliciting a pain 
signal only upon direct compression. From a clinical point of view, ATrPs are 
thought to be a common source of pain in patient populations and 
accordingly have been the subject of increased study over the past ten years 
(Simons, D., Travell & Simons 1999). Conversely, LTrPs have been 
considered by clinicians to be sub-clinical and perhaps most significant as 
potential precursors to ATrPs if the affected tissue continues to be subjected 
to some noxious stimulus (Hong, C. Z. & Simons 1998). Whether they are 
“forerunners” of ATrPs or produce adverse affects of their own appears to be 
unknown, though clinical experience would suggest that they are a common 
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phenomenon in both the pain-free population and patients presenting for 
treatment of musculoskeletal disorders (Simons, D., Travell & Simons 1999). 
In addition to causing pain, given that ATrPs are clinically associated with 
significant motor dysfunctions including muscle weakness, loss of 
coordination, decreased work tolerance and autonomic phenomena such as 
abnormal sweating, persistent lacrimation, excessive salivation and pilomotor 
activity (Simons, D., Travell & Simons 1999), it is important to determine 
whether LTrPs can also produce deleterious effects since there may be no 
pain signal to alert the sufferer.  
 
One way of gauging the effects of ATrPs on neuromuscular performance is 
by recording muscle activation patterns (MAPs) in sufferers performing 
normal movement patterns. The mechanism(s) by which ATrPs bring about 
changes in MAPs may relate to a number of factors, including the direct 
effects of pain (Lund et al. 1991; Sterling, Jull & Wright 2001) but also 
indirectly due to fatigue which may occur earlier during ongoing activity in 
painful muscles and muscle groups not recruited in an efficient pattern 
(Sterling, Jull & Wright 2001). Muscle activation patterns have commonly 
been investigated through the application of electromyography (EMG), using 
both surface and indwelling electrodes (Bogey, Cerny & Mohammed 2003) 
and altered MAPs so revealed, have been associated with painful 
musculoskeletal conditions such as low back pain (Hodges, P. W. & 
Richardson, C. A. 1999), ankle sprain (Bullock-Saxton 1994) and shoulder 
impingement syndrome (Wadsworth & Bullock-Saxton 1997) but have not 
been previously investigated in relation to myofascial TrPs. 
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Pain and an earlier onset of fatigue coupled with repetitive muscular activity 
can exacerbate or lead to overuse injuries which are a common source of 
disability in sports (Gosheger et al. 2003), work (Fry 1987) or activities of 
daily living (Barthel et al. 1998). Furthermore, shoulder/neck and upper 
extremity overuse injuries are second only to lower back injuries in their 
prevalence among workers and in their cost to industry (Mehlum et al. 2006), 
making the upper limb a prime target for investigation and the region chosen 
for the current investigation. More specifically, the shoulder girdle was 
described as comprising the scapula, clavicle and humerus, their articulations 
with each other and the muscles that position and stabilise them. The 
shoulder girdle represents the most proximal of a series of well delineated 
functional units which must act in concert to ensure the normal positioning, 
range of motion and strength of the upper extremity and acts in what might 
be called “intrinsic motions” (where the limb is used relatively independently), 
and as a link through which forces summed in the lower extremities and torso 
are transferred to the upper extremity and ultimately to the hand, the most 
distal segment of the upper extremity kinetic chain (Kibler, W. B. 1998b). 
Kibler (1998) suggested that where there was dysfunction (caused by such 
factors as muscle weakness or altered activation patterns) in a proximal 
segment of a kinetic chain, more distal segments may alter function in order 
to preserve the movement outcome at the most distal segment. In theory, this 
process might expose more distal muscles and other tissues to increased 
loads, predisposing them to overuse injury.  
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The paucity of information regarding the occurrence and effects of LTrPs, the 
likelihood that they occur commonly in pain-free individuals and may develop 
into ATrPs, which have known deleterious effects, brands them worth 
investigating. Furthermore, overuse injuries in the upper extremity muscles 
are common and their amenability to the application of sEMG makes them a 
logical target for the investigation of the effects of LTrPs on muscle function 
both locally and “downstream” in more distal functional related segments.  
 
The results of this work will contribute to improved understanding of the 
clinical relevance of LTrPs, the desirability of treating them in the absence of 
pain and may provide a foundation for future investigations into interventions 
that may reduce the prevalence of common upper extremity overuse 
conditions, including myofascial pain (Rashiq & Galer 1999; Simons, D. G., 
Hong & Simons 2002; Skootsky, Jaeger & Oye 1989), rotator cuff dysfunction 
(Blevins 1997) and shoulder impingement syndrome (Kibler, W.B. 
2006{Michener, 2003 #1821), in those patients with a predisposition to 
developing them.  
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1.3 Aims of the Research Project 
 
The general aim of this research was to investigate the effects of LTrPs on 
the timing of muscle activation in scapular rotator muscles and selected 
muscles located more distally in the kinetic chain. More specifically the work 
was designed to: 
 
1. Investigate the frequency with which LTrPs occur within the scapula rotator 
muscles in a group of normal males and females. 
 
2. Use sEMG to establish the MAPs of selected shoulder girdle muscles 
during elevation of the shoulder in the scapular plane in a healthy, LTrP-free 
sample under three conditions: 
a. Unloaded 
b. Holding external load 
c. After fatiguing arm elevations 
 
3. To determine the effects of LTrPs on MAPs by performing the same tests 
(aim 2) under the same conditions in a sample of individuals having one or 
more LTrPs in the scapular rotator muscles of the dominant arm. 
 
4. To further test the effects of LTrPs on MAPs by comparing performance of 
the same tests (aim 2) after either sham (LTrPs remain) or clinically verified 
LTrP therapy (LTrPs removed) in the LTrP group. 
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Chapter Overview 
 
This chapter is set out in the following manner: first, the scope of the problem 
of Myofascial Pain Syndromes (MPS) is briefly presented followed by a 
discussion of the types of TrPs (the clinical hallmarks of MPS) their 
identification and differential diagnosis. An overview of pathophysiology, 
including the underpinning biochemical and electrophysiological features, is 
then presented to provide insight into the mechanisms by which TrPs exert 
their actions, which, given the major aim of the current work, is not meant to 
be exhaustive. The final sections deal with both the optimal and dysfunctional 
biomechanics of elevation of the arm in the scapular plane (the motion 
studied) and the underpinning motor control strategies. 
 
 
Section 1: Myofascial pain syndromes (MPS) 
 
2.1.1 The scope of the problem 
 
In 2002, it was estimated that ten percent of the population of the USA or 23 
million people had one or more chronic musculoskeletal problems (Alvarez & 
Rockwell 2002), while a study performed on the Dutch population suggested 
that the impact of unexplained musculoskeletal pain syndromes on perceived 
general wellbeing in the Netherlands was a significant problem for patients 
and physicians producing considerable economic consequences (Boonen et 
al. 2005). The same authors suggested that the complex nature of pain 
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syndromes including myofascial pain syndromes (MPS) and fibromyalgia 
created uncertainty and feelings of decreased control when compared to 
better understood inflammatory conditions such as ankylosing spondylitis or 
osteoarthritis. Given the apparent common occurrence of MPS and the 
significant adverse effects they appear to have on the physical and 
psychological wellbeing of humans, further investigation of the factors that 
underpin these conditions is warranted. 
 
Myofascial trigger points (TrPs) are the characteristic clinical sign of MPS 
that cause regional muscular pain (Simons, D., Travell & Simons 1999). 
Though no large epidemiological studies reporting the prevalence of TrPs 
have been published, anecdotal evidence from experienced examiners 
implies that pain caused by TrPs is a very common phenomenon (Huguenin, 
LK 2004; McCain 1994; Simons, D., Travell & Simons 1999), particularly after 
trauma or sustained muscular fatigue. Supporting this view, Rashiq and 
Galer (1999) found that 70 percent of 41 patients diagnosed with Complex 
Regional Pain Syndrome had TrPs in the proximal musculature of the upper 
limb (Rashiq & Galer 1999). Other studies have reported TrPs as a source of 
pain in 50 percent of patients with temporomandibular disorders (Schiffman 
et al. 1990), 54 percent of patients presenting with head and neck pain 
(Fricton et al. 1985) and 30 percent of patients presenting with pain 
(unspecified) to a university medical centre (Skootsky, Jaeger & Oye 1989). 
Although the examination procedures used to identify TrPs in these studies 
were not uniform, making comparisons difficult, these findings lend support to 
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the notion that pain due to TrPs is common in patients with a variety of pain 
complaints. The following section will define these clinical entities. 
 
 
2.1.2 Myofascial Trigger Points (TrPs): Definitions 
 
The breadth and impact of MPS and the current lack of understanding of 
underlying mechanisms, provides a strong case for their investigation. 
Myofascial Pain Syndromes, of which the TrP is the defining clinical sign, is a 
common pain condition treated by many types of health practitioners 
(Simons, D. G. 2003). According to the most commonly accepted theory, a 
TrP is a hypersensitive nodule, or contraction knot contained in a taut band of 
skeletal muscle (Simons, D., Travell & Simons 1999), as opposed to healthy 
muscle, which does not contain taut bands or TrPs (Shah, J. P. et al. 2005). 
The TrP becomes painful, or the pain is exacerbated upon compression and 
may give rise to a characteristic referred pain pattern, referred tenderness, 
motor dysfunction and autonomic phenomena (Hong, C. 2006; Simons, D., 
Travell & Simons 1999; Simons, D. G. 2004a). Trigger points are classified 
as either Active (ATrP) or Latent (LTrP) with ATrPs causing spontaneous 
pain, whereas LTrPs are pain-free except when directly compressed, though 
they may give rise to more mild degrees of the other characteristics 
associated with ATrPs (Simons, D. G. 2004a).  
 
In addition to being classified as active or latent, TrPs can be defined by 
location as “Central”, or “Attachment” and also according to precedence as 
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“Key” or “Satellite”. In these schemes, Central TrPs occur in the muscle belly 
within the motor endplate zone, while Attachment TrPs are found at the 
musculotendinous or tenoperiosteal junctions and are thought to be caused 
by the unresolved tension of the taut band of skeletal muscle produced by a 
Central TrP, indicating that Attachment TrPs occur secondary to Central 
TrPs. A Key TrP is responsible for inducing the formation of one or more 
Satellite TrPs and may be thought of as the ‘primary’ TrP and is usually a 
Central TrP. Satellite TrPs are considered Central TrPs that have been 
induced neurogenically or mechanically by the activity of a Key TrP but unlike 
the Attachment variety, Satellite TrPs have a wider distribution potentially 
developing in other muscles associated with the referred pain zone of the 
Key TrP, including synergists of the muscle harbouring the key TrP, or in its 
antagonists. Illustrating the interdependence of Satellite and Key TrPs, 
Simons and colleagues (1999) noted that when Key TrPs are treated 
effectively, symptoms associated with their Satellite TrPs also resolve without 
requiring direct treatment. The next section provides an overview of the 
principles which underlie the identification of TrPs in the clinical setting, 
obviously crucial to any investigation of their effects. 
 
 
2.1.3 Diagnosis of Myofascial Pain Syndrome: Identifying myofascial 
TrPs 
 
A diagnosis of MPS relies upon the identification of TrPs in specific muscles 
where their presence is known to account for a patient’s particular symptoms. 
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Because there are no readily available, reliable and appropriate objective 
tests for identifying TrPs, the diagnosis of MPS currently involves the 
recognition of a number of distinguishing features in the patient history, 
physical examination and the identification of specific clinical signs that 
characterise TrPs, as outlined in the following sections. 
 
2.1.3.1 Patient history 
 
Trigger point pain is typically described as a fairly constant, regional, usually 
deep, dull ache that is exacerbated by the performance of certain movements 
or adoption of particular postures in contrast to neuropathic pain, which is 
more commonly associated with burning, electricity-like sensations (Baldry, 
PE. 2005). Sufferers usually describe one of the following activities as 
preceding the onset of TrP-related pain: 
1. Sudden muscle overload (e.g. a sudden and forceful contraction of the 
gastrocmenius when pushing off to begin sprinting). 
2. Sustained muscular contraction with the muscles in a shortened position 
(e.g. sustaining head rotation to watch television or read in bed). 
3. Repetitive activity, with pain increasing with increased exposure to the 
repetitive activity (e.g. using a screwdriver).          (Simons, D. G. 2004a) 
 
At times, patients may be aware of specific movements that are restricted 
due to the pain elicited by activating the TrP-affected muscle (Simons, D. G. 
2004a) but can often move through a large proportion of the full range of 
movement at the joints crossed by the affected muscles, with pain or stiffness 
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appearing only at the end of the movement. For this reason, Simons (2004) 
suggested that it would be more correct to refer to such movement-related 
findings as ‘increased sensitivity to stretch’, rather than as an absolute 
decrease in the range of movement. In addition to increased sensitivity to 
stretch, patients may also report a loss of strength in affected muscles, in the 
absence of obvious atrophy. However, upon questioning the patient or 
resisted movement testing, it is often apparent that though the patient can 
perform tasks requiring strength, the effort needed is perceived as greater 
than before the onset of TrP symptoms. Furthermore the quality or 
coordination of movement may look or feel “wrong” (Simons, D., Travell & 
Simons 1999; Simons, D. G. 2003). Finally, Baldry (2005) pointed out, that 
because of the presence of sympathetic nerve fibres at TrP sites, TrP activity 
is frequently associated with the development of sympathetically-mediated 
symptoms including pilomotor changes (localised “goosebumps”), sweating, 
persistent lacrimation or sensations of intense coldness in the distal part of a 
limb, all of which can occur spontaneously or when pressure is applied to the 
tissues overlying a TrP. Where the patient history suggests TrP-mediated 
pain, a physical examination of specific muscles is initiated to attempt to 
identify the clinical signs of TrPs as discussed in the following paragraphs. 
 
2.1.3.2 Physical examination findings 
 
Baldry (2005) considered that, locating Active TrPs (ATrPs) through palpation 
was the most important part of the clinical examination, though he also 
advocated the use of physical tests to identify, or confirm a patient’s reported 
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limited, painful, or uncoordinated movement. According to Simons and co-
workers (1999), the best guide to the precise location of myofascial TrPs is 
the identification of the “taut band”, a task facilitated by positioning the patient 
to lengthen the muscle being examined to the point of a perceptible increase 
in resistance to movement. In this position, normal muscle fibers are still 
slack but the fibers of any taut bands are placed under additional tension, 
rendering them more easily distinguishable. When the muscle being 
examined has been positioned, “snapping palpation” (a cross-fiber plucking 
motion similar to plucking a guitar string) has been suggested to differentiate 
any taut bands from adjacent normal muscle fibers. Importantly, the presence 
of a taut band of skeletal muscle is not considered in itself, diagnostic of the 
presence of an ATrP and therefore a MPS, because taut bands and LTrPs 
have been identified in subjects with no pain complaint (Gerwin, R. D. et al. 
1997; Njoo & Van der Does 1994; Wolfe et al. 1992). Once a palpable taut 
band of skeletal muscle has been located, the next critical sign is the 
identification of a tender nodule within it, by palpating along the taut band 
searching for a slightly enlarged nodule or the ‘focus’ of the contraction. 
According to Baldry (2005), these nodules are usually only a few millimetres 
in diameter, exquisitely painful to external manual compression and 
constitute the entity clinically referred to as a TrP. In patients who are pain-
free prior to external compression, such a TrP is said to be ‘latent’ (LTrP). On 
the other hand, when pain is present, it is important that the application of 
external pressure elicits the patient’s complaint, which can be local or 
referred (Gerwin, R. D. et al. 1997). The presence of referred pain and the 
extent of the referred pain pattern, whether it be the partial or complete 
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referred pain pattern associated with a particular TrP, has been taken by 
Simons and colleagues (1999) as an indication of the irritability or sensitivity 
of the ATrP. An ATrP that exhibits local and all aspects of the referred pain 
pattern prior to the application of external compression is thus considered the 
most sensitive or irritable.  
 
A further diagnostic indicator of the presence of a TrP is the local twitch 
response (LTR), a transient twitch contraction that occurs either in the fibers 
of the taut band containing the putative TrP, a different taut band in the same 
muscle, or in a taut band in another muscle (Simons, D. G. 2004a). The LTR 
can be elicited by either strong compression of, or needle insertion into, the 
suspected TrP (Chen, J. T. et al. 2001) and is considered the most objective 
sign that a TrP has been identified or effectively treated (Gerwin, R. D. et al. 
1997; Hong, C. Z. 1994b). Local twitch responses (LTRs) are spinal cord 
reflexes and have been recorded using electromyography (EMG), and 
palpated or observed by many authors (Audette, Wang & Smith 2004; Baldry, 
P. 2002a; Cummings & White 2001; Gerwin, R. D. et al. 1997; Hong, C. Z. 
1994a).  
 
In summary, according to current thinking, a myofascial TrP is said to be 
present when compression of a tender nodule located within a taut band of 
skeletal muscle reproduces the patient’s pain complaint (ATrP) or elicits local 
or referred pain in otherwise pain-free individuals (LTrP) with confirmation 
provided by observation, palpation or EMG demonstration of an LTR in 
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response to stimulation of the TrP with external compression or needle 
insertion. 
 
In terms of appropriate treatment, Chaitow (2003) stressed the point that the 
presence of TrPs indicates what he described as “neuromuscular overload” 
and could be either the cause (primary) or the result (secondary) of a 
condition where the outcome is neuromuscular overload. In the case of the 
latter, differential diagnosis of the original condition is clearly essential for 
effective treatment. Though critical in the diagnosis and treatment of MPS 
and TrPs, the many conditions that form part of the differential diagnosis are 
beyond the scope of the current work, however individuals interested in the 
breadth of the conditions that should be considered are referred to Appendix 
E (page 287) which provides an overview of the topic.  
 
 
2.1.4 Clinical characteristics of TrPs 
 
Finally, to highlight the generally agreed clinical characteristics of TrPs, the 
following list is provided reflecting the opinions of a number of authors (Hong, 
C. Z. 2000; Hong, C. Z. & Torigoe 1994; Simons, D., Travell & Simons 1999; 
Yunus 1994): 
1. Compression of a TrP may elicit local and/or referred pain that is 
recognisable to the patient as their clinical complaint (pain recognition), or 
may aggravate their existing pain (where the TrP is Active). 
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2. Snapping palpation or rapid needle insertion into the TrP may elicit a local 
twitch response (LTR). 
3. Restricted range of stretch or increased sensitivity to stretch of muscle 
fibres in a taut band may cause perceived tightness of the involved 
muscle and some discomfort at the end of the range of motion. 
4. A muscle with a TrP may be weak, but usually displays no noticeable 
atrophy. 
5. Patients with TrPs may have localised autonomic phenomena. 
6. An ATrP causes pain at rest or in response to movement, whereas a LTrP 
is asymptomatic except when compressed. 
 
These clinical characteristics will be discussed later in the chapter with 
regard to the reliability and validity of the TrP examination process (Section 
2.1.8, page 55) 
 
 
2.1.5 Pathophysiology of myofascial TrPs 
 
Based upon extensive work over many years, recently presented in an 
invited editorial, Simons (2005) suggested that ATrPs usually affect the 
sensory nervous system by either augmenting sensation, manifested as 
referred pain and tenderness, or inhibiting it as evidenced by a region of 
referred anaesthesia. In contrast, he considered that LTrPs more commonly 
augmented or inhibited the motor functions of the muscle(s) containing them 
and possibly referred these affects to functionally related muscles (Simons, 
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D. G. 2005). Both clinical (Simons, D., Travell & Simons 1999) and 
biochemical (Shah, J. P. et al. 2005) differences have been found when 
comparing ATrPs and LTrPs, suggesting that they are different entities, 
however most TrP authorities (Gerwin, R. D. 2005; Hong, C. Z. & Simons 
1998; Huguenin, LK 2004; Simons, D. G. 2004b) currently appear to consider 
that LTrPs can be clinical forerunners of ATrPs. For example, Simons (2005) 
suggested that though the roles of LTrPs had not been reported in the peer-
reviewed scientific literature, they had been the subject of clinical discussion 
and observation by clinicians, with a growing consensus that the motor 
effects of LTrPs profoundly influence the coordination of muscle activation 
and overall balance (Simons, D. G. 2005). In this vein, Simons (2005) posited 
a mechanism by which LTrPs could progress to the spontaneously active 
form through muscle overload secondary to altered MAPs. In this model, the 
abnormal pattern produces overload in inappropriately recruited muscles in 
order to implement a normal motor program. Hong (2004) suggested that 
LTrPs may exist in almost every pain-free skeletal muscle and, depending on 
the stimuli to which that muscle is exposed, could become ATrPs in the face 
of continued noxious stimuli. More controversially, he considered that though 
ATrPs could be inactivated (no longer spontaneously painful) through 
treatment, that they never fully “disappeared”, rather, they converted to the 
latent form, tender upon compression but not spontaneously painful (Hong, 
C. Z. 2004). These notions raise a number of questions: 
1. Do LTrPs have deleterious effects on motor function if left untreated? 
2. Is it possible to completely de-activate LTrPs? 
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3. Do any positive effects on motor function follow de-activation of 
LTrPs? 
The current experimental program was designed primarily to answer these 
questions (Chapters 4 and 5). 
 
To consider the suggested nature and effects of Active and Latent TrPs by 
Hong (2004) and Simons (2005) respectively, and to better understand the 
clinical presentation of myofascial TrPs it is useful to have some 
understanding of the underlying pathophysiology. The following section 
provides the underpinning knowledge for this understanding by presenting an 
overview of the relevant electrophysiological and biochemical TrP studies, 
beginning with the former. 
 
 
2.1.5.1 Electrophysiological studies of myofascial TrPs 
 
(a)  Abnormal endplate noise/Spontaneous electrical activity 
 
Many authors have reported electrical phenomena associated with TrPs. A 
marked increase in the frequency of continuous, low voltage (50-100 
microvolts (µV)) electrical activity with occasional spike activity (200 to 
700µV), has been found in both animal (Hong, C. Z. & Yu 1998; Macgregor & 
Graf von Schweinitz 2006; Simons, D. G., Hong & Simons 1995) and human 
skeletal muscle (Hubbard, D. R. & Berkoff 1993; Simons, D. G., Hong & 
Simons 2002), centred on the point of maximal tenderness of a taut band of 
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skeletal muscle, within the motor endplate zone, that is, a TrP. Originally this 
TrP associated electrical activity was coined ‘spontaneous electrical activity’ 
(SEA), but more recently it has been referred to as abnormal ‘endplate noise’ 
(EPN) (Hong, C. Z. 2002; Kuan et al. 2002; Simons, D. G. 2004b; Simons, D. 
G., Hong & Simons 2002; Simons, D. G. & Mense 2003). Simons and co-
workers (1995) found that the continuous low-amplitude electrical activity (10 
to 50µV and occasionally up to 80µV) could be recorded from both active and 
latent TrP regions, however, the intermittent spike activity (>100µV, biphasic) 
could only be recorded from ATrP regions (Simons, D. G., Hong & Simons 
1995). The minute loci from which TrP EPN can be recorded have been 
defined as the “active loci” of TrPs and are described as dysfunctional motor 
endplates (Hong, C. Z. & Simons 1998; Simons, D. G., Hong & Simons 1995; 
Simons, D. G., Hong & Simons 2002). It has been suggested that EPN 
results from excessive leakage of acetylcholine (ACh) from nerve terminals 
across the synaptic cleft, resulting in an endogenous shortening of the 
exposed contractile elements in the absence of a ‘nerve-initiated’ muscle 
contraction (Hong, C. Z. 2004; Simons, D.G. 2001). To support this notion, 
blocking or inhibiting acetylchonlinesterase (AChE), an enzyme that breaks 
down the neurotransmitter acetylcholine at the synaptic cleft, effectively 
increasing ACh concentrations at the neuromuscular junction, produced 
intense focal sarcomere contraction in the exposed muscle fibers in rats 
(Duxson & Vrbova 1985).  
 
The normal nerve excitation-induced quantal release of ACh from pre-
synaptic terminal vesicles into the synaptic cleft to be taken up by 
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acetylcholine receptors (AChRs) in the post-synaptic membrane of the 
muscle cell is dependent upon the influx of calcium ions (Ca2+) across the 
pre-synaptic terminal membrane. However, leakage of individual molecules 
of ACh (termed non-quantal release) from the motor nerve pre-synaptic 
terminal is neither excitation-induced nor dependent on the presence of Ca2+ 
(Gerwin, RD, Dommerholt & Shah 2004). Both mechanisms of ACh release 
(quantal and non-quantal) trigger miniature endplate potentials (MEPPs), 
which in turn can result in a propagated action potential, the usual trigger for 
muscle contraction. In the case where a TrP is developing, significantly 
increased non-quantal ACh release is thought to increase the number of 
MEPPs enough to depolarise an exposed post-junctional membrane to 
threshold initiating a single fiber action potential that can be recorded as an 
endplate spike (Simons, D.G. 2001; Simons, D. G., Hong & Simons 2002) As 
pointed out by Simons and colleagues (1999), this process may produce the 
taut band of the TrP through contracture of individual sarcomeres by causing 
a sustained partial depolarisation of the muscle cell membrane, rather than 
activation of the entire muscle fibre (Gerwin, RD, Dommerholt & Shah 2004), 
Activation of whole muscle fibres would be expected to result in EMG activity 
at rest, a phenomenon not associated with TrPs, the exceptions being 
endplate spikes associated with TrP endplate noise and where a LTR is 
elicited (Simons, D. G. & Dexter 1995).  
 
As comprehensively discussed by Gerwin and colleagues (2004), AChE can 
inhibit or terminate ACh action at the post-synaptic neuromuscular junction 
by breaking it down in the synaptic cleft. This action can decrease the 
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miniature endplate potential activity associated with TrPs (TrP EPN) along 
with any motor endplate induced muscle cell depolarisation. However, AChE 
activity is inhibited by an acidic pH (Mense 2003), such as can result from 
muscle ischemia and certain exercise regimes (Stauber et al. 1990). In 
addition, low pH augments the release of Calcitonin Gene Related Peptide 
(CGRP), which also acts to down-regulate the activity of AChE. These 
processes result in increased concentrations of ACh available to act on the 
muscle cell membrane and can cause abnormal EPN. As will be discussed 
later in the chapter, TrPs have been shown to be associated with both 
increased CGRP secretion and decreased pH locally, thereby providing a 
potential mechanism for TrP-related abnormal EPN. Clinically, abnormal EPN 
may therefore provide a valuable tool to evaluate the effects of different 
interventions on TrPs. For example, both phentolamine (a sympathetic 
nervous system blocking agent) (Chen, J. T. et al. 1998) and verapamil (a 
calcium channel blocker) (Hou, C.R. et al. 2002), have been used to inhibit 
SEA/EPN at TrP sites in rabbits, confirming the involvement of the autonomic 
nervous system in the development and perpetuation of TrPs and giving 
insight into potential methods of treatment. 
 
(b) Local Twitch Response (LTR) 
 
Simons and Dexter (1995) recorded EMG activity from TrP-related taut 
bands of skeletal muscle in response to snapping palpation of the TrP. In 
every case, the taut band was electrically silent in the absence of TrP 
stimulation or when the subject was relaxed. However, intramuscular 
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electrodes detected obvious electrical (contractile-related) activity 
milliseconds after snapping palpation of the TrP, which the authors 
concluded was objective evidence that an LTR resulted from stimulating 
TrPs. The minute sites within clinically identified TrPs, that when stimulated, 
elicit LTRs from their associated taut bands, have been defined as the 
“sensitive loci” of the TrP and are thought to be sensitised nociceptors (Hong, 
C. Z. & Simons 1998; Hong, C.-Z. et al. 1996). Interestingly, LTRs have also 
been recorded from muscle tissue outside of the TrP region, suggesting that 
stimulation of activated nociceptors in the TrP region generates a spinal 
reflex that has widespread inputs (Hong, C. Z. 1994a) including nearby 
muscle nociceptors (other than those situated within the TrP region), which 
may also be also sensitised (Hong, C. Z. & Simons 1998; Hong, C. Z. & 
Torigoe 1994; Hong, C. Z., Torigoe & Yu 1995). Hence, the transient, 
contraction that is the LTR can appear at sites other than the taut band 
containing the TrP, even in a taut band in another muscle (Borg-Stein & 
Simons 2002; Simons, D., Travell & Simons 1999). Other than the 
observable twitch, elicitation of an LTR is sometimes associated with quite 
intense discomfort, paresthesia or sharp pain (Hong, C. Z. 2004), as opposed 
to the dull, aching pain that digital compression of the TrP usually elicits or 
exacerbates. However, eliciting an LTR is currently considered the most 
reliable sign that a TrP has been stimulated and is therefore present (Gerwin, 
R. D. et al. 1997). Unfortunately, eliciting LTRs requires specific and effective 
stimulation of the TrP, which in turn requires both adequate access to the TrP 
and an appreciable level of skill (Hong, C. Z. & Torigoe 1994; Huguenin, LK 
2004). In addition, LTRs can vary in size and the number that can be elicited 
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from multiple stimulations of the same TrP, depends upon the irritability of the 
TrP (that is, the more sensitive ATrPs more readily produce larger and more 
numerous LTRs than the pain-free LTrPs) and how effectively the TrP is 
stimulated (Shah, J P 2003). Shah (2003) suggested that the appearance of 
a large, visually observable (as opposed to palpable or recordable) LTR 
during treatment was indicative of a more complete resolution of TrP-
mediated symptoms. Indeed, Hong (1994) had previously established the 
importance of eliciting an LTR as an indication of effective treatment of TrPs 
(Hong, C. Z. 1994b) and more recent investigations have used the LTR for 
this purpose. For example, in an animal study investigating the inhibitory 
effect of dry needling on TrP-related EPN, Chen and co-workers (2001) 
found that eliciting an LTR was associated with a significant reduction in 
abnormal EPN at the TrP site (Chen, J. T. et al. 2001). As discussed more 
fully in later sections of this chapter, Shah and co-workers (2005) collected 
analytes from the local environment of TrPs pre and post LTR and found that 
interstitial concentrations of pain mediators were significantly different, 
particularly at ATrP sites, post LTR, hinting at a mechanism by which LTRs 
can alter TrP status.  
 
A number of authors (Hong, C. Z. 1994b, 1994a, 2002; Hong, C. Z. et al. 
1997; Hong, C. Z. & Simons 1998; Hong, C. Z. & Torigoe 1994; Hong, C. Z., 
Torigoe & Yu 1995) have provided evidence that LTRs are primarily spinal 
cord reflexes. Hong (1994b) found that the electrical activity associated with 
LTRs was diminished in denervated human muscle (Hong, C. Z. 1994a) and 
nearly completely lost in rabbits following lidocaine block or transection of the 
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innervating nerve (Hong, C. Z. & Torigoe 1994). In addition, another group 
lead by Hong found that LTRs were lost in rabbits following spinal shock 
(induced by spinal cord transection above the level of the nerves supplying 
the TrP-affected muscle), but returned over a 2.5 hour recovery period, while 
cutting the motor nerve from the spinal cord to the affected muscle resulted in 
total loss of LTRs (Hong, C. Z., Torigoe & Yu 1995), indicating that higher 
levels of the central nervous system are not required for an LTR, but the 
motor nerve is essential. The fact that the response was diminished rather 
than abolished in human studies suggests that local transmission (for 
example: axon reflexes) may also play a role (Hong, C. Z. 1994a).  
 
In summary, eliciting LTRs is extremely useful in first confirming the presence 
of a TrP and the size and number LTRs elicited during treatment appears to 
give the clinician an indication of the sensitivity of the TrP and the 
effectiveness of the TrP treatment.  
 
(c) TrP referred pain  
 
In addition to the LTR, sensitive loci are also the sites from which pain and 
referred pain can be elicited by mechanical stimulation, particularly through 
needling techniques (Hong, C. Z. 1994b; Hong, C. Z. et al. 1997; Hong, C. Z. 
& Simons 1998). In an investigation of the referred pain associated with TrPs, 
Hong and co-workers (1997) found a pressure-dependent ability to elicit 
referred pain from ATrPs and to a lesser extent LTrPs, but also from what 
was considered to be normal muscle tissue within the same muscle (Hong, 
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C. Z. et al. 1997). They hypothesised that the ability to elicit referred pain at 
the less irritable LTrP and from normal muscle was at least in part due to a 
chemical sensitisation of nociceptors in and around a TrP. However they did 
not exclude other recognised mechanisms of referred pain such as localised 
inflammatory responses, scar or skin TrPs or myofascial TrPs too small to be 
clinically identified in the ‘normal’ muscle tissue, any of which could account 
for referred pain in response to pressure. As an alternative explanation, a 
number of workers have suggested that referred pain following noxious 
stimulation of sensitive loci in a TrP is due to central sensitisation in the 
spinal cord (Hoheisel, Mense & Simons 1993; Hong, C. Z. 2000; Mense & 
Simons 2001; Woolf & Salter 2000). Central sensitisation in the current 
context refers to a process in which there is an expansion of the neuron 
population in the spinal cord responding to ongoing nociceptive input from 
muscle, resulting in additional sensory neurons being activated (particularly 
wide dynamic range neurons) and pain perception in the structures 
associated with the expanded receptive field. In a review of the pathogenesis 
of muscle pain, Mense (2003) described the mechanism underlying this 
process and speculated that a sequence of events, described in Figure 2.1, 
was likely to occur in the dorsal horn neurons.  
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Figure 2.1: Proposed process that underpins the development of a 
hyperexcitable dorsal horn neuron. 
Muscle nociceptive input releases excitatory amino acids (glutamate) 
and neuropeptides (SP, CGRP) from the pre-synaptic button of the 
muscle afferent onto dorsal horn neurons in the pain pathway 
Combined action of glutamate and SP opens post-synaptic N-
methyl-D-aspartate (NMDA) channels through which Ca2+ ions 
enter the dorsal horn neurons 
Ca2+ ions activate a multitude of intracellular enzymes 
One action of these enzymes is to phosphorylate existing ion 
channels in the membrane of the post-synaptic neuron 
Phosphorylated ion channels are more permeable to ions and can 
open for a longer period of time in response to depolarisation 
Ultimately gene expression in the nucleus of the affected dorsal 
horn neurons changes 
This results in “de novo” synthesis of ion channel proteins 
Ultimately results in sensitised neurons that are hyperexcitable to 
both noxious and innocuous stimuli 
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To provide an example of this process, in experiments on anesthetised rats, 
the most prominent effect of an acute experimental inflammation of the 
gastrocnemius muscle was an expansion of the neurons responding to the 
noxious muscle’s afferent input. Dorsal horn neurons responding to 
stimulation in control animals were restricted to the L4 and L5 spinal levels 
whereas populations of neurons responding to the inflammatory stimulus in 
experimental group animals included the L3 in addition to the L4 and L5 
levels. This response occurred within a relatively short time period (a few 
hours), indicating that the population of dorsal horn neurons responding to 
nociceptive input from the gastrocnemius muscle had grown (Hoheisel, Koch 
& Mense 1994). This higher “synaptic efficacy” was said to be caused by 
hyperexcitability of the spinal neurons, involved the actions of numerous 
neurotransmitters, is called central sensitisation and is well recognised in 
pain medicine. One example of the complex nature of this process is 
provided by Mense (2003), who reported that hyperalgesia was mediated by 
SP acting on neurokinin receptors and glutamate acting on NMDA receptors 
on post-synaptic dorsal horn neurons, but thought that spontaneous pain 
resulted from other processes including reduced spinal release of nitric oxide, 
a substance that is usually released continuously in the dorsal horn and acts 
to inhibit the background discharge of nociceptive neurons (Hoheisel, Sander 
& Mense 1995). 
 
To summarise, TrP referred pain arises in a situation where nociceptive input 
from the muscle is strong or long-lasting, (e.g. where ATrPs are present), 
leading to the induction of central sensitisation in dorsal horn neurons 
 35 
associated with pain transmission. Synapses in adjacent spinal cord 
segments that are usually ‘silent’ then become responsive to input from the 
affected muscle leading to an ‘expansion’ of the ‘target area’ of the muscle in 
the spinal cord or brain stem. Should the expansion reach sensory neurons 
that service peripheral areas other than the affected muscle, the patient 
perceives pain in those areas as well, even though no injury or damage has 
occurred in the structures of the new receptive field (Mense 2003). 
 
 
(d) TrP associated autonomic nervous system involvement 
 
Autonomic phenomena have been observed to develop as a result of TrP 
activity (Hong, C. Z. 2000; Simons, D., Travell & Simons 1999). and the 
alpha-adrenergic antagonists phentolamine and phenoxybenzamine have 
been shown to eliminate (Hubbard, D. 1996) or significantly decrease (Chen, 
J. T. et al. 1998) EMG spike activity recorded at active loci of TrPs as well as 
significantly reduce subjective reports of TrP-related pain, observations that 
confirm autonomic nervous system involvement. In other human studies 
(Chung, Ohrbach & McCall 2004; Hubbard, D. 1996; McNulty et al. 1994) 
sympathetic activity has been shown to modulate motor activity at TrPs 
(EMG activity). In addition, a recent study (Ge, Fernandez-de-Las-Penas & 
Arendt-Nielsen 2006) provided evidence of a sympathetic-sensory interaction 
at TrPs manifested as sympathetic hyperactivity to mechanical sensitisation 
and related sympathetic facilitation of the mechanisms underlying local and 
referred muscle pain. The authors found that elevating intrathoracic pressure, 
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(a manoeuvre known to increase sympathetic outflow to muscles) resulted in 
decreased pain thresholds and increased the perceived intensity of both local 
and referred pain at TrPs sites, phenomena which did not occur at control 
sites. These findings infer either local (rather than generalised sympathetic 
hyperactivity) or some form of differentiated sympathetic activation in the 
painful and non-painful muscles. Given their findings and the fact that 
referred pain is a central sensitisation process initiated by peripheral 
sensitisation (Mense 2004), Ge and colleagues (2006) suggested that 
sympathetic facilitation of referred pain may involve specific peripheral, spinal 
and supraspinal sensory and sympathetic structures and their interactions 
(Ge, Fernandez-de-Las-Penas & Arendt-Nielsen 2006). The mechanisms by 
which sympathetic activity might facilitate sensory sensitisation are unknown 
and the data that do exist have been described as controversial (Maekawa, 
Clark & Kuboki 2002). In any case, Ge and colleagues (2006) speculated that 
because elevated intrathoracic pressure induces sustained and pronounced 
sympathetic efferent activity to muscles, resultant increased vasoconstrictor 
activity might reduce blood flow to TrP-affected muscle fibres and lead to 
delayed clearance of inflammatory substances. The result is a changed 
biochemical milieu at the TrP site, one amenable to inducing referred pain 
and the subject of the following discussion. 
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2.1.5.2 The Biochemical Milieu of TrPs 
 
Local myofascial pain occurs because of the release of substances from 
damaged muscle such as adenosine triphosphate (ATP) (Reinohl et al. 
2003), bradykinin (BK), 5-hydroxytryptamine (5-HT or serotonin), 
prostaglandins (PGs) and potassium (K+) and because of an increase in 
protons (H+), causing local acidity, such as occurs with ischemia and 
exercise (Gerwin, RD, Dommerholt & Shah 2004) In groundbreaking work on 
TrPs, Shah and co-workers (2005) developed and tested a device to 
measure the biochemical milieu of muscle tissue in vivo. The measuring 
device consisted of an acupuncture needle with a hollow bore converting it 
into a microdialysis needle which could be used simultaneously as an 
acupuncture needle during routine treatment of TrPs. The investigators 
recruited three groups of subjects: control group (no pain and no TrPs, N=3); 
a LTrP group (no pain, but upper trapezius LTrPs, N=3) and an ATrP group 
(pain and upper trapezius ATrPs, N=3). Analytes were measured at three 
time points. A ‘pre’ level was measured two minutes after needle insertion but 
before needle advancement (used in the control group to simulate needle 
movement required to obtain a LTR) or eliciting an LTR for both TrP groups. 
The ‘peak’ values were measured at five minutes after needle insertion which 
was immediately after the needle advancement/LTR. The ‘post’ values were 
measured at 11 minutes after needle insertion, six minutes after the 
respective needle movements. The ATrP group had a lower pressure-pain 
threshold (PPT) than both LTrP and control groups, though this difference did 
not reach statistical significance (p<0.08). For all three time points combined, 
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the amounts of the pro-inflammatory cytokines: tumour necrosis factor-α 
(TNF-α), interleukin-1beta (IL-1β) and the pain-associated neuropeptides: 
bradykinin, calcitonin gene-related peptide (CGRP), substance P (SP), 5-
hydroxytryptamine (5-HT or serotonin) and norepinephrine were significantly 
higher in the ATrP group than the other two groups (p<0.01). At peak time, (5 
minutes after the start of data collection when the needle was advanced and 
both TrP groups demonstrated LTRs), peak values of CGRP and SP were 
significantly different in all three groups (active>latent>normal, p<0.02). In the 
ATrP group, the ‘post’ or recovery values (six minutes after LTR had been 
elicited) of CGRP and SP were significantly lower than the pre and peak 
values (p<0.02). While accepting potential limitations in the data collection 
procedure (such as using optimal flow rates for the collection of the analytes), 
the authors considered their most important finding to be the higher analyte 
levels and lower pH values for the ATrP group. In addition, the drop in 
analyte levels that followed the ‘peak’ values was greatest in the ATrP group, 
suggesting a greater treatment response due to chemical changes which 
they associated with the LTR. However, since there was also a decrease of 
analyte levels in the other two groups, they conceded that needle movement, 
whether it elicits an LTR or not, may cause similar chemical changes in the 
immediate vicinity. Importantly, the concentrations were higher in the ATrP 
group compared with both the LTrP and control groups from the first moment 
of data collection, which the authors suggested could be due to either an 
altered biochemical milieu associated with ATrPs, or an increased sensitivity 
of the tissue surrounding an ATrP to a mechanical stimulation like needle 
insertion. In addition, local tissue chemical concentrations are known to 
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fluctuate with variations in blood flow (Langberg et al. 2002). An area of 
increased oxygen saturation, (presumably associated with increased blood 
flow), surrounding a central area of hypoxia, (presumably related to 
ischemia), in the vicinity of TrPs has been demonstrated (Bruckle et al. 
1990). This finding resulted in the ‘working hypothesis’ that TrPs are 
associated with increased metabolic demand and a decreased ability to 
support those demands, both concepts implying that ATrPs may induce 
different blood flow patterns which in turn may alter membrane recovery 
properties or interstitial chemical concentrations.  
 
Since a number of pain and inflammatory mediators have been found at TrP 
sites, it is important to consider what each may contribute to the 
pathophysiology of the TrP. However, it is also important to note that the 
nature of the relationships between these mediators and MTrPs though likely, 
is speculative, since much of the discussion is based upon the findings of 
Shah and colleagues (2005), which though a well designed study, was based 
upon a small subject pool (N=9). 
 
 
(a) Local tissue pH 
 
Hyperalgesia secondary to mechanical stimulation of muscle arises when the 
dorsal horn has been bombarded with persistent nociceptive input from 
peripheral afferents, (such as is presumed to result when ATrPs are present) 
and is maintained by neuroplastic changes in the CNS, even after the 
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cessation of nociceptor activity (Sluka, Kalra & Moore 2001). Sluka and 
colleagues (2001) used an animal model of persistent mechanical 
hyperalgesia induced by repeated intramuscular injections of low pH saline at 
levels similar to those seen with tissue inflammation, muscle pain, 
fibromyalgia and eccentric and maximal concentric exercise, and found that 
an acidic milieu, in the absence of muscle damage, appeared sufficient to 
cause significant changes in the properties of nociceptors, associated 
afferent fibers and dorsal horn neurons. An acidic pH is well known to 
stimulate the production of bradykinin (also found at ATrP sites) during local 
ischemia and inflammation (Gerwin, RD, Dommerholt & Shah 2004) and may 
contribute to an explanation for the occurrence of secondary mechanical 
hyperalgesia in patients with ATrPs, since lower pH values and secondary 
mechanical hyperalgesia both appear to characterise ATrPs (Gerwin, RD, 
Dommerholt & Shah 2004; Shah, J. P. et al. 2005).  
 
 
(b) Pain-associated neuropeptides: 
 
(i) Calcitonin gene-related peptide (CGRP) and Substance P (SP) 
 
Calcitonin gene-related peptide (CGRP) co-exists with ACh at the alpha 
motoneuron (α-motoneuron) terminals and acts as a facilitator of ACh 
release into the synaptic cleft (Mense et al. 2003) It is released when the 
motor nerve is stimulated or when ACh accumulates, as may occur when 
acetylcholinesterase (AChE) secretion is inhibited (Mense et al. 2003). 
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Generally speaking, CGRP is known to be a vasodilator, an augmenter of 
autonomic and immunologic functions and a modulator of neurotransmission 
at central and peripheral synapses (Gerwin, RD, Dommerholt & Shah 2004). 
Importantly, in relationship to TrPs, by increasing the number of surface 
acetylcholine receptors (AChRs) on the muscle cell membrane near the 
motor endplate (Fernandez et al. 2003) and by inhibiting AChE activity at the 
neuromuscular junction (Hodges-Savola & Fernandez 1995), it has been 
hypothesised that CGRP increases the relative concentration of ACh at the 
motor endplate, ultimately resulting in an increased frequency of miniature 
endplate potentials or endplate noise (EPN), followed by sarcomere 
contraction and the formation of a taut band of skeletal muscle (Gerwin, RD, 
Dommerholt & Shah 2004) characteristic of all TrPs (see Gerwin et al. (2004) 
for comprehensive review). 
 
According to Shah and colleagues (2005), SP and CGRP are produced in the 
dorsal root ganglion (DRG) cells and over 90 percent of these chemicals are 
transported antidromically to the sensory endings, allowing a constant basal 
release from the nociceptor to its local milieu (Yaksh 1995). This basal 
release of SP and CGRP is greatly increased in response to nociceptor 
activation caused by sensitising agents, such as occurs when H+ and BK 
bind to their receptors on the nociceptor. This results in “bursts” of SP and 
CGRP release into the muscle where they have a profound effect on the local 
biochemical milieu and microcirculation by stimulating a continuous cycle of 
increasing production of inflammatory mediators and neuropeptides, leading 
to an increasing barrage of nociceptive input to dorsal horn neurons 
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associated with pain transmission (Gerwin, RD, Dommerholt & Shah 2004). 
Some orthodromic transport of small amounts of SP are also conveyed from 
the dorsal root ganglion to the dorsal horn cells, a process that contributes to 
neuroplastic changes in the dorsal horn which are amplified with prolonged 
nociceptor activation, ultimately affecting neuronal activity and the perception 
of pain (Shah, J. P. et al. 2005). Recall that Shah and colleagues (2005) 
found significantly elevated levels of SP and CGRP in the vicinity of active 
and latent (ATrPs > LTrPs) TrPs and that SP and CGRP levels decreased 
significantly after the LTR was elicited in the ATrPs. They suggested this 
decrease in SP and CGRP concentrations might be due to an “interference 
with nociceptor membrane channels” or “transport mechanisms that are 
associated with an augmented inflammatory response”. In addition, the post 
LTR decrease in SP and CGRP concentrations may occur relative to a local 
increase in blood flow (Shah, J. P. et al. 2005). Both of these findings provide 
insight into the potential mechanisms underlying the symptomatic relief that 
follows TrP treatments that have the capacity to elicit LTRs or increase local 
blood supply. 
 
 
(ii) Bradykinin (BK) 
 
Muscle cell local ischemia, resulting in local hypoxia and associated with a 
local acidic pH, is known to stimulate the production of BK in muscle cells 
(Shah, J. P. et al. 2005; Sluka, Kalra & Moore 2001) which results in first 
activating, then sensitising muscle nociceptors (Baldry, PE 2001). Shah and 
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co-workers (2005) found significantly greater BK concentrations in the ATrP 
group compared with subjects with LTrPs or no TrPs (p<0.01), which might 
be expected given that ATrPs are spontaneously painful suggesting that 
nociceptors have been sensitised and patients therefore are aware of pain. 
Given that LTrPs are painless except when directly compressed, this 
suggests that nociceptors associated with LTrPs have been activated by 
lower levels of BK and therefore will react to direct mechanical stimulation of 
those nociceptors. With continued or increased exposure to BK or other 
endogenous nociceptor stimulating compounds, nociceptors may become 
sensitised and cause spontaneous pain, presumably converting a LTrP to an 
ATrP. 
 
(iii) Serotonin and norepinephrine 
 
According to Shah and colleagues (2005), SP causes mast cell 
degranulation, with resultant release of serotonin and histamine and the up-
regulation of pro-inflammatory cytokines, including TNF-α, which in turn, 
stimulates the production of norepinephrine (noradrenalin), a process which 
may explain the significantly elevated levels of serotonin and noradrenalin 
that were found in ATrP subjects (Shah, J. P. et al. 2005). Since increased 
levels of noradrenalin are likely associated with increased sympathetic 
activity in the motor endplate region and increased sympathetic activity has 
also been associated with ATrPs (Chen, J. T. et al. 1998; Ge, Fernandez-de-
Las-Penas & Arendt-Nielsen 2006), Shah’s group hypothesised that 
noradrenaline-mediated increased sympathetic activity may reduce the 
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mechanical threshold to elicit an LTR, a finding reported by Shah’s group in 
subjects with ATrPs. 
 
 
(c) Pro-Inflammatory cytokines:  
 
(i) Tumour necrosis factor-alpha (TNF-α) and Interleukin-1beta (IL-1β) 
 
Tumour necrosis factor-alpha and IL-1β were significantly elevated in ATrP 
subjects in Shah’s study (2005). In vivo and in vitro serological studies of 
peripheral blood and CNS assays have shown TNF-α to be critically involved 
in the pathogenesis of pain states (Myers, R., Wagner & Sorkin 1999). In 
animal models, local administration of TNF-α evoked spontaneous 
electrophysiological activity in afferent C and A-delta nerve fibers, resulting in 
low grade nociceptive input which contributed to central sensitisation in the 
dorsal horn. This electrophysiological activity was reduced when anti-TNF-α 
was administered to these animals (Myers, R., Wagner & Sorkin 1999). 
Tumour necrosis factor-alpha has also been shown to cause hyperalgesia 
several hours after injection in rat muscles that was reversed by systemic 
administration of a non-opioid analgesic, metamizol, indicating that TNF-α is 
associated with hyperalgesia in an animal model (Schafers, Sorkin & 
Sommer 2003). Additionally, TNF-α did not cause histopathological evidence 
of tissue damage nor motor dysfunction, however one day after injection, 
TNF-α did cause elevated levels of CGRP, nerve growth factor (NGF) and 
prostaglandin E2 (PGE2) in the muscle, potentially influencing the ability of 
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the muscle to develop a taut band (due to the effects of increased CGRP) or 
nociceptive pain. 
 
In summary, TNF-α is increased in ATrPs and is capable of inducing ongoing 
nociceptive activity onto dorsal horn cells, acting as one of the drivers for 
central sensitisation and expansion of the receptive field, resulting in referred 
pain, spontaneous activity of dorsal horn transmission cells and an increased 
magnitude of response from these cells to nociceptive input. These findings 
suggest that TNF-α and pro-inflammatory cytokines such as IL-1β may play a 
role in the development of muscle hyperalgesia and directing treatment at 
pro-inflammatory cytokines may therefore be beneficial for the treatment of 
ATrPs (Schafers, Sorkin & Sommer 2003). 
 
A link between the presence of ATrPs and the development of a chronic 
musculoskeletal pain state has not been specifically studied in a controlled 
environment, however, local muscle pain is known to be associated with the 
activation of muscle nociceptors by a variety of endogenous substances 
including neuropeptides, prostaglandins and inflammatory mediators (Mense 
& Simons 2001) as previously discussed. Nociceptive receptors in muscle 
display a host of different receptor molecules in their membranes, including 
receptors for BK, 5-HT, H+ and prostaglandins that are released from 
damaged tissues. These biochemicals bind with their receptors on 
nociceptors bringing the membrane closer to threshold for an action potential. 
Once summation is sufficient, action potentials result, leading to local muscle 
pain and tenderness (Mense & Simons 2001). Because BK, 5-HT and H+ 
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lower the usually high threshold for stimulation of the muscle nociceptors, the 
activated muscle nociceptors are then more easily sensitised and begin 
responding to otherwise innocuous, weak stimuli such as light pressure and 
muscle movement (Shah, J. P. et al. 2005). The continued presence of such 
biochemicals may therefore underpin the mechanisms that perpetuate TrP 
pain.  
 
The following section provides an overview of the most current theory of the 
pathogenesis of TrPs, which brings together much of the biochemical and 
electrophysiological findings just discussed. 
 
 
2.1.6 The Integrated Trigger Point Hypothesis 
 
The following proposition is the work of Simons and colleagues (1999) and 
has been referred to as the “Integrated Trigger Point Hypothesis” and 
represents an amalgamation of information from electrophysiological and 
histopathological studies in an attempt to clarify the pathophysiology of TrPs. 
Simons (1999) first postulated that an ‘energy crisis’ occurred in local muscle 
tissue when energy requirements, due to persistent levels of increased 
muscle fiber tension, exceeded supply. In an effort to explain both the origin 
of the energy crisis and the absence of motor unit action potentials in the 
palpable taut band of a TrP in resting muscle, it was postulated that an 
increase of calcium ions (Ca2+) occurred independently of depolarization 
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stimulated sarcoplasmic reticulum (SR) release. Though damage to either 
the SR itself or to the muscle cell membrane (sarcolemma) could expose 
local actin and myosin filaments to a sufficient increase in Ca2+ to initiate 
contractile activity, repair processes could be expected to rapidly respond to 
such a phenomenon. However, in the case of the taut bands of TrPs, which 
are electrically silent, it appeared likely that the sustained contractile activity 
was associated with abnormal depolarisation of the exposed part of the post-
synaptic membrane due to continued non-quantal release of ACh from 
dysfunctional motor nerve terminals. This phenomenon could then account 
for the contracture of sarcomeres in the vicinity of the motor endplate 
persisting indefinitely without motor unit action potentials. It then follows that 
ongoing contractile activity of the sacromeres markedly increases the 
metabolic demands of this tissue and the shortening of the filaments 
compresses the local network of capillaries compromising tissue metabolism 
which has been shown to fail when contractile activity reaches 30% to 50% of 
maximal effort, if the contraction is sustained. The result of this combination 
of events is a localised but critical energy crisis. Removing excessive Ca2+ 
from the muscles fibers should, under normal circumstances, reverse the 
effect in a short period of time, however, since the Ca2+ pump responsible for 
returning excess Ca2+ to the SR, is dependent upon an adequate supply of 
ATP and also appears to have increased sensitivity to low ATP levels relative 
to the contractile mechanism itself, impaired uptake of Ca2+ associated with 
the effects of the energy crisis further exposes the contractile elements to 
continued high concentrations of Ca2+ and continued contractile activity – 
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completing a vicious cycle (Simons, D., Travell & Simons 1999). The process 
is summarised in Figure 2.2. 
 
 
Figure 2.2: The development and perpetuation of the ‘energy crisis’ 
component of Simons’ Integrated TrP Hypothesis. Adapted from 
Simons et al. (1999, p. 71). 
 
Taking the hypothesis further, Simons concluded that the tissue energy crisis 
(incorporating severe local hypoxia) might be associated with the release of 
vasoreactive and nociceptor sensitising substances such as H+, bradykinin, 
CGRP, SP, TNF-α, IL-1β, serotonin and noradrenalin, thus resulting in 
nociceptive and autonomic sensory afferent input to the dorsal horn, as 
depicted in Figure 2.3 taken from Simons (2004a).  
Abnormal ACh release in 
presence of Ca2+ from SR 
↑ sarcomere shortening 
and muscle fiber tension ⇒ 
↑ metabolic needs 
Taut band development 
(clinical sign of TrP) 
Local hypoxia due to 
compression of local 
circulation 
Energy Crisis 
caused by local ischemia + ↑ 
local metabolism (depletion 
of ATP to remove excess 
Ca2+) 
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Figure 2.3: Flow diagram of Simons’ integrated hypothesis. The 
numbers indicate a possible order, though the cyclic nature of the 
relationship between events has been noted. Reproduced from Simons 
(2004a). 
 
Another hypothesis to explain the pathogenesis of TrPs that combined the 
experimental findings of the motor and sensory phenomena associated with 
TrPs was published by Hong and Simons (1998). Figure 2.4 provides their 
schematic of the TrP which they described as multiple active loci in a TrP 
region from which EPN could be recorded. This low amplitude, continuous 
electrical activity was said to be caused by increased concentrations of ACh 
at dysfunctional motor endplates which contributed to a focal contracture of 
local sarcomeres, the precursor to the formation of a taut band. They stated 
1. Abnormal 
ACh release 
2. ↑ muscle 
fiber tension 
3. Taut band 
3. Local 
hypoxia  
4. Local tissue 
distress 
SR 
dysfunction 
5. Pain sensitising 
substances 
Pain 
6. Autonomic 
modulation 
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that a TrP region and its surrounding muscle tissue also contained many 
sensitive loci, which were in fact sensitised nociceptors from which local pain, 
referred pain and LTRs could be elicited when adequately stimulated (Hong, 
C. Z. 2004). 
 
Figure 2.4: Schematic of the motor and sensory components of a 
myofascial TrP. Reproduced from Hong and Simons (1998). 
 
2.1.7 An expansion of the Simons’ Integrated Hypothesis 
 
In an extensive discussion incorporating recent and related studies, with the 
intent of expanding on Simons’ “Integrated Hypothesis”, Gerwin and 
colleagues (2004) concluded that in healthy muscle there exists an 
equilibrium between the release, breakdown and removal of ACh from its 
receptors (AChRs) in the post-synaptic membrane by acetylcholinesterase 
(AChE) that is disturbed by muscle injury. In injured muscle, there is a 
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release of substances that activate muscle nociceptors causing pain but also 
facilitating ACh release, inhibiting ACh breakdown and removal from the 
AChRs and up-regulating AChRs. These changes could then result in an 
ongoing increased binding of ACh to the muscle cell membrane, leading to 
the development of persistent sarcomere contraction, as is characteristic of 
the myofascial TrP. The authors (Gerwin, RD, Dommerholt & Shah 2004) 
hypothesised that the activating event in the development of TrPs was the 
execution of either unaccustomed eccentric exercise or maximal concentric 
exercise all of which can lead to muscle fiber damage and to segmental 
hypercontraction within the muscle fiber. The resulting hypoperfusion 
(caused by capillary constriction), might then increase the damage caused by 
continuation of the exercise, exacerbated by increased capillary constriction 
through sympathetic nervous system adrenergic activity. The resultant 
ischemia and hypoxia then add to the development of tissue injury with a 
resultant local acidic pH which in turn inhibits AChE activity, increases 
release of CGRP and activates acid sensing ion channels (ASICs) on muscle 
nociceptors as previously discussed. An acidic pH, whether induced 
experimentally (Sluka, Kalra & Moore 2001), or resulting from inflammation, 
or muscle overload through exercise, is sufficient by itself to cause 
widespread changes in the properties of nociceptors, axons and dorsal horn 
neurons. In addition, any breakdown of muscle fibers (that might result from 
exercise), results in the release of pro-inflammatory mediators such as SP, 
CGRP, BK, 5-HT and cytokines (TNF-α and IL-1β) that can profoundly alter 
the functioning of the motor endplate and the sensitivity and activity of 
muscle nociceptors as well as wide dynamic range neurons in the spinal 
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cord. Increased availability of ACh, caused by several factors (increased 
release of ACh mediated by CGRP; increased pre-synaptic motor terminal 
adrenergic receptor activity; inhibition of AChE caused by CGRP; up-
regulation of AChRs through the action of CGRP, acidic pH), leads to 
increased motor endplate activity. In their scenario (Gerwin, RD, Dommerholt 
& Shah 2004), the taut band then results from the increase in ACh activity. 
With regard to sensory changes associated with TrPs the model implicates 
alterations in miniature endplate potential frequency, or EPN, which is 
increased as a result of greater ACh effect. Release of BK, K+, H+ and 
cytokines from injured muscle, activate nociceptors, thereby causing 
tenderness and pain. The presence of CGRP compels the system to become 
chronic, potentiating the motor endplate response and, along with SP, 
potentiates the activation of muscle nociceptors. The combination of acidic 
pH and pro-inflammatory mediators at the ATrP contributes to segmental 
spread of nociceptive input into the dorsal horn and leads to the expansion of 
multiple receptive fields. These neuroplastic changes in dorsal horn neurons 
occur in response to a continuous nociceptive barrage, with further activation 
of neighbouring and regional dorsal horn neurons that now have lower 
activation thresholds. This results in the observed phenomena of 
hypersensitivity, allodynia and referred pain that is characteristic of ATrPs 
(Gerwin, RD, Dommerholt & Shah 2004) (see Figure 2.5, reproduced from 
Gerwin, Dommerholt and Shah (2004)). 
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Figure 2.5: A schematic outline of the expanded TrP hypothesis. (ACh-
acetylcholine, AChE-acetylchonlinesterase, AChR-acetylcholine receptors, 
ATP-adenosine triphosphate, CGRP-calcitonin gene-related peptide, H+-
protons, K+-potassium, MEPP-miniature endplate potential, SP-substance P) 
Reproduced from Gerwin et al. (2004). 
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To clarify, the figure illustrates the following steps in the model put forward by 
Gerwin and colleagues (2004): the activating event is muscle activity that 
stresses muscle beyond its tolerance and leads to muscle injury and capillary 
constriction. Muscle injury results in release of substances that activate 
muscle nociceptors and causes pain. Capillary constriction occurs as a result 
of both muscle contraction and sympathetic nervous system activation 
resulting in hypofusion and ischemia. The local pH becomes acidic, inhibiting 
AChE activity. CGRP is released from the motor nerve terminal and from 
injured muscle. CGRP inhibits AChE, facilitates ACh release and up-
regulates AChRs. The end result is increased ACh activity with increased 
frequency of miniature endplate potentials (MEPPs), sarcomere 
hypercontraction and the formation of taut bands. The highlighted boxes 
indicate those events that have been identified or are supported by 
microdialysis studies of the TrP. (Gerwin, RD, Dommerholt & Shah 2004).  
 
Now that the potential mechanisms of TrP pathology have been highlighted, 
the ability to accurately identify them in both clinical and research settings, (a 
critical factor in assessing, treating or researching TrPs effectively), will be 
discussed. 
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2.1.8 The identification of TrPs and the reliability of the examination  
process 
 
Where the patient history suggests TrP-mediated symptoms, the ability to 
identify the appropriate clinical signs is obviously of great importance, since 
no imaging or laboratory tests exist to diagnose them (Borg-Stein & Simons 
2002). In addition, there are no official clinical diagnostic criteria for their 
identification, although a number of authors have suggested that the minimal 
criteria are “spot tenderness”, ‘’pain recognition” and a “taut band”. 
Confirmatory signs include eliciting referred pain and local twitch responses 
(LTRs) (Gerwin, R. D. et al. 1997; Simons, D. G. 2004a). 
 
Attempts have been made to objectify the identification process. An early 
pioneer in this area, Fischer (Fischer, AA 1987b, 1987a; Fischer, A. 1988; 
Fischer, L. 1999; Kraus & Fischer 1991), validated the use of a pressure 
algometer as a reliable and useful tool for measuring the pressure-pain 
threshold (PPT) of TrPs and compared them to the PPT of normal muscle 
tissue and thus defined the PPT as the minimum pressure causing a pain 
response (Fischer, A. 1988; Hanten, W. et al. 2000; Reeves, Jaeger & Graff-
Radford 1986). Reeves and co-workers (1986) conducted three small studies 
and concluded that pressure algometry measurements were reliable in 
measuring the PPT of TrPs reporting good to excellent intra- and inter-
examiner reliability ((r=0.69-0.97, N=15) and (r=0.71-0.89, N=15)) 
respectively. In their work, the validity of measuring the PPT of TrPs was 
demonstrated by discriminating between TrPs and adjacent, non-TrP muscle 
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tissue. In a related study, dealing with PPTs and associated referred pain, 
Hong and colleagues (1997) found that when no limit was placed on the 
amount of pressure used by examiners, referred pain could be elicited not 
only from sensitive loci within ATrPs, but also from the taut band and normal 
muscle tissue (Hong, C. Z. et al. 1997). Together, these results suggest that 
using PPTs to standardise the pressure under which a lesion responds with 
pain may decrease the likelihood of obtaining false positives when examining 
for the presence of TrPs. Many studies (Edwards & Knowles 2003; 
Fernandez-de-Las-Penas, C et al. 2003; Ge, Fernandez-de-Las-Penas & 
Arendt-Nielsen 2006; Hong, C-Z. 1998; Hou, C. R. et al. 2002; Kamanli et al. 
2005; Sciotti et al. 2001; Simons, D. G. 1988, 2004b) have since used 
algometers to measure PPTs of TrPs to contribute to the identification 
process and also to measure any changes post-intervention.  
 
Another approach to the problem of reliable TrP identification has been the 
use of thermography. While early results showed promise (Diakow 1988, 
1992; Kruse & Christiansen 1992), Swerdlow and Dieter (1992), soon 
showed that thermographic ‘hot spots’ often observed in the upper back were 
not ATrPs, thereby casting doubt on thermographic techniques for TrP 
identification (Swerdlow & Dieter 1992). In still another approach, Sciotti and 
colleagues (2001) specifically focused on the precision with which four 
trained clinicians could locate LTrPs in the upper trapezius muscle of 10 
subjects, as opposed to measuring the inter-examiner reliability of identifying 
the clinical signs of a TrP (for example taut band, tender point, LTR etc). 
Using a three-dimensional camera system they found this system a valid tool 
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for measuring the location of LTrPs in the upper trapezius to a similar level of 
precision as the most commonly used locating methods – the clinicians’ 
fingers.  
 
In terms of the clinical signs of TrPs: spot tenderness, jump sign (where the 
patient ‘jumps’ or moves because of pain caused by compressing the TrP), 
pain recognition, taut band, referred pain and LTR, a number of authors have 
carried out studies of inter-examiner reliability calculating and reporting the 
resultant Kappa statistics (Gerwin, R. D. et al. 1997; Hsieh et al. 2000; Nice 
et al. 1992; Njoo & Van der Does 1994; Wolfe et al. 1992)). Table 2.1 
adapted from Simons and colleagues (1999, p. 32), summarises the 
available Kappa values for each clinical sign.  
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Table 2.1: Kappa values for inter-examiner reliability of examinations 
for TrP characteristics.  
Examination 
for clinical 
sign 
Wolf et 
al. 1992 
Nice et 
al. 1992 
Njoo et 
al. 1994 
Gerwin 
et al. 
1997 
Hsieh et al. 
2000 (best 
of 2 
studies) 
Mean 
Spot 
tenderness 
0.61  0.66 0.84  0.70 
Jump sign   0.70   0.70 
Pain 
recognition 
0.30  0.58 0.88  0.59 
Taut band 0.29  0.49 0.85 0.22 0.46 
Referred 
pain 
0.40 0.38 0.41 0.69 0.34 0.44 
LTR 0.16  0.09 0.44 0.12 0.19 
Mean 0.35 0.38 0.49 0.74 0.23  
 
As can be seen, inter-examiner reliability varied with the different clinical 
signs with the most consistent results found with spot tenderness, jump sign 
and pain recognition, then locating a taut band and eliciting referred pain, 
with the least agreement between examiners found for the LTR. In 
agreement, Simons and colleagues (1999) rated the difficulty of identifying 
each clinical sign from easiest to most difficult as follows: spot tenderness 
and jump sign < pain recognition < taut band and referred pain, with eliciting 
an LTR being the most difficult (Table 2.2) (Simons, D. 1997). The same 
author estimated the diagnostic value of each sign (regardless of examiner 
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agreement or ease of examination), from least to most valuable as: jump 
sign, referred pain and spot tenderness < taut band < pain recognition < LTR, 
though conceding that successful identification was dependent upon the 
degree of “palpatory access” to the muscle. Simons and colleagues (1999) 
also suggested that the combination of spot tenderness within a palpable taut 
band identified by a skilled examiner, was likely to be ‘highly diagnostic’ of a 
TrP. 
 
Table 2.2: Comparative reliability of diagnostic examination for TrPs, 
including estimates of relative difficulty of performing the examinations 
and estimated relative diagnostic value of each examination by itself 
regardless of other findings. Reproduced from Simons et al. (1999), p. 
33. 
 No of Studies Mean Kappa Difficulty Diagnostic 
value alone 
Jump sign 1 0.70 + + 
Spot 
tenderness 
3 0.70 + + 
Pain 
recognition 
3 0.59 ++ +++ 
Taut band 4 0.46 +++ ++ 
Referred pain 5 0.44 +++ + 
LTR 4 0.19 ++++ ++++ 
One ‘+’ = easiest to identify or least diagnostic value. Multiple “++++” = most 
difficult to identify or greatest diagnostic value. 
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In the light of multiple reliability studies (Lew, Lewis & Story 1997; Nice et al. 
1992; Njoo & Van der Does 1994; Wolfe et al. 1992) (as referred to above) 
that have found poor inter-examiner reliability in identifying TrPs, a number of 
authors either stated (Gerwin, R. D. et al. 1997; Sciotti et al. 2001) or 
suggested (Lew, Lewis & Story 1997) that the accurate identification of TrPs 
relied heavily upon effective palpation skills and specific knowledge of 
musculoskeletal structure and function and was therefore an individual skill 
that might be trainable. However, in the most recent inter-examiner reliability 
study located, Hsieh and colleagues (2000) found that the reliability for 
identifying the clinical signs of TrPs (palpating a taut band, eliciting referred 
pain and LTRs) in muscles associated with low back pain in 52 subjects (26 
asymptomatic and 26 subacute low back pain) was no different between 
trained and untrained clinicians (Hsieh et al. 2000), a finding contrasting with 
those of Gerwin’s group (Gerwin, R. D. et al. 1997). It has been suggested 
that this discrepancy may in part be explained by the different anatomical 
regions and patient populations studied by the two groups (Sciotti et al. 
2001). 
 
Only one study was identified that investigated the intra-examiner reliability of 
identifying the clinical signs of TrPs in the rotator cuff muscles (one muscle 
group under investigation in the current work). In 51 patients diagnosed with 
rotator cuff tendinitis (Al-Shenqiti & Oldham 2005), Al-Shenqiti and Oldham 
(2005) used a test-retest protocol over three days, and found that the same 
examiner reliably identified the presence or absence of the taut band, spot 
tenderness and pain recognition, but had more variable success with referred 
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pain and LTRs (Table 2.3), suggesting the former clinical signs were more 
reliable than the latter in identifying TrPs. 
 
 
Table 2.3: Kappa statistics for intra-examiner reliability of the 
identification of clinical signs of TrPs in the rotator cuff muscles of 51 
patients with rotator cuff tendonitis, extracted from the results of Al-
Shenqiti and Oldham (2005). 
Examination for clinical sign Al-Shenqiti and Oldham 2005 
Spot tenderness 1 
Jump sign 1 
Pain recognition 1 
Taut band 1 
Referred pain 0.79-0.88 
LTR 0.75-1 
Mean 0.92-0.98 
 
 
As previously stated, Gerwin and colleagues (1997) listed the minimal criteria 
for ATrP identification as ‘spot tenderness’, ‘pain recognition’ and a ‘taut 
band’, with confirmatory signs including ‘referred pain’ and ‘LTR’. However, 
the ability to elicit or recognize a LTR has consistently been found to have 
poor inter-examiner agreement suggesting its utility is dependent upon 
palpatory access to the muscle fibers being examined and the skill and 
experience of the examiner. Notwithstanding, the LTR has been identified as 
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the most reliable sign of TrP presence (Shah, J P 2003; Simons, D. 1997), 
and has also been linked with effective treatment (Hong, C. Z. 1994b; Shah, 
J P 2003) (see also pages.19-21 and 28-31), hence, the ability to effectively 
stimulate a TrP to elicit LTRs, either by palpation or needling, is a clinical skill 
of utmost importance for the successful management of myofascial TrPs.  
 
Two studies have investigated aspects of TrP identification in asymptomatic 
subjects alone. In the first, Lew and colleagues (1997) used two experienced 
clinicians to identify the location of LTrPs in the upper trapezius muscles of 
58 volunteers and mark their locations on an enlarged body diagram. These 
authors did not report Kappa statistics because of limitations in their data, but 
reported that both examiners showed complete agreement on the LTrP 
location in two subjects (3.85% of those subjects with LTrPs) and both 
identified the same six subjects who had no LTrPs in the upper trapezius 
(Lew, Lewis & Story 1997), implying that inter-examiner agreement for 
locating LTrPs in this muscle was poor. Sciotti and co-workers (2001) also 
published results pertaining to the inter-examiner reliability of precisely 
locating LTrPs in the upper trapezius of 20 healthy subjects using a highly 
sensitive and specific three-dimensional camera analysis system. They used 
a coordinate system to record the positions of LTrPs in the upper trapezius in 
three planes as they were identified by two trained examiners and reported 
that their ability to reliably localise them essentially approached a precision 
limited only by the physical dimensions of the clinician's own fingertips. The 
same authors also suggested that the clinical characteristics of a LTrP might 
be somewhat different to those of an ATrP, particularly with regard to the 
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better inter-examiner reliability of identifying the taut band of the LTrP, a 
suggestion they based upon earlier work that found lower kappa values for 
identification of the taut band in ATrPs (Gerwin, R. D. et al. 1997; Wolfe et al. 
1992). In support of this contention, Hsieh and colleagues (2000) found that 
the ‘expert examiner’ in their study was able to identify a taut band in 70% of 
10 muscles in 26 healthy subjects, a finding that also supported the idea that 
the taut band may have greater reliability as a clinical sign for LTrPs than for 
ATrPs. In addition, because LTrPs are pain-free unless stimulated by digital 
compression or needle insertion, the ‘pain recognition’ criterion for TrP 
recognition would seem to be more appropriately defined as the presence of 
local and/or referred pain in response to stimulation. Finally, because LTrPs 
are also likely to produce less marked examination findings than ATrPs 
(Simons, D. G. 2004a), the criteria of ‘a tender nodule within a taut band that 
elicits pain upon compression’ are all that are required to identify the less 
irritable LTrPs.  
 
Considering that the focus of the present study, it is important to gain some 
insight into how commonly TrPs occur. The following section provides 
information on the prevalence of TrPs in general followed by an introduction 
to the prevalence of LTrPs in particular. The available information on LTrPs is 
fleshed out in Chapter three which presents an investigation of the topic. 
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2.1.9 The prevalence of TrPs  
 
The information under this heading has also been presented at the beginning 
of Chapter Three which presents a study of the occurrence of LTrPs in the 
scapular rotator muscles (page 119). Its duplication here is in the interests of 
continuity through the literature review and for the reader’s convenience. 
 
There have been no large epidemiological studies specifically examining the 
prevalence of TrPs (Baldry, PE 2001), although anecdotal evidence from 
experienced examiners implies that pain caused by TrPs is a very common 
phenomenon (Huguenin, LK 2004; McCain 1994), particularly after trauma or 
sustained muscular fatigue. In support of this view, Rashiq and Galer (Rashiq 
& Galer 1999) found that 70 percent of 41 patients diagnosed with Complex 
Regional Pain Syndrome had TrPs in the proximal musculature of the upper 
limb. Other studies have reported TrPs as a source of pain in 50 percent of 
patients with temporomandibular disorders (Schiffman et al. 1990), 54 
percent of patients presenting with head and neck pain (Fricton et al. 1985) 
and 30 percent of patients presenting with pain (unspecified) to a university 
medical centre (Skootsky, Jaeger & Oye 1989). An average of 3.9 TrPs was 
found in the upper trapezius, sternoocleidomastoid and temporalis muscles 
of 25 patients with chronic tension type headache (Fernandez-de-Las-Penas, 
C et al. 2006) and a mean of 4.3 in the upper trapezius, sternocleidomastoid 
and levator scapulae muscles of 20 patients with mechanical neck pain 
(Fernandez-de-Las-Penas, C., Alonso-Blanco & Miangolarra 2006) Although 
the examination and reporting procedures used to identify TrPs were not 
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uniform, making comparisons difficult, these studies lend support to the 
notion that pain due to TrPs is common in patients with a variety of pain 
complaints. While circumstantial evidence is mounting to support the idea 
that myofascial TrPs (ATrP and LTrP) are prevalent in those suffering from 
musculoskeletal pain, some clinicians have suggested that the prevalence of 
LTrPs in healthy individuals is even higher (Simons, D., Travell & Simons 
1999), or even innately normal (Hong, C. Z. 2004). However, a paucity of 
experimental data are available to support this idea. In an earlier study, Sola 
and co-workers (1955) investigated what they described as the occurrence of 
“hypersensitive spots” in the posterior shoulder muscles of 200 healthy, 
young military recruits (Sola, Rodenberger & Gettys 1955). It was later 
suggested by Simons and colleagues (Simons, D. 1997; Simons, D., Travell 
& Simons 1999), that the “hypersensitive spots” identified in 50 percent of 
this sample were probably LTrPs. The only other information concerning the 
occurrence of LTrPs in healthy, pain-free subjects comes from studies that 
have used control subjects for comparison with patient populations. For 
example, as mentioned in the previous paragraph Fernandez-de-Las-Penas 
and colleagues (2006) conducted two studies that reported the numbers of 
LTrPs in healthy controls, one in relation to patients with chronic tension type 
headache (Fernandez-de-Las-Penas, C et al. 2006) and the second looking 
at patients with a mechanical cause of neck pain (Fernandez-de-Las-Penas, 
C., Alonso-Blanco & Miangolarra 2006). In the first they found an average of 
2.0 LTrPs in the upper trapezius, sternoocleidomastoid and temporalis 
muscles of 20 healthy subjects and 1.4 LTrPs in the upper trapezius, 
sternocleidomastoid and levator scapulae muscles of 25 healthy subjects 
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(Fernandez-de-Las-Penas, C et al. 2006) in the other. In general, it may be 
concluded that the available evidence supports the notion that TrPs are a 
common phenomenon, though the case for LTrPs is less convincing. This 
situation provided the rationale for the study on LTrP prevalence reported in 
Chapter three of the present work.  
 
The next section provides information pertaining to the treatment of TrPs, 
which formed part of the basis upon which the effects LTrPs on MAPs in the 
shoulder girdle muscles could be confirmed, (Chapter five).  
 
 
2.1.10  Treatment of Myofascial TrPs 
 
It has been suggested that ice, heat, ultrasound and massage are used in the 
treatment of TrPs because these modalities might achieve temporary relief of 
TrP-mediated pain (Fernandez-de-Las-Penas, C et al. 2003). Unfortunately, 
to date, there have been no controlled studies that support this proposition 
(Hanten, W. et al. 2000). Treatments such as dry needling or injection with 
lidocaine (Hong, C. Z. 1994b; Kamanli et al. 2005) or botulinum toxin A 
(Kamanli et al. 2005), spray (with vapocoolant) and stretch (Jaeger & Reeves 
1986), transcutaneous electrical nerve stimulation (TENS) (Graff-Radford et 
al. 1989) and post-isometric relaxation (Lewit & Simons 1984) have all been 
investigated for their effectiveness in resolving TrP pain (measured with 
visual analogue scales - VAS) and/or altering pressure-pain thresholds 
(PPTs), most often by taking pre and post pain measurements for 
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comparison. However, these studies had no control groups. Interestingly, 
Baldry (2002) reported that various dry needling techniques, injections of 
analgesics and the spray and stretch technique were the most commonly 
reported forms of TrP treatment in the medical literature (Baldry, P. 2002b).  
 
Therapeutic interventions used to treat TrPs can be divided into three 
categories: 
(i) Manual therapies; including ischemic compression, spray and stretch, 
strain and counterstrain, muscle ‘energy techniques’, trigger point 
pressure release and transverse friction massage. 
(ii) Needling therapies; dry needling (superficial and deep), injections 
(analgesics, corticosteroids, Botox A, vitamin B12). 
(iii) Other techniques; thermotherapy, transcutaneous electrical nerve 
stimulation (TENS), ultrasound therapy, laser therapy, magnetic 
stimulation therapy, exercise (Fernandez-de-Las-Penas, C et al. 2003) 
and frequency specific microcurrent (McMakin 2004).  
 
Each of these categories of treatment are now briefly discussed either in the 
coming sections or presented in various appendices as referred to in the text. 
 
2.1.10.1 Manual therapies 
 
A systematic review of the effectiveness of various manual therapies for the 
treatment of myofascial TrPs conducted by Fernandez-de-Las-Penas and co-
workers (2003) revealed few randomised controlled trials (RTCs) on the 
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subject and none that showed any statistically significant effects beyond 
placebo. Although no effect beyond placebo was found for any manual 
therapy, some findings of the trials discussed below may provide a platform 
upon which to base future, more rigorous work.  
 
In a trial that studied various combinations of exercise, manual therapy, 
stretching and thermal modalities, Hou and colleagues (2002b) found that all 
groups that received some form of electrotherapy (eg: TENS, interferential 
current) as part of the therapy combination, had significantly reduced pain 
intensity compared to the group that received ‘hot pack’ intervention (Hou, C. 
R. et al. 2002). The same authors also found that the combination of hot 
pack, range of motion exercise, interferential current (IFC) and myofascial 
release, produced the largest reduction in pain immediately after treatment, 
though long-term effects were not measured. Similarly, Hanten and 
colleagues (2000) compared the effects of a home program of self-
administered ischemic compression followed by stretching with a control 
treatment of active range of motion exercises in a group of 40 adults with 
neck and upper back pain and found a significant increase in PPT for the 
treatment group, but no difference in total duration of pain (measured with 
VAS) three days post treatment. In contrast, Edwards and Knowles (2003) 
reported no difference in TrP pain scores between stretching and control 
groups and suggested that where TrPs had not been de-activated, stretching 
might be a pain aggravator, a notion supported by others (Simons, D., Travell 
& Simons 1999). 
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In a trial comparing the effects of massage, exercise and ultrasound to 
massage, exercise and placebo ultrasound in 58 patients with neck and 
shoulder TrPs (Gam et al. 1998), the TrP number and pain intensity were 
significantly reduced for both groups receiving massage and exercise, 
suggesting that ultrasound had no therapeutic effect on neck and shoulder 
TrPs. Similarly, in a trial that compared Thai Massage combined with 
stretching with a Swedish massage and stretching combination, 
Chatchawana and co-workers (2005), found that both groups had significant 
reductions in pain and disability measures, though there were no differences 
between treatments (Chatchawana et al. 2005). An immediate improvement 
within groups, but not between groups, was also reported in a trial comparing 
the techniques of ischemic compression with transverse friction massage 
(Fernandez-de-las-Penas et al. 2005).  
 
In summary, from the research and clinical opinion cited, there appears to be 
no incontrovertible evidence to support the efficacy beyond the effect of 
placebo of the manual therapies currently used in the management of 
myofascial pain syndromes caused by TrPs. There is some support for the 
application of some interventions (spray and stretch, deep pressure, soft 
tissue massage and ischemic compression) as effective in reducing 
pressure-pain sensitivity and pain in TrP conditions, however many trials 
(Fernandez-de-Las-Penas, C et al. 2003; Hong, C. 2006; Hou, C. R. et al. 
2002; Rickards 2006) have combined treatments and therefore any 
improvement in symptoms can only be related to the combined effect as 
opposed to any single modality.  
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2.1.10.2 Needling therapies 
 
A thorough history of the development of TrP needling therapies has been 
provided by (Baldry, P. 2002a) starting in the 1940s when Janet Travell 
began her life-long study of myofascial pain and TrPs, terminology she 
introduced to the medical world. According to Baldry (2002), she realised that 
the analgesia produced by injecting procaine into a TrP could not be due to 
the nerve blocking effect of this drug because the effect lasted too long. She 
later observed that pain relief of a similar duration could be obtained by 
inserting a needle into the TrP without injecting any substance, however, not 
surprisingly, the soreness produced was much greater than occurred when 
an analgesic was injected (Cummings & White 2001; Hong, C. Z. 1994b; 
Kamanli et al. 2005; McMillan, Nolan & Kelly 1997), but produced fewer 
allergic reactions in the patients. In the mid 1950s, Sola, first with Kuitert 
(Sola & Kuitert 1955) and later with Williams (Sola & Williams 1956), 
investigated and confirmed the efficacy of alleviating TrP pain by injecting 
saline into the TrP and still later, Frost’s group (Frost, Jessen & Siggaard-
Andersen 1980) compared the effects of injecting saline with that of a long-
lasting analgesic (mepivacaine). Seventy six percent of the saline recipients 
had pain relief compared with 57% of the local anaesthetic group, reaffirming 
Travell’s original hypothesis that it was the effect of the needle, as opposed 
to the substance injected that relieved TrP pain, a finding that has led 
clinicians to adopt the use of acupuncture needles to ‘dry needle’ TrPs. To 
clarify the various needling techniques, Baldry (2002) categorized them as: 
“deeply applied techniques” all involving the direct injection of TrPs either 
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with some substance (corticosteroids, a non-steroidal anti-inflammatory 
drugs, local anaesthetics, botulinum A toxin or vitamin B12) or with needle 
insertion alone (so-called deep dry needling - DDN) and “superficially applied 
techniques” involving needle insertion into the skin and subcutaneous tissues 
over TrPs with the delivery of an injectable or simply needle insertion alone 
(superficial dry needling - SDN)  
 
More recently, in a systematic review of the available needling therapies in 
the management of TrP pain, Cummings and White (2001) confirmed that 
“wet needling” (injecting drugs) was not therapeutically superior to dry 
needling of TrPs. The review, which covered the period until 2001, found that 
though needling therapies improved various measures associated with TrP 
pathology, they found no evidence that they had an effect beyond placebo in 
myofascial pain treatment, predominantly due to the fact that a valid placebo 
needle or needling technique had not been developed. For example, in a 
randomised, double blind trial, low back strain subjects who received dry 
needling treatment of TrPs reported it was effective in subjectively reducing 
TrP pain, though the difference was not statistically significant nor compared 
to a placebo needling intervention (Garvey, Marks & Weisel 1989). More 
recently, it has been suggested that needling therapies would be more 
effective if a LTR is obtained during the treatment (Hong, C. Z. 1994b; Shah, 
J P 2003).  
 
In summary, it would appear that TrP needling (both DDN and SDN) is an 
effective treatment given that all studies where TrPs were needled produced 
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marked, though not placebo controlled, improvement of symptoms 
(Cummings & White 2001) with the only adverse affect appearing to be that 
dry needling produced more post-injection soreness when compared to 
lidocaine (Hong, C. Z. 1994b). The other significant outcome of Cummings 
and White’s work (2001) was to provide impetus for the development of a 
‘placebo needle’ to allow researchers to test the efficacy of any needling 
techniques beyond placebo (Cummings & White 2001). In this vein, 
researchers over recent times have endeavoured to develop, validate and 
employ what might be called sham acupuncture needles in various ways and 
with various degrees of success. Attempts have ranged from home-made 
options such as cutting the needle tips off and using a blunt, non-penetrating 
needle (Huguenin, L. et al. 2005) through to purpose built products (eg: the 
“Park Sham Device”) and it now appears more likely that a sham 
acupuncture needle provides a valid placebo in acupuncture-naive subjects 
(Park et al. 2002) as opposed to acupuncture aware subjects (Park et al. 
2002; White et al. 2003).  
 
(a) Deep Dry Needling (DDN) of TrPs.  
 
Deep dry needling (DDN) of TrPs involves rapidly inserting a needle, usually 
an acupuncture needle, into the centre of a TrP in order to elicit one or 
multiple local twitch responses (LTRs) (see pages 19-21 and 28-31) (Borg-
Stein & Simons 2002). The change in the length of the fibres caused by the 
LTR is thought to stimulate mechanoreceptors, with large diameter, fast-
conducting fibres. Many authors in the myofascial needling field (Chu 1997, 
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2002; Chu & Schwartz 2002; Hong, C. Z. 1994b, 1994a) have postulated that 
the input from the large diameter sensory afferents blocks the intra-dorsal 
horn passage of smaller, slower conducting input generated in the TrP 
nociceptors, resulting in at least short-term alleviation of TrP pain. A number 
of authors (Chu 2002; Shah, J P 2003) have suggested that the greater the 
amplitude of the LTR, the greater the pain relief afforded by the needling 
treatment, opinions based upon clinical observation but yet to be confirmed 
by experimental evidence. Notwithstanding this deficiency, this postulate has 
provided a theory to account for the therapeutic relief associated with the 
LTR and the belief that LTRs may be the key to pain relief, rather than just a 
diagnostic sign for the localisation of TrPs. For this reason, Hong (1994) and 
Chu (2002) strongly supported obtaining multiple LTRs in treating TrPs, 
believing that doing so (by rapidly re-inserting the needle into the TrP region), 
increased the effectiveness of DDN. However this must be tempered by the 
fact that in two early studies (Hong, C. Z. 1994b; Hong, C. Z. & Torigoe 
1994), the authors found that though both DDN and injection with lidocaine 
(0.5%) reduced subjective pain, increased the pressure-pain threshold (PPT) 
of TrPs as well as improved cervical ROM, all subjects who received DDN 
had significantly more intense post-needling soreness which persisted for 
longer than pain associated with lidocaine injection. Furthermore, the 
techniques used to elicit LTRs apparently cause immediate sensory 
responses, ranging from minor, transient discomfort to considerable initial 
sharp pain that lingers as a dull ache for up to 48 hours (Hong, C. Z. 1994b). 
Finally, Baldry (2002) suggested that DDN and in particular, the elicitation of 
a LTR was liable to cause damage to neighbouring blood vessels and 
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nerves, and for this reason has been a strong advocate for using superficially 
applied needling techniques as a general rule, except in the case where 
there is significant muscle spasm secondary to radiculopathy.  
 
(b) Superficial dry needling (SDN) over TrPs 
 
The mechanism by which SDN produces favourable effects on TrP pain 
appears to be related to afferent responses caused by stimulation of A-delta 
nerve fibers from cutaneous receptors secondary to needle insertion into the 
skin and subcutaneous tissues over a TrP. This is thought to lead to release 
of opioid peptides in the dorsal horn, which inhibit the intra-dorsal horn 
transmission of nociceptive information arriving at the spinal cord from group 
IV afferents from the TrP (Baldry, PE. 2005). Pomeranz (2001) confirmed 
that needle induced analgesia was opioid peptide-based by administering a 
known endorphin antagonist, which cancelled the effect of SDN (Pomeranz 
2001). 
 
In addition to the mechanical stimulation of A-delta nerve fibers in the skin 
and subcutaneous tissues, it has been suggested that SDN establishes a low 
intensity galvanic current as a result of the difference in the electrical 
potential between the needle and the skin that persists for up to 72 hours 
after needle removal (Baldry, PE. 2005). If this be true then, SDN may act by 
briefly stimulating the A-delta fibres mechanically, but also by producing an 
electric current that might produce these pain-reducing afferent effects for 
extended periods, concepts that require further investigation. 
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(c) Summary of the known effects produced by dry needling of TrPs  
 
A number of studies have investigated the effects produced by needling TrPs 
and have found various effects including reduction of the endplate noise 
(EPN) associated with TrPs, improved local muscle and skin blood flow, 
reduced TrP pain sensitivity and improved neck range of motion, as outlined 
in the following paragraph.  
 
Chen and colleagues (2001) investigated the effects of obtaining multiple 
LTRs in rabbit TrPs in one biceps femoris, using deep dry needling in the 
opposite side ‘normal’ muscle as control and found a significant decrease in 
the EPN due to their treatment (Chen, J. T. et al. 2001). With regard to TrP 
sensitivity, in a study involving 40 patients with musculoskeletal pain, 
Edwards and Knowles (2003) found that the pressure-pain threshold (PPT) of 
TrPs was significantly improved after a three-week follow up for patients who 
received SDN with active stretching compared with patients who did 
stretching alone or had no treatment (Edwards & Knowles 2003). In a recent 
study, Sandberg and colleagues (2005) investigated patterns of blood flow 
response in the trapezius following needle stimulation (both DDN and SDN) 
in 19 healthy subjects, 20 patients with fibromyalgia and seven with work-
related trapezius myalgia. Where DDN was employed, skin and upper 
trapezius blood flow was significantly improved in healthy subjects compared 
with SDN, whereas both needling methods produced a comparable 
improvement of blood flow in the trapezius and its overlying skin in the 
fibromyalgia patients. However, in myalgia patients, there were no 
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differences between needling techniques and generally a reduced blood flow 
response compared with the fibromyalgia patient group. In addition, positive 
correlations were found between increased blood flow (both muscular and 
skin) and increased PPT, cervical ROM and pain experienced due to the 
stimulation of the needling during the trial. In other words, in terms of pain 
reduction post-treatment, those who experienced most discomfort during 
needle stimulation (movement of the needle, possibly eliciting LTRs though 
not reported) experienced greater treatment responses, suggesting that the 
intensity of needle stimulation, that is the amount of needle movement, 
should be taken into consideration when applying dry needling techniques in 
order to increase the muscle blood flow in chronic pain conditions. 
Importantly, patients who had greater pain levels pre-needling had less 
favourable treatment results, pointing to the importance of nociceptor 
activation as a limiting factor when attempting to increase local blood flow for 
a therapeutic response (Sandberg et al. 2005). Finally with regard to the 
effects of TrP dry needling treatment on range of motion (ROM), the literature 
provides mixed results. Some authors have found an improvement in ROM 
(Sandberg et al. 2005) after TrPs have been needled either deeply or 
superficially, while others (Huguenin, L. et al. 2005) have found no significant 
effects post needling. In this vein, Irnich and colleagues (2002) found that dry 
needling had no effect on ‘motion related pain’, suggesting that where 
movement related pain was the main symptom, dry needling to treat TrPs 
would be unlikely to improve the condition (Irnich et al. 2002). These 
contradictory findings suggest that changes in ROM are not reliable 
indicators of the effectiveness of dry needling for TrP treatment. 
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In summary, DDN is probably useful under the following conditions or 
situations: 
 To increase blood flow to the muscle and overlying skin in healthy (no 
pain) subjects (Sandberg et al. 2005), possibly to enhance blood flow 
to certain muscles prior to sporting endeavour or promote continued 
recovery from an old injury. 
 To elicit LTRs from the TrP region (Hong, C. Z. 1994b). 
 Where significant muscle spasm exists secondary to another problem 
(eg: radiculopathy) (Baldry, P. 2002b). 
 Where a patient is a weak reactor to needling therapies and requires a 
stronger stimulus to elicit a response (Baldry, P. 2002a). 
 Where the client and practitioner are both experienced with this more 
aggressive technique and are not affected by fear (Baldry, P. 2002b; 
Simons, D., Travell & Simons 1999). 
 
The less invasive SDN approach on the other hand, may be indicated: 
 Where the TrP pain is not chronic or is not rated as severe (Sandberg 
et al. 2005). 
 Where other conditions affecting neurophysiology, such as 
fibromyalgia co-exist (Sandberg et al. 2005). 
 For clients who are strong negative reactors to needling therapies and 
require a more gentle stimulus or where the reaction of the patient is 
unknown (Baldry, P. 2002b). 
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 Where the TrP is situated close to important anatomical structures (eg: 
in the anterior scalene muscles in relationship to the phrenic nerve or 
subclavian vessels) (Baldry, P. 2002a). 
 
 
(d) Relative contra-indications to consider 
 
The following list summarises what can be considered the main 
contraindications to the application of DDN or SDN.  
 If the patient is undergoing anticoagulation therapy. 
 If the patient has taken aspirin within three days of injection. 
 If the patient has a needle phobia. 
 
 
2.1.10.7 TrP injections and Other TrP Therapies 
 
Myofascial TrP injections, including analgesics, botulinum toxin A, anti-
inflammatory agents and occasionally vitamin B12 are commonly used by 
physicians to manage myofascial pain syndromes, as are a broad ranges of 
electrotherapeutic modalities. Considering the nature of the current work, 
these techniques were only of peripheral interest and therefore, only a brief 
outline of the topic has been included in Appendix F (page 289) for the 
interested reader.  
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2.1.11  LTrPs: Symptoms, effects and relationships to ATrPs 
 
As was discussed earlier (page 23), based upon a synthesis of the relevant 
literature, his own research and many years of clinical experience, Simons 
(2005), concluded that there were fundamental differences between the 
effects produced by the two basic types of TrP (active and latent). He 
suggested that ATrPs usually augment sensory phenomena, (manifested as 
referred pain and tenderness), but at times inhibit them (manifested as 
referred anaesthesia). Latent TrPs in contrast, were said to commonly 
amplify or inhibit motor functions of the “parent” muscle and possibly refer 
these changes in motor behaviour to functionally related muscles. 
Furthermore, both clinical (Sciotti et al. 2001; Simons, D., Travell & Simons 
1999) and biochemical (Shah, J. P. et al. 2005) differences have been found 
when comparing ATrPs and LTrPs, providing support for the notion that they 
are quite different entities. These differences notwithstanding, most TrP 
authorities (Gerwin, R. D. 2005; Hong, C. Z. & Simons 1998; Huguenin, LK 
2004; Simons, D. G. 2004b) still appear to consider the LTrP a clinical 
forerunner of the ATrP. In this vein Simons (2005) felt that the motor effects 
of LTrPs could profoundly influence muscle coordination which could 
promote their conversion to ATrPs. More controversially, Hong (2004) 
suggested that LTrPs might be found in many pain-free skeletal muscles, 
where they could be “activated” (becoming an ATrPs) by continued noxious 
stimuli (for example, overload caused by prolonged or repetitive contractions 
of the muscle). Furthermore, Hong considered that although ATrPs could be 
“inactivated” (no longer spontaneously painful) through treatment, he felt that 
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they never fully disappeared but rather converted to latent form. These views 
prompt a number of questions, particularly given Hong’s belief in the ubiquity 
of LTrPs: 
1. How prevalent are LTrPs? 
2. What are the deleterious effects on motor function of LTrPs? 
3. Do currently recommend treatments de-activate LTrPs ? 
4. Are there any positive effects on motor function produced by de-
activating LTrPs? 
Much of the present work was directed at answering these questions through 
an investigation of the prevalence of LTrPs in a sample of normal healthy 
adults (Chapter 3) and investigations of their effects on scapular muscle 
activation patterns (MAPs) during a common upper extremity motion, 
(elevation of the arm in the scapular plane) (Chapters 4 and 5) Given the 
latter, it is important to review the fundamental processes involved in 
generating scapular plane elevation of the arm to set the stage for the work 
described in subsequent chapters. First is presented a description of the 
normal movement and this is followed by discussions of some of the common 
overuse conditions that may predispose to or result from LTrPs in the 
scapular muscles 
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Section 2: Elevation of the Arm in the Scapular Plane 
The arm moves in a combination of three planes of motion about three 
separate axes, allowing great mobility (Downar & Sauers 2005). When 
elevating the arm (combining abduction at the glenohumeral joint and 
predominately upward rotation of the scapula), the most common plane of 
motion during functional tasks, such as those used in daily living and athletic 
performance, is the scapular plane, defined as lying 30-40° anterior to the 
coronal plane (Borsa, Timmons & Sauers 2003; Kibler, W. B. 1998a). This 
movement requires that the contributing motions of the respective bones and 
joints occur in an optimal sequence so that appropriate loads are apportioned 
to the contributing tissues in a manner that does not result in functional 
overload and subsequent injury (Price et al. 2000). The smooth integrated 
movements of the humerus, scapula and clavicle necessary to elevate the 
arm were first referred to as “scapulohumeral rhythm” by Codman in 1934 
(Codman 1934). A description of scapular plane elevation, including proximal 
humerus and scapular kinematics, the muscle activity that produces them 
and the resulting scapulohumeral rhythm, is outlined in the following sections. 
 
 
2.2.1 Kinematics of the humeral head during elevation of the arm in the 
scapular plane 
 
The glenohumeral joint possesses six degrees of freedom including three 
rotations and three translations (Michener, McClure & Karduna 2003). During 
scapular plane elevation, of particular interest is the relationship maintained 
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between the humeral head and the glenoid fossa and how it affects the 
subacromial space, defined as the area between the superior surface of the 
humeral head and the inferior surface of the coracoacromial arch (acromion, 
coracoacromial ligament and acromioclavicular (AC) joint) (Neer 1972). In 
healthy shoulders, the subacromial space with the arm in the anatomical 
position, has a vertical diameter of between 1 and 1.5cm (Flatow et al. 1994) 
which decreases slightly during arm elevation movements in healthy 
shoulders. The latter results in an increase in the contact between the inferior 
surface of the acromion and the underlying subacromial structures which 
include the subacromial bursa and the tendons of the long head of the biceps 
and supraspinatus (Brossmann et al. 1996). The humeral head translates 1-
3mm superiorly during the first 30-60° of active elevation in the scapular 
plane and then remains close to the centre of the glenoid cavity (± 1° 
superior/inferior translation) as the movement continues (Ludewig & Cook 
2002). Presumably, via its attachment to the anterior superior aspect of the 
glenoid labrum, activation of the long head of the biceps decreases both the 
superior (Pradhan et al. 2000) and anterior translation of the humeral head 
(Kumar, Satku & Balasubramaniam 1989) as well as reducing the pressure in 
the subacromial space (Payne et al. 1997), the former helping to maintain the 
stability of the humeral head both superiorly and anteriorly. However, given 
the negligible contribution that the Biceps makes to shoulder abduction, 
particularly with the elbow extended, the importance of these functions in 
scapular plane elevation is questionable. Even more effective as stabilisers 
of the humeral head are the teres minor, infraspinatus and subscapularis 
whose contractions produce vectors that limit the superior translation of the 
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humeral head generated by the deltoid during early arm elevation. In 
addition, these muscles generate horizontal forces that compress the 
humeral head against the glenoid fossa adding further stability (Neumann 
2002) According to Flatow and colleagues (1994), the greatest contact 
between the tendons of the supraspinatus and biceps with the 
coracoacromial arch occurs in the mid-range of arm elevation (Brossmann et 
al. 1996; Flatow et al. 1994). Given that the scapula and humerus are both 
moving while attempting to preserve the functionally important relationship of 
the humeral head to the glenoid fossa and subacromial space, the position of 
the scapula and its motions about the thoracic cage, are critical for normal 
motion and are discussed next. 
 
 
2.2.2 Scapular kinematics during elevation of the arm in the scapular 
plane 
 
According to a biomechanical study by Bagg and Forrest (1988) the scapula 
rotates around a migrating centre of rotation, or instantaneous centre of 
rotation (ICR), during upward rotation as follows: initially (arm at 0° in the 
fundamental standing position), the ICR is located at or near the root of the 
scapular spine. Then as arm elevation in the scapular plane progresses, the 
ICR begins to migrate toward the region of the AC joint. There is apparently 
considerable variability of the point in the range of elevation that the scapular 
ICR begins to move laterally, reportedly anywhere between 60° and 90° of 
elevation, however, it has been shown that the ICR reaches the AC joint 
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somewhere between 120-150° of elevation. During the middle phase of 
elevation, where the ICR is located somewhere in the upper central scapular 
area, a variable amount of clavicular elevation occurs about the 
sternoclavicular (SC) joint, coupled with scapular rotation around the AC 
joint. This concurrent motion is purportedly responsible for the ICR’s gradual 
shift toward the AC joint as arm elevation in the scapular plane continues. 
Finally, as arm elevation passes 150°, clavicular elevation ceases and the 
scapular ICR remains at the AC joint (Bagg & Forrest 1988). In summary, 
these authors suggested that three phases of scapular upward rotation could 
be described: an initial phase (from 0° until the middle phase began) where 
the scapular ICR was near the root of the scapular spine, a middle phase 
(commencing somewhere between 60° and 90° of elevation), where the ICR 
migrated from the root of the spine toward the AC joint and a final phase 
(150°-180°), where the ICR remained at the AC joint. Variability in the 
patterns of electrical activity recorded from the scapular rotator muscles 
during these movements (Bagg & Forrest 1986), and in the position of the 
scapular ICR lead Bagg and Forrest (1998) to conclude that there was more 
than one mechanically efficient strategy for coupling scapula and humeral 
motion during elevation of the arm in the scapular plane. 
 
The scapula moves on the thoracic cage at what is sometimes referred to as 
the scapulothoracic articulation, a physiological rather than anatomical joint. 
In fact, all motions of the scapula occur through combined motions at the SC 
and AC joints and can be defined by the resultant scapular movements. 
These motions are listed in most anatomy texts as upward and downward 
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rotation, protraction (abduction) and retraction (adduction) and elevation and 
depression with upward rotation the main action occurring during elevation of 
the arm (Bagg & Forrest 1986). A more detailed description of scapular 
upward rotation based upon a three-dimensional analysis was provided by 
van der Helm and Pronk (1995). They described scapular upward rotation as 
occurring about an anterior-posterior axis (inferior angle moving laterally) 
accompanied by external rotation (superior-inferior axis, lateral border 
moving posteriorly); and posterior tilt (medial-lateral axis, inferior angle 
moving anteriorly). In summary, according to many studies, the scapula 
demonstrates a pattern of predominantly upward rotation, with lesser 
degrees of external rotation and posterior tilting during elevation of the arm 
(Karduna et al. 2001; Ludewig & Cook 2000; Ludewig, Cook & Nawoczenski 
1996; McQuade, Hwa Wei & Smidt 1995; van der Helm & Pronk 1995).  
 
In addition to upwardly rotating, the scapula translates upon the rib cage, 
produced by clavicular rotations about the SC joint, that is, clavicular 
elevation/depression (superior/inferior rotation) and clavicular 
protraction/retraction (anterior/posterior rotation). Measurement of the motion 
of the clavicle at the SC joint provides an opportunity to estimate scapular 
translations because of the interposed rigid clavicle that joins the scapula at 
the AC joint (Karduna et al. 2001; McClure et al. 2001). During elevation of 
the arm in the scapular plane, the clavicle retracts and elevates, causing 
relative translations of the scapula in superior and posterior directions 
(McClure et al. 2001; van der Helm & Pronk 1995). In any case, the clavicle, 
scapula and humerus and the joints they form are positioned and moved by 
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the muscles that attach them to the ribs, vertebrae and each other (Kibler, W. 
B. 1998b). An outline of the activity of the scapular positioning muscles and 
the glenohumeral stabilising muscles during scapular plane elevation forms 
the section below.  
 
 
2.2.3 Muscle activation during scapular plane elevation 
 
The muscles responsible for upwardly rotating the scapula include all parts of 
the trapezius and the lower part of the serratus anterior (Moore 1992). In the 
early stages of scapular plane elevation when the scapular ICR is located 
near the root of the spine of the scapula, Bagg and Forrest (1986), using 
EMG techniques, found that the upper trapezius and lower serratus anterior 
were strongly activated, probably in accordance with their relatively large 
moment arms (compared to the middle and lower parts of trapezius) in this 
phase of the movement. Interestingly, the same authors found that in cases 
where the ICR shifted laterally at a relatively early stage of arm movement, 
the mechanical advantage of the lower trapezius increased earlier in the 
movement, though the upper trapezius remained in a significantly more 
mechanically favourable position (Bagg & Forrest 1988). The most common 
pattern in their 1986 study was a gradual increase in electrical activity of the 
upper trapezius and lower serratus anterior in the early range of elevation, 
with the lower trapezius remaining relatively quiet until the arm approached 
the 90° range (Bagg & Forrest 1986).  
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According to earlier work (Doody, Freedman & Waterland 1970), and later 
supported by Bagg and Forrest (1988), scapular upward rotation contributes 
most to elevation of the arm in the middle phase of the movement (average 
range, 82° to 139°) when the scapular ICR is migrating away from the root of 
the scapular spine toward the AC joint. During this phase of elevation, the 
greater tubercle of the humerus can closely approximate the inferior surface 
of the acromion, particularly in the presence of insufficient activation of 
external rotator muscles, which necessitates that the acromion continue to be 
elevated (achieved by upward rotation of the scapula) in order to preserve 
the subacromial space (Neumann 2002). Another feature of this phase of 
elevation is the better mechanical advantage enjoyed by upper trapezius and 
lower serratus anterior for upward rotation (Neumann 2002) compared with 
the glenohumeral abductors (deltoid and supraspinatus), plus an improving 
lower trapezius moment arm (Bagg and Forrest, 1988). However, above 90° 
of elevation, a rapid increase in the activity of the lower trapezius occurs, 
which was thought to be related to a corresponding reduction in the rate of 
increase of electrical activity in both the upper trapezius and lower serratus 
anterior towards the end of the middle phase of elevation (Bagg & Forrest 
1986). A possible explanation for the increasing EMG activity, may lie in the 
increased activation of these muscles to compensate for their worsening 
length-tension relationships as they continue to shorten (Neumann 2002). 
However, in any consideration of the changing activity of the muscles, during 
upward rotation, the need to accommodate for the changing resistance 
torque of the upper extremity (increasing to 900 and decreasing beyond the 
horizontal) is an obvious factor.  
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The third and final phase of scapular plane elevation, defined by a major 
decrease in the scapular contribution to arm elevation, was said to begin on 
average at 139° of elevation (Bagg & Forrest 1986). In this position the force 
generating capability of the upper trapezius is greatly diminished because the 
scapular ICR approximates the AC joint resulting in both a minimum moment 
arm and unfavourable length-tension relationship. Bagg and Forrest (1986), 
suggested that in this phase, the upper trapezius becomes a supporter of the 
shoulder girdle, opposing downwardly acting forces produced by the weight 
of the upper extremity and any loads held in the hand. Conversely, the lower 
trapezius and lower serratus anterior retain good mechanical advantage for 
preserving upward rotation of the scapula (Bagg & Forrest 1986). 
Importantly, as mentioned earlier (page 34), Bagg and Forrest (1988) 
demonstrated that slight differences in the EMG patterns of muscle activation 
and ICR locations could produce the same ratio of scapulohumeral rhythm, 
indicating that there must be more than one mechanically efficient strategy 
for coupling scapula and humeral motion during elevation of the arm in the 
scapular plane (Bagg & Forrest 1988). 
 
According to Michener and co-workers (2003), an important role of the 
scapular musculature is to stabilise the scapula in order to maintain the 
position of the glenoid fossa (Ludewig & Cook 2000; McQuade, Dawson & 
Smidt 1998; Pascoal et al. 2000). By acting to dynamically stabilise the 
scapula and therefore dynamically position the glenoid fossa during elevation 
of the arm in the scapular plane, the upward rotators of the scapula provide 
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for optimal kinematics of the humeral head, a role primarily performed by the 
rotator cuff muscles (Kibler, W. B. 1998b).  
 
The rotator cuff muscles, supraspinatus, infraspinatus, teres minor and 
subscapularis, apart from their rotary actions, act to maintain the congruence 
between the humeral head and the glenoid fossa by producing a 
compressive force during glenohumeral movements (Michener, McClure & 
Karduna 2003). In addition, these muscles impart an inferior translatory force 
to the head of the humerus which serves to depress it, thereby countering an 
upward vector produced by the deltoid (particularly during the early phase of 
the movement (Thompson et al. 1996)) and critically, helping to preserve the 
subacromial space. In addition, these muscles form part of a force couple 
with the deltoid, assisting glenohumeral abduction (Neumann 2002). Some 
authorities (Halder et al. 2001), also attribute depression of the humeral head 
during elevation of the arm to latissimus dorsi and teres major, though it 
seems unlikely that these muscles would be strongly activated during 
elevation of the arm since both are prime adductors of the glenohumeral 
joint. Perhaps it is as passive restraints that they perform this function. The 
roles of the rotator cuff muscles are evidenced by the well documented 
observation of dysfunctional or weak rotator cuff musculature in patients with 
subacromial impingement (Baltaci 2003; Blevins 1997; Burke, Vangsness & 
Powers 2002; Corso 1995; Powers et al. 1994), a condition in which their 
function of providing a smooth trajectory for the humerus during all phases of 
arm elevation is compromised (Alpert et al. 2000; McMahon et al. 1995), a 
phenomenon which most likely existed prior to the development of the 
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shoulder impingement. Furthermore, Payne and colleagues (1997) found that 
decreased activity in the rotator cuff during elevation of the arm, required the 
deltoid to increase its contribution for the movement to occur, an adaptation 
that they proposed could pose problems for maintaining the subacromial 
space. This notion has been supported by both an artificially induced 
disruption in the force couple between deltoid and supraspinatus (Chen, S. K. 
et al. 1999; Deutsch et al. 1996) and in a naturally occurring state of rotator 
cuff dysfunction (degeneration or muscle tears) (Deutsch et al. 1996; 
Yamaguchi et al. 2000). Under both conditions, an increase in superior 
translation of the humeral head occurred. In addition to alterations to humeral 
head kinematics, Michener and colleagues (2003) suggested that weakness 
or dysfunction of the rotator cuff could also lead to changes in optimal 
scapular kinematics, predisposing to compression of the structures of the 
subacromial space. Such inefficient or disorganised scapular kinematics 
have been referred to by clinicians as scapular “dyskinesis” (Kibler, W. B. & 
McMullen 2003), the clinical relevance, causes and effects of which will be 
outlined after a discussion of the upper extremity kinetic chain and how it 
contributes to scapular plane elevation.  
 
 
2.2.4 The kinetic chain of the upper extremity 
 
To complete the discussion of aspects that contribute to the normal 
functioning of the upper extremity during elevation of the arm in the scapular 
plane, Kibler’s (1998) “kinetic chain” concept is discussed (Kibler, W. B. 
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1998b). He described human motion in terms of a series of segments that 
link to form kinetic chains acting to transfer forces around the body. In this 
vein, one of the roles of the scapula and the muscles that position it, is to 
transfer force and kinetic energy developed by the muscles of the lower 
limbs, trunk, and shoulder girdle to the upper limb as a whole (Kibler, W. B. 
1998b). Logically, a deficiency of function in any segment comprising a 
kinetic chain, could compel changes in the function of linked systems both 
“upstream” and “downstream” of the original site in an attempt to preserve 
normal movement. Kibler (1998) suggested that such adaptations could 
predispose to dysfunction and pain if they changed the loading patterns in 
any segment sufficiently. In this model then, tissues that alter their normal 
function are at risk of compensatory overload and treatment of any resulting 
overuse injury would necessitate addressing the original, sometimes 
asymptomatic (for example LTrPs), deficiency. In accordance with Kibler’s 
hypothesis, minor dysfunctions such as muscle weakness or fatigue or 
altered timing of muscle activation in the scapular positioning muscles, could 
initiate a process of compensatory adaptation in the next functional segment 
of the kinetic chain of the upper extremity, involving the glenohumeral joint 
itself or the rotator cuff muscles that stabilise it. Theoretically, should this 
process continue the muscles and joints of the forearm and hand could also 
become involved. Since the focus of the current work was the segment of the 
kinetic chain that links the torso to the shoulder girdle, namely the scapula 
and the muscles that position it, the discussion will now turn to dysfunction of 
the upper extremity chain and associated pathologies, beginning with a 
description of scapular dyskinesis, its relevance, causes and effects. 
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2.2.5 Scapular dyskinesis 
 
Scapular dyskinesis is an alteration in the normal position or motion of the 
scapula that is manifested during coupled scapulohumeral movements 
(Burkhart, S. S., Morgan & Kibler 2003b). It may occur subsequent to a 
shoulder girdle injury, but can also result from altered muscle activation 
patterns secondary to muscle imbalance or tight or weak muscles and 
frequently associated with inappropriate inhibition in the scapular positioning 
muscles (Kibler, W. B. & McMullen 2003). Such altered activation patterns 
can increase the functional deficit associated with shoulder injury by 
changing the normal motions of the scapula (Kibler, W.B. 2006). Dyskinesis, 
usually results from a loss of coordinated upward scapular rotation (usually 
due to muscle weakness, tightness or altered motor control) and the 
translation associated with scapular retraction, the latter resulting in a 
rounded shoulder posture (Sevinsky 2006). Sevinsky (2006) went on to 
explain that once the condition has developed, it is characterised by altered 
timing and range of upward scapular rotation, excessive anterior tilting of the 
glenoid, and reduced strength (due to deficits in the ability to activate the 
rotator cuff muscles fully). As a result of the altered scapular kinematics and 
posture, scapular dyskinesis is accompanied by altered length-tension 
relationships of the muscles attached to the scapula, particularly those of the 
rotator cuff muscles (Liu et al. 1997; Otis et al. 1994), suggesting that a 
dysfunctional rotator cuff could result from or cause dyskinesis of the 
scapula. Though its relationship with shoulder dysfunction appears to be non-
specific, that is no specific patterns of dyskinesis have been associated with 
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any specific shoulder ailment (Burkhart, S. S., Morgan & Kibler 2003a), 
treatment of scapular dyskinesis is currently directed at managing underlying 
causes, for example pain or inflammation, and re-establishing normal 
scapular MAPs, usually by rehabilitation programs that restore the function of 
the kinetic chain (Kibler, W. B., Livingston & Chandler 1997; Kibler, W. B. & 
McMullen 2003; Kibler, W. B., McMullen & Uhl 2001). These 
pathophysiologic and pathomechanical alterations of scapula posture and 
movement can predispose to conditions such as subacromial impingement, 
or where shoulder joint injury and pain already exist, can perpetuate or 
increase dysfunction (Kibler, W.B. 2006).  
 
According to some authors (Kibler, W.B. 2006; Sevinsky 2006), the known 
causes of scapular dyskinesis include: 
(i) Postural abnormality or anatomical disruption such as increased 
thoracic kyphosis or AC joint injury or anatomic abnormality. 
(ii) Nerve injury to: the spinal accessory nerve (CNXI) resulting in 
trapezius weakness; the long thoracic nerve, resulting in serratus 
anterior weakness; the dorsal scapular nerve resulting in rhomboids 
weakness. 
(iii) Muscular tightness or capsular stiffness. A shortened pectoralis minor 
and/or short head of biceps increase anterior tilt of the scapula while a 
shortened pectoralis major restricts posterior clavicular motion 
affecting normal scapular motion. Anterior capsular stiffness results in 
an increased upward scapular rotation component of scapulohumeral 
rhythm as well as decreased posterior scapular tilt. Posterior capsular 
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stiffness results in the humeral head being positioned more superiorly 
and anteriorly, predisposing to impingement of the subacromial 
structures (Lin, Lim & Yang 2006). 
(iv) Muscle imbalance or weakness. The most commonly weakened or 
inhibited scapular muscles are the serratus anterior, the middle and 
lower trapezii and the rhomboids. Inhibition (for example, due to 
myofascial TrPs or pain) manifests as a decreased ability to exert 
torque and position the scapula and also as disorganisation of normal 
MAPs. 
(v) Proprioceptive dysfunction arising from noxious stimuli (due, for 
example to ischemia or inflammation of a muscle, joint effusion or 
hemarthosis) in a muscle or a joint, affects both the source tissues but 
also functionally related muscles, altering sensory information 
provided by mechanoreceptors that sense the mechanical deformation 
in soft tissues. This results in inefficient or uncoordinated muscle 
group activation.  
Broadly speaking, the most likely clinical manifestations associated with 
scapular dyskinesis are latent and active TrPs (the presence of the latter 
constituting a myofascial pain syndrome (MPS)) in shoulder girdle muscles, 
rotator cuff overuse or dysfunction and subacromial impingement syndrome, 
though the cause and effect relationship between such clinical conditions and 
scapular dyskinesis has been difficult to elucidate (Burkhart, S. S., Morgan & 
Kibler 2003a). Given the association of TrPs, muscle imbalance and 
overload, scapular dyskinesis and shoulder joint pathology, the following 
section reviews the kinematic and muscular contributions that underpin 
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shoulder impingement syndrome and incorporates a description of rotator 
cuff dysfunction and its effects. 
 
 
2.2.6 Subacromial impingement syndrome 
 
Since the term subacromial impingement was first introduced in 1972 (Neer 
1972), it has been acknowledged as the most widely recognised mechanism 
of chronic shoulder pain (Michener, McClure & Karduna 2003; Yanai, Fuss & 
Fukunaga 2006), accounting for between 44 and 66% of all complaints of 
shoulder pain during visits to physicians (Michener, McClure & Karduna 
2003). This disorder can present in a variety of forms ranging from 
inflammation to degeneration of the bursa and tendons in the subacromial 
space which can ultimately result in a full-thickness tear of these tendons 
with subsequent degenerative joint disease (Michener, McClure & Karduna 
2003), likely due at least in part, to the altered scapular kinematics which 
have been demonstrated in patients with subacromial impingement (Endo et 
al. 2001; Ludewig & Cook 2000; Lukasiewicz et al. 1999; Warner et al. 1992). 
For example, Warner, Micheli and colleagues (Warner et al. 1992). used 
Moire topography1. to demonstrate a pattern of increased scapular winging in 
subjects with subacrominal impingement, while three-dimensional kinematic 
analysis in more recent work has demonstrated decreased posterior tilt 
(Ludewig & Cook 2000; Lukasiewicz et al. 1999), and decreased upward and 
external rotation (Ludewig & Cook 2000) during arm elevation in patients with 
subacrominal impingement. Optimal scapular upward and external rotation 
                                                     
1 A method of 3D morphometry in which contour maps demonstrate symmetry of the body. 
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and posterior tilting serve to elevate the acromion and increase subacromial 
space, hence disturbances in these movements predispose to impingement 
as described below.  
 
An “occupational” example of dyskinesis associated with subacromial 
impingement syndrome was described by Ludewig and Cook (2000) in 52 
overhead construction workers. During elevation of the arm, these subjects 
showed increased EMG activity in both the upper and lower trapezii while the 
serratus anterior had decreased activity. These muscle patterns were 
accompanied by decreased upward rotation, increased anterior tilt and 
increased internal rotation of the scapula (medial border of the scapular 
moving posteriorly) compared with controls. While it is not clear whether 
these deviations from normal cause or are the result of impingement, some 
authors have stated that to maximise the space for the subacromial 
structures, trapezius and serratus anterior must function “normally” to 
upwardly rotate the scapula during arm elevation, particularly in the mid-
range (60-150°) where subacromial compression is most likely to occur 
(Brossmann et al. 1996; Flatow et al. 1994). Furthermore, Deutsch and 
colleagues (1996) found that active elevation of the arm in impingement 
sufferers increased superior and anterior humeral head translation by 1-
1.5mm and by approximately 3mm respectively. A similar increase in 
superior translation (1–1.5mm) has also been found in patients with rotator 
cuff tendon degeneration during both active or simulated arm elevation 
(Deutsch et al. 1996; Thompson et al. 1996; Yamaguchi et al. 2000). 
Importantly, from the point of view of the current work, superior translations of 
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a similar or greater magnitude (1-5mm) have also been demonstrated with 
weakness or fatigue of the deltoid and rotator cuff in healthy subjects during 
elevation in the scapular plane (Chen, S. K. et al. 1999; Sharkey & Marder 
1995) Though the alterations in the magnitude of humeral head translations 
mentioned may seem small, the space available under normal conditions is 
only 10-15mm (Flatow et al. 1994) leaving little room for error. Three 
common clinical presentations associated with scapular dyskinesis and 
subacromial impingement: forward shoulder posture, posterior shoulder joint 
tightness and dysfunctional rotator cuff muscles, will now be briefly 
summarized.  
 
The most common clinical manifestation of scapular dyskinesis is forward 
shoulder posture which has been defined as a position of protraction and 
elevation with internal rotation of the scapula, (often referred to as ‘scapular 
winging’ in the clinical setting where the medial border of the scapula does 
not sit flush against the thoracic cage) in company with medial rotation of the 
humerus (Neumann 2002). The same author suggested that this posture may 
be produced by, or result from, a combination of tightness of the pectoralis 
minor and upper trapezius and weakness of the serratus anterior and middle 
and lower trapezii, the same muscular imbalance pattern that has been 
implicated in the development of subacromial impingement (Fu, Harner & 
Klein 1991). Alterations of the scapular resting posture have also been noted 
in patients with subacromial impingement involving greater anterior tilt of the 
scapula (Lukasiewicz et al. 1999) and increased scapular winging (Warner et 
al. 1992) giving these patients a ‘slouched’ posture. The coupling of this 
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scapular position with medial rotation of the humerus brings the greater 
tubercle closer to the coracoacromial arch, reducing the subacromial space 
and increasing risk of impingement.  
 
Another functional change that can predispose to scapular dyskinesis and 
subacromial impingement is tightness or stiffness of the posterior shoulder 
joint capsule (Sevinsky 2006). According to Michener, McClure and 
colleagues (2003), posterior shoulder joint tightness can cause changes in 
humeral head kinematics that lead to subacromial impingement. This opinion 
was supported by a recent study of six patients with posterior capsular 
stiffness (although posterior capsular stiffness was difficult to isolate from 
posterior rotator cuff tightness) who were found to have anterior shifts of the 
humeral head of 2.2-3.4mm during arm elevation movements (Lin, Lim & 
Yang 2006). Though these patients were not compared with matched 
controls, the findings add weight to the notion that tightness of the posterior 
glenohumeral joint structures alters kinematics thereby contributing to 
subacromial impingement. With regard to rotator cuff muscle function, 
increased rotator cuff and deltoid activity (EMG) at 120° of abduction in 10 
healthy subjects was associated with increased subacrominal space 
(Graichen et al. 1999) and simulated activation of the same muscles based 
on the parameters measured in 10 human cadaveric shoulders was shown to 
decrease subacromial pressure during elevation of the arm (Payne et al. 
1997). Conversely, a decrease in EMG activity in the infraspinatus, 
subscapularis and middle deltoid between 60° and 90° of scapular plane 
elevation has been reported in patients with subacromial impingement 
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(Reddy et al. 2000), adding further evidence for the importance of the rotator 
cuff muscles in maintaining normal glenohumeral joint function. The work 
cited in the foregoing discussion provides good evidence that a large 
percentage of patients presenting with subacromial impingement have 
scapular dyskinesis (Kibler, W.B. 2006) and often other shoulder girdle 
conditions like rotator cuff tendinopathy, bursitis, joint degeneration 
(Michener, McClure & Karduna 2003), long head of biceps tendinopathy 
(Yanai, Fuss & Fukunaga 2006) or myofascial pain (Sevinsky 2006). 
Although these variables are clearly associated with each other, their 
concurrent presentation does not allow the determination of a causal 
relationship. However, they do indicate that alterations in the synergies 
between the shoulder girdle muscles that produce elevation of the arm in the 
scapular plane are associated with dysfunction and potentially, pathology. 
Hence it is important to establish what effects LTrPs (which are pain-free 
neuromuscular lesions (Simons, D., Travell & Simons 1999) commonly found 
in these muscles (Chapter 3)) may have on muscle action and the 
preservation of this common upper extremity movement, during two 
situations that occur regularly during daily tasks: raising the loaded hand 
above shoulder level with scapular plane elevation, or performing elevation of 
the arm when fatigued. A brief review of the published literature on these two 
conditions comprises the following sections. 
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2.2.7 Effects of load during scapular plane elevation 
 
No studies were found that investigated the effects of load on the timing of 
muscle activation in shoulder girdle muscles during elevation of the arm in 
the scapular plane. However it is known that during concentric muscle 
contraction, muscles contract at a maximum velocity when the external load 
in negligible and contraction velocity decreases as the external load is 
increased until an extreme load results in a contraction velocity of zero with 
respect to the well known “Force Velocity Relationship” (Neumann 2002). In 
related research, in a study on 16 asymptomatic shoulders, Alpert and 
colleagues (2000) measured the degree of muscle activation, as opposed to 
the timing of muscle activation, of the deltoid and rotator cuff muscles in 
response to various external loads during scapular plane elevation. The 
authors found that EMG activity of deltoid, supraspinatus and infraspinatus 
increased in the 0°-90° range and decreased in the 120°-150° range and that 
the change in activity with increasing load was greater from 0-25% and from 
25-50% of maximum load than it was for the change from 50-75% and 75-
90% of maximum load. The peak muscle activity for anterior and middle 
deltoid and supraspinatus and infraspinatus occurred between 30° and 60° of 
scapular plane elevation. The EMG activity of the posterior deltoid was less 
than 20% of maximum for all parts of the range of scapular plane elevation 
with peak activity occurring between 1200 and 150°, which was expected 
given the investigated movement and position of posterior deltoid. The 
subscapularis and teres minor were most active between 00 and 90°, but only 
when the external load was greater than 50% of maximum. These data 
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suggest that deltoid, supraspinatus and infraspinatus are utilised to a greater 
extent in the first 90° of elevation and show greater increases of activity when 
lighter loads (25-50% of maximum) are used whereas increased activity from 
the subscapularis and teres minor are required when the external loads are 
higher (greater than 50% of maximum). These results imply that deltoid, 
supraspinatus and infraspinatus are preferentially recruited in response to 
initial increases in external load, with the subscapularis and teres minor 
increasing their contributions when load increases above 50% of maximal.  
 
With regard to scapulohumeral rhythm, two studies (Doody, Freedman & 
Waterland 1970; Michiels & Grevenstein 1995) employing three dimensional 
analysis at three different loads found no significant influence on 
scapulohumeral rhythm. In other words muscle activation stretegies were 
unchanged with load variations. Similarly, two later three dimensional studies 
found that increasing external loads (0-3kg) (de Groot, van Woensel & van 
der Helm 1999) and (0-4kg) (Pascoal et al. 2000) had no effect on either 
clavicular or scapular kinematics during scapular plane elevation. However 
McQuade and Smidt (1998), reported changes to scapulohumeral rhythm 
produced by maximum resisted (performed against a dynamometer) arm 
elevation in the scapular plane, suggesting that high external loads can affect 
scapulohumeral rhythm. In summary, these studies suggest that external 
loads of four kilograms of less do not alter scapulohumeral rhythm during 
scapular plane elevation, but maximum loads might. 
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2.2.8 Effects of fatigue during scapular plane elevation 
 
According to Neumann (2002), fatigue involves a variety of elements located 
in central and/or peripheral parts of the neuromuscular system. Central 
fatigue may be affected by psychological factors, such as perceived effort or 
physiological factors, such as inhibition of pathways that prevent efficient 
activation of motor neuron pools. Peripheral fatigue on the other hand may 
result from neuophysiological factors related to action potential propagation 
in motor nerves and transmission of activation to muscle fibers, for example 
repetitive activation of motor units may result in a short-term reduction of ACh 
release, and the muscle fiber cytoplasm may undergo a variety of 
biochemical changes that reduce force output over time (Fitts & Metzger 
2004).  
 
Fatigue has been found to affect three dimensional scapular kinematics 
during scapular plane elevation. Tsai, McClure et al. (2003) used a repetitive 
external rotation task to fatigue 30 healthy subjects then measured three 
rotations (anterior/posterior tilting, upward/downward rotation and 
internal/external rotation) of the scapula at six points of humeral elevation. 
They found that fatigue caused increased anterior tilt of the scapular up to 
90° of elevation with the greatest anterior tilt occurring at 4°. Fatigue 
decreased external rotation from zero to 120° of arm elevation with the 
greatest degree of internal rotation (where the medial border of the scapula 
lifts posteriorly off the thoracic cage) occurring at 2.4° of arm elevation after 
fatigue. Upward rotation was significantly reduced during the first 60° of 
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humeral elevation after fatigue with the greatest decrease occurring at 2.5°. 
These findings suggest that fatigue has the greatest impact on scapular 
position at the beginning of scapular plane elevation. Similarly, three 
additional studies found a significant decrease in posterior tilt in the early part 
of scapular plane elevation in response to fatigue (Ebaugh, McClure & 
Karduna 2006; McQuade, Hwa Wei & Smidt 1995; McQuade & Smidt 1998). 
In a more recent investigation into the effects of fatigue on scapulothoracic 
and glenohumeral kinematics (Ebaugh, McClure & Karduna 2006), 20 
healthy subjects underwent a fatiguing protocol until they could no longer 
perform a battery of tasks. Median power frequency (MPF) dropped by at 
least eight percent in all muscles except the lower trapezius, indicating that 
the upper trapezius, serratus anterior, anterior and posterior deltoid and the 
infraspinatus muscles had indeed been fatigued by the protocol employed. 
Compared with the pre-fatigued state, upward rotation increased at the 
following angles of elevation: 60° (5.3°), 90° (7.4°), 120° (6.4°) and maximum 
elevation (2.9°). Scapular external rotation increased at the following angles 
of elevation: 90° (6.4°), 120° (8.2°) and maximal elevation (5.2°) and finally, 
clavicular retraction increased at 60° (2.6°), 90° (5.4°), 120° (6.4°) and 
maximal elevation (3.3°). For humeral motion, subjects demonstrated 
decreased humeral external rotation when fatigued. These findings suggest 
that greater scapulothoracic motion and less glenohumeral motion occur 
during scapular plane elevation following muscle fatigue which the authors 
speculated may have resulted from increased scapular rotator muscle 
activation in compensation for fatigue in the deltoid and infraspinatus 
muscles. 
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Muscular fatigue has been shown to alter motoneuron firing rates during 
sustained maximal voluntary contractions (Bigland-Ritchie, B. et al. 1983; 
Bigland-Ritchie, B. & Woods 1984; Duchateau & Hainaut 1985; Viitasalo & 
Komi 1981) and has also been shown to affect proprioceptive feedback and 
cortical control (Macefield et al. 1991; Taylor et al. 1996; Taylor, Butler & 
Gandevia 2000) For example, shoulder proprioception in active repositioning 
in external rotation of the arm was significantly altered after a fatiguing 
protocol using an isokinetic dynamometer to maximally resist internal and 
external rotation of the shoulder (Lee, H. M. et al. 2003). Furthermore, in a 
study on segmental posture and movement, where seven healthy adults 
performed a series of fifteen fast wrist flexions and extensions while being 
instructed to keep a dominant upper limb posture as constant as possible, it 
was concluded that there was no clear understanding of the mechanisms by 
which the CNS adapts to fatigue in order to preserve normal movement 
patterns (Chabran, Maton & Fourment 2002). One way to gain insight into 
both peripheral and central output related to movement performance, is to 
record MAPs which reflect the temporal sequence of muscle recruitment. 
This approach is discussed in relation to elevating the arm in the scapular 
plane in the following section of this review. 
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Section 3: Muscle Activation Patterns (MAPs) in the Shoulder Girdle 
 
The timing and sequence of muscle activation can be investigated by 
electromyographic recordings of MAPs and this approach has been used in 
various regions of the body including the lower back (Hodges, P. & 
Richardson, C. 1999; O'Sullivan, P. et al. 1997), the pelvic floor (Smith, 
Coppieters & Hodges 2006), the neck (Falla, D., Bilenkij & Jull 2004), the 
knee (Mellor & Hodges 2005) and the shoulder (Wadsworth & Bullock-Saxton 
1997). Focusing on the latter, Wadsworth and Bullock-Saxton (1997) used 
surface EMG (sEMG) to investigate the temporal sequence of muscle 
recruitment of the upward scapular rotator muscles (upper and lower 
trapezius and the lower part of serratus anterior) in nine young, elite 
swimmers with chronic unilateral shoulder impingement and compared them 
with nine swimmers with healthy shoulders during elevation of the arm in the 
scapular plane. In the healthy shoulders, the timing of muscle activation for 
the upward scapular rotators was as follows: upper trapezius was activated 
217ms prior to movement start (the arm leaving the side of the body), 
serratus anterior was activated 53ms after movement start and the lower 
trapezius was activated last at 349ms after movement start, which correlated 
with the arm reaching 15° of elevation. No significant differences in MAPs 
were found between the injured and non-injured sides of the shoulder 
impingement group, however when the non-injured side of the impingement 
group was compared to the control group, serratus anterior was significantly 
delayed in its time of activation in the healthy shoulders of the impingement 
subjects (p<0.05). Interestingly, no differences we
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any muscle between the control group and the injured side of the 
impingement group. The investigators found that the presence of shoulder 
impingement syndrome significantly increased the variability (as indicated by 
the standard deviations of onset times) of the timing of activation of all the 
upward scapular rotator muscles compared to the control group and within 
the impingement group, serratus anterior was significantly more variable in its 
time of activation on the injured side compared to the non-injured side 
(Wadsworth & Bullock-Saxton 1997). In this scenario, there was both a 
deficiency of function in a proximal segment of the upper limb (altered 
activation patterns of the upward scapular rotator muscle group) and a 
chronic, painful condition of the shoulder joint (shoulder impingement 
syndrome). If Kibler’s theory regarding dysfunction in a proximal segment of 
a kinetic chain is correct (see page 90), then the initial change would be 
expected in the recruitment patterns of the upward scapular rotator muscle 
group, possibly leading to changed biomechanics at the glenohumeral joint. 
In the Wadsworth and Bullock-Saxton (1997) study, however, there was no 
opportunity to establish a cause and effect relationship between these two 
variables since all subjects had been diagnosed with shoulder impingement 
syndrome prior to the investigation. In this situation, pain arising from 
impingement might explain the findings. Therefore, in order to establish 
whether deficiency in the muscles of a proximal segment of the upper limb 
chain is associated with changed function in a more distal segment, the 
subjects need to be pain-free at the time of investigation, a situation that 
exists when LTrPs alone constitute the deficiency. Given the dependence of 
muscle activation and therefore movement performance, on effective 
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neuromuscular function, the next section of this discussion will focus on 
aspects of motor control.  
 
 
2.3.1 Effect of pain on motor activity and control 
 
Examples of changes in motor activity and control include increased activity 
in some muscle groups and inhibition or weakness in others and pain 
avoidance motor patterns such as limping, decreased ranges of motion and 
loss of spinal curves, can also be observed in clinical settings (Sterling, Jull & 
Wright 2001). Pain has been associated with motor control deficits in the 
form of muscle inhibition and altered patterns of muscle recruitment, both of 
which have been shown to affect joint control and have been found in the 
lumbar spine (Hodges, P. & Richardson 1996; O'Sullivan, P et al. 1997), the 
cervical spine (Falla, D 2004) and the knee (Mellor & Hodges 2005; Owings 
& Grabiner 2002; Voight & Wieder 1991). Loss of joint control may leave the 
subject vulnerable to further injury or be the cause of ongoing pain or 
recurrence of injury (O'Sullivan, P et al. 1997). A vicious cycle model was 
proposed by Johannson and Sojka (1991) to explain altered muscle function 
and loss of joint control in response to painful and non painful conditions 
alike. At the heart of their proposal was an increase in muscle tension or 
spasm produced by increased gamma motor neuron (γ-motoneuron) 
discharge in response to input from receptors in joints, muscles and skin 
(Johansson & Sojka 1991). Though the influence (if any) of the gamma 
system in altered joint control remains uncertain because of continuing 
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debate, especially with respect to afferent input from muscle (Sterling, Jull & 
Wright 2001), a brief description of the vicious cycle model is now provided in 
point form  
• Stimulation of group III and IV muscle afferents by algesic substances 
produced by “distressed” muscle fibers, sensitised nociceptors or from 
other structures (e.g. joints) reflexively excite both dynamic and static 
γ-motoneurons (Appelberg et al. 1983). These in turn enhance the 
activity of primary and secondary muscle spindle afferents that 
ultimately determine muscle stiffness by the following mechanism.  
•  Increased activity in primary and secondary muscle spindle afferent 
input increases excitability in alpha (α) and γ motoneurons projecting 
back to the muscle increasing both stiffness and metabolite production 
secondary to the increased muscular contraction, which continues the 
cycle and leads to further stiffness. (Johansson & Sojka 1991).  
 
In support of this theory, animal studies have shown enhanced ipsilateral 
activity in primary and secondary spindle afferents after application of 
chemical mediators such as potassium chloride, lactic acid, bradykinin and 
serotonin to muscle tissue (Djupsjobacka, Johansson & Bergenheim 1994; 
Djupsjobacka, M et al. 1995; Djupsjobacka, M. et al. 1995) as well as 
modulation of secondary spindle afferents after injection of bradykinin into the 
contralateral muscle (Djupsjobacka, M et al. 1995). Similarly, bradykinin 
injection of the trapezius and splenius muscles of cats produced excitatory 
effects in the γ-motoneurons manifested as increased static stretch sensitivity 
of muscle spindles in both contralateral and ipsilateral muscles (Pedersen et 
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al. 1997). In addition to chemical stimulation of muscle sensory afferents, it 
has been suggested that input from the articular afferents of inflamed joints 
may also increase activity in the γ-efferent system, thereby amplifying any 
affects of a vicious cycle model (Johansson & Sojka 1991). These findings 
and ideas notwithstanding, the validity of the vicious cycle model has not yet 
been established because no increase in α-motoneuron activity has been 
shown in any relevant study (Graven-Nielsen, Svensson & Arendt-Nielsen 
1997; Stohler, Zhang & Lund 1996). In addition, the model does not account 
for all situations in which muscle tension or spasm exist such as occurs in 
conjunction with myofascial TrPs. In this case, muscle acidity secondary to 
inflammation produced by injury or exercise-induced muscle overload 
(Gerwin, RD, Dommerholt & Shah 2004) is believed to initiate 
neurophysiological activities (increased CGRP in synaptic cleft, decreased 
AChE and increased AChRs on the post-synaptic membrane) that results in 
an increase of acetylcholine-mediated miniature high frequency endplate 
potentials that act to cause a sustained partial depolarisation of the muscle 
cell membrane. The explanation of how sarcomere contracture occurs within 
sarcomeres near the myoneural junction may involve an associated 
depolarisation of the T tubule leading to Ca2+ release from the SR. These 
events occur in the absence of motor nerve activation of the post-synaptic 
muscle membrane (Gerwin, RD, Dommerholt & Shah 2004). The TrP makes 
the muscle feel tense but is not associated with propagated action potentials 
that would be identified as EMG activity. Simons and Mense (1998) also 
highlighted the possibility that increased muscle tension may result from 
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alteration of the visco-elastic properties of the muscles (non-electrical) as 
opposed to contractile (electrical) changes.  
 
In direct opposition to the a vicious cycle explanation, Lund and colleagues 
(1991), suggested that pain itself, does not cause muscles to become 
hyperactive, but in fact, reduces the ability to voluntarily contract muscle 
fibers (Lund et al. 1991). They reported that when pain was experimentally 
induced in an animal study, EMG activity of the painful agonist muscle 
decreased but increased in its antagonist, presumably as a protective 
strategy to limit the range or velocity of movement. It was suggested by 
others that these changes in motor output resulted from alterations in the 
firing pattern of segmental interneurons in the spinal cord or brain stem 
(Westberg et al. 1997). This interaction (between muscle pain and muscle 
coordination) was termed the “Pain Adaptation Model” (Lund et al. 1991). 
However, though loss of voluntary muscle contraction may be caused by 
pain-mediated inhibition, it has also been shown to occur when pain is not 
present, as when saline is infused into the knee joint (Shakespeare et al. 
1985). Stokes and Young (1984) suggested that knee joint swelling produced 
by saline infusion resulted in quadriceps inhibition derived from joint afferent 
inhibition of α-motoneurons and that this was also the cause of atrophy over 
time (Stokes & Young 1984). Based upon his work on the vertebral column, 
Panjabi (1992) suggested that deterioration in muscle function, resulting from 
“disuse, degeneration, disease or injury” to the vertebral column could give 
rise to inaccurate feedback to neuronal control systems, thereby affecting 
spinal joint control (Panjabi 1992).  
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A further mechanism to explain how pain affects motor control was put 
forward by Sterling, Jull and Wright (2001). They suggested that reflexes 
mediated by pain, altered patterns of neuromuscular activation, delaying the 
activation of specific muscles or muscle groups thereby disturbing their 
synergies. This concept finds support in the work of several authors who 
demonstrated altered MAPs in the presence of pain including the transversus 
abdominis and multifidus in subjects with low back pain (Hodges, P. W. & 
Richardson, C. A. 1999), the deep neck flexors in whiplash patients (Jull 
2000) and the upward scapular rotators in subjects with shoulder 
impingement syndrome (Wadsworth & Bullock-Saxton 1997). Importantly, 
Hides and Richardson (1994) contended that though such changes might be 
initiated in the acute phase of an injury, they could persist into the period of 
chronicity. It has also been suggested that inhibition usually occurs in deep 
muscles of the joint involved and that these muscles act as joint stabilisers. 
(Hodges, P. & Richardson 1996). Perhaps lending support to this view, 
altered patterns of neuromuscular activation were found in a study of low 
back pain patients in whom selective fatigue of lumbar multifidus (lying deep 
to longissimus and iliocostalis) was detected using EMG, even though the net 
extensor torque remained unchanged (Hides, Richardson & Jull 1994). 
Furthermore, patients with spondylolysis or spondylolisthesis generated 
greater levels of activity in the superficial rectus abdominis (than controls), to 
stabilise the spine with abdominal straining manoeuvres which was 
considered by the authors to represent compensation for “loss” of control of 
the deep abdominal muscles which normally perform this function 
(O'Sullivan, P et al. 1997). Similarly, O’Sullivan and colleagues (1997), 
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suggested that the heightened EMG activity in superficial muscles that they 
observed in 12 chronic low back pain patients performing an abdominal 
“drawing in” manoeuvre could represent a measurable compensation for loss 
of segmental spinal support (O'Sullivan, P. et al. 1997). These findings 
implicate dysfunction of synergistic muscle control as a specific and 
important consequence of pain and injury (Sterling, Jull & Wright 2001). 
Furthermore, when experimental muscle pain was induced in 10 healthy 
subjects by intra-muscular injection of hypertonic saline into the trapezius, 
the investigators found that shoulder coordination was adversely influenced 
and a reorganisation of the pattern of muscle recruitment occurred during 
work related tasks such as cutting (Madeleine et al. 1999), increasing the 
evidence available that suggests that pain alters patterns of neuromuscular 
activation.  
 
The foregoing section demonstrates how pain can affect motor control 
through several mechanisms and in particular, by impinging on patterns of 
muscle activation. In contrast, Sterling and co-workers (2001) proposed that 
changes in motor control systems may occur before the onset of pain via 
some sort of afferent input that does not register consciously as pain. The 
consequence of this afferent input, for example due to LTrPs, may be to 
produce various patterns of reflex inhibition in the CNS and adversely affect 
motor control systems and decrease the effectiveness of movement. This 
process may potentially predispose to the development of pain in tissues 
exposed to changed loads as a consequence of the inefficient muscle 
activation (Sterling, Jull & Wright 2001). This suggestion aligns well with 
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Kibler’s (1998) proposal i.e. that dysfunction in one segment of a kinetic 
chain, causes ineffective or inefficient activation of muscles, predisposing 
muscles in related segments to alter their activation patterns in order to 
preserve normal movement more distally. Because of the clearly 
demonstrated affects of pain on muscle activation (as cited above), a pain 
producing entity like an ATrP would be expected to affect motor control in 
accordance with models (and material) discussed above including the 
Vicious Cycle, Pain Adaptation and Altered Patterns of Neuromuscular 
Activation models. However, whether Kibler’s proposal, “holds up” in the face 
of a non-painful lesion capable of producing sensory input, the LTrP, remains 
to be seen and was tested in the present investigation using the upper 
extremity kinetic chain operating in a common motor pattern, elevation of the 
arm in the scapular plane. Accordingly, whether taking a neurophysiological 
(Sterling, Jull & Wright 2001) or biomechanical (Kibler, W. B. 1998b) 
standpoint, it seems logical that the effects of lesions that allow pain-free 
movement, such as LTrPs, in a proximal segment of the upper extremity may 
produce effects that alter optimal MAPs and therefore movement efficiency 
and effectiveness of the entire upper limb. Given that decreased movement 
efficiency exposes ‘compensating’ tissues to altered functional loads, the end 
point of this process may be an overuse injury developing in the 
compensating structures. Such endpoints in the shoulder girdle include 
inflammatory or degenerative conditions of the rotator cuff, shoulder 
impingement syndrome (Michener, McClure & Karduna 2003) or ATrPs in 
overloaded muscles (Simons, D., Travell & Simons 1999), all conditions that 
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can cause significant disability and can be difficult to treat, making prevention 
of this process all the more appealing. 
 
 
2.3.2 Surface EMG in the measurement of muscle activation patterns 
 
Surface Electromyography (sEMG) of selected shoulder girdle muscles was 
the technique of choice to determine MAPs in the current work and has been 
employed by many authors (Christensen 1986; Ebaugh, McClure & Karduna 
2005; Elert et al. 2000; Gerdle, Edstrom & Rahm 1993; Hagberg 1981; 
Hermans & Spaepen 1997; Lucas, Polus & Rich 2004; Lundblad, Elert & 
Gerdle 1998) to investigate these muscles, though some have used 
indwelling fine wire bipolar electrodes for the infraspinatus muscle 
(Ballantyne et al. 1993; Kelly et al. 1996). In a closely related study 
Wadsworth and Bullock-Saxton (1997), used sEMG to measure the “time of 
onset” of the upward rotators (upper and lower trapezius; lower part of the 
serratus anterior) of nine young male swimmers with unilateral shoulder 
impingement syndrome during scapular plane elevation, with their main 
finding being that the timing of muscle activation was more variable in 
subjects with the shoulder condition as compared to matched controls 
(Wadsworth & Bullock-Saxton 1997). This work and others (referenced 
though not described, above), provide evidence that sEMG is a useful tool for 
the measurement of muscle activation patterns of the trapezius, serratus 
anterior, infraspinatus and middle deltoid during elevation of the arm in the 
scapular plane. 
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2.3.3 Development of the research hypotheses  
 
Unless being directly compressed, LTrPs are pain-free neuromuscular 
lesions that are thought to be prevalent and potentially can become activated 
to become spontaneously painful ATrPs that might ultimately develop into a 
recalcitrant Myofascial Pan Syndrome associated with pain and disability. 
Myofascial TrPs, whether active or latent, are most likely to develop in 
postural muscles that are exposed to prolonged or repetitive activity (Simons, 
D., Travell & Simons 1999). Postural muscles that can rotate the scapula, 
including all parts of the trapezius, serratus anterior, rhomboids major and 
minor, levator scapulae and pectoralis minor, are known to function in 
optimally positioning the scapula to facilitate effective transference of forces 
generated in the legs and torso to the upper extremity in order to move the 
hand and vice versa (Kibler, W. B. 1998b). The upward scapular rotators are 
responsible for this scapular positioning during arm elevation movements, the 
most common being elevation in the scapular plane (Michener, McClure & 
Karduna 2003). 
 
One measure of motor output that affects movement is MAPs where the 
temporal sequence of muscle activation is measured using 
electromyography. Pain, one type of sensory afferent input, is known to affect 
muscle activation, but the effects of LTrPs, which contribute afferent input 
that is not perceived as pain, on MAPs have not been investigated. Because 
LTrPs are pain-free with movement, any effects on MAPs found will not be 
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due to the presence of pain but presumably will occur in response to the 
sensory afferent input from the LTrP or other structures. 
 
If LTrPs are common in the scapular positioning muscles (chapter three), it 
would appear appropriate to investigate their effects on the MAP of 
functionally related shoulder girdle muscles during this common upper 
extremity movement. The muscles investigated in this study: upper and lower 
trapezius and lower serratus anterior (upward rotators of the scapula); the 
infraspinatus (stabilising function on the humeral head and part of the force 
couple for arm elevation with the scapular upward rotators) and the middle 
deltoid (abductor of the arm in the scapular plane) have different functional 
roles. This will allow study of the effects of LTrPs on the MAP of the upward 
scapular rotators and also to establish whether there is any alteration to 
functionally related muscles within the upper extremity kinetic chain in 
accordance with Kibler’s proposal (1998). It is clear from the research 
reviewed that the effects of LTrPs located in the scapular rotator muscles 
have the potential to produced effects that may adversely affect scapular 
positioning and movement of the upper extremity and importantly, to 
predispose an individual to a significant overuse injury of the shoulder. 
Therefore the following research hypotheses were formulated: 
 
1. LTrPs occur commonly within the scapular positioning muscles in a 
group of normal males and females (Chapter 3). 
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2. LTrPs in the scapular rotator muscles alter muscle activation patterns 
of these and functionally related muscles during elevation of the arm in 
the plane of the scapula under each of three conditions (Chapter 4): 
a. Unloaded  
b. Loaded 
c. Fatigued 
3. A commonly applied LTrP treatment (Superficial Dry Needling) is an 
effective means of “removing” LTrPs and restoring normal muscle 
activation patterns altered by their presence (Chapter 5). 
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CHAPTER 3 
 
 
THE PREVALENCE OF LATENT TRIGGER POINTS (LTRPS) IN THE 
SCAPULAR POSITIONING MUSCLES IN HEALTHY SUBJECTS 
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3.1 Introduction 
 
Myofascial trigger points (TrPs) are the characteristic clinical sign of 
Myofascial Pain Syndromes (MPS) that cause regional muscular pain 
(Simons, D., Travell & Simons 1999). There have been no large 
epidemiological studies specifically examining the prevalence of TrPs 
(Baldry, PE 2001), although anecdotal evidence from experienced examiners 
implies that pain caused by TrPs is a very common phenomenon (Huguenin, 
LK 2004; McCain 1994), particularly after trauma or sustained muscular 
fatigue. In support of this view, Rashiq and Galer (Rashiq & Galer 1999) 
found that 70 percent of 41 patients diagnosed with Complex Regional Pain 
Syndrome had TrPs in the proximal musculature of the upper limb. Other 
studies have reported TrPs as a source of pain in 50 percent of patients with 
temporomandibular disorders (Schiffman et al. 1990), 54 percent of patients 
presenting with head and neck pain (Fricton et al. 1985) and 30 percent of 
patients presenting with pain (unspecified) to a university medical centre 
(Skootsky, Jaeger & Oye 1989). Although the examination procedures used 
to identify TrPs were not uniform, making comparisons difficult, these studies 
lend support to the notion that pain due to TrPs is common in patients with a 
variety of pain complaints. 
 
There are two main classifications of TrPs: ‘Active’ and ‘Latent’. According to 
Simons (2004), an Active myofascial trigger point (ATrP) is a nodule of 
exquisite spot tenderness in a palpable taut band of skeletal muscle that can 
produce local or characteristic referred pain both spontaneously or when the 
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ATrP is compressed. Latent myofascial trigger points (LTrPs), on the other 
hand, are considered to be associated with muscle stiffness but are not 
painful unless directly compressed and are thought by some (Bonica 1957; 
Simons, D., Travell & Simons 1999), to be the clinical ‘forerunners’ of ATrPs 
and therefore myofascial pain. Experienced clinicians (Simons, D., Travell & 
Simons 1999) suggest that during manual palpation, ATrPs produce pain 
(local and often referred), motor dysfunction (muscle weakness, loss of 
coordination, decreased work tolerance) and autonomic phenomena 
(abnormal sweating, persistent lacrimation, excessive salivation, pilomotor 
activity). When stimulated appropriately, usually by ‘snapping palpation’ 
(plucking perpendicular to the muscle fiber direction) or by rapidly inserting a 
needle into the ATrP, a twitch contraction occurs within the fibers of the taut 
band containing the ATrP or within the fibers of another muscle with a taut 
band (Simons, D. G. 2004a). This Local Twitch Response (LTR) is a spinal 
cord reflex (Hong, C. Z. & Yu 1998) and is said to be the most reliable sign 
that an ATrP has been identified and effectively treated (Hong, C. Z. 1994b).  
 
When strongly stimulated (increased pressure), clinically silent LTrPs can 
elicit the clinical signs and symptoms listed above for ATrPs, (Hong, C. Z. 
1996), although the responses are usually less pronounced (Simons, D. G. 
2004a). With regard to the palpation pressure applied during physical 
examination of LTrPs, most earlier work relied upon the subjective judgment 
of experienced examiners to employ a pressure that would not cause pain in 
normal muscle. However, Hong and co-workers (Hong, C. Z. 1996) found 
that compression of normal muscle tissue near a LTrP produced referred 
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pain in 23 percent of subjects examined if there was no regulation of the 
pressure applied. Therefore it may be helpful to quantify the amount of 
pressure used to identify a LTrP, in order to decrease the likelihood of false-
positives. This idea was supported by Lew and colleagues (Lew, Lewis & 
Story 1997) and Gerwin and co-workers (1997) and later put into practice by 
Sciotti’s group (2001) who used an algometer to measure the pressure-pain 
threshold (PPT) of LTrPs in their investigation into the clinical precision of 
LTrP location in the trapezius muscle. In earlier work, Fischer (1987a, 1987b) 
used pressure algometry to measure the PPT of normal back and shoulder 
girdle muscles (Fischer, AA 1987b, 1987a). A mathematical algorithm was 
then employed to calculate the PPT below which a muscle could be 
considered abnormal. Fischer (1987a) noted that males and females had 
different PPT’s for the same muscles and that PPT’s decreased in a 
cephalad direction. These values were published (Fischer, AA 1987a) and 
are displayed in Table 3.1.  
 
Some confusion exists in the TrP literature as to which entity has been 
examined; ATrPs only or all TrPs, including LTrPs. While most investigations 
have been conducted in ‘patient’ populations (meaning the subjects definitely 
had ATrPs and possibly had LTrPs), there are few if any studies that have 
specifically investigated LTrPs or their relationship to ATrPs. Hong and 
Simons (Hong, C. Z. & Simons 1998) suggested that the sub-clinical LTrP 
could become a pain-causing ATrP if the cause of the LTrP was not 
addressed. If this is true, it follows that identification and treatment of LTrPs 
will reduce the incidence of myofascial pain. Given this hypothesis, it is 
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important to determine whether LTrPs are a common phenomenon in the 
scapular positioning muscles, a muscle group often subjected to postural 
overload in subjects who spend prolonged periods in inappropriate sitting 
postures (Simons, D., Travell & Simons 1999) which, according to the same 
authors, may increase the likelihood of developing LTrPs (Simons, D., Travell 
& Simons 1999) In addition, given the negative impact of shoulder disorders 
on workplace productivity (Svendsen et al. 2004) and the importance of the 
scapular positioning muscles in relation to upper limb function (Kibler, W., 
McMullen & Uhl 2000), this muscle group is often targeted during 
rehabilitation programs for patients with chronic shoulder pain due to altered 
motor control (Wadsworth & Bullock-Saxton 1997).  
 
The aim of the present study was to provide data on the prevalence of LTrPs 
in the scapular positioning muscles in a sample of normal men and women. 
This work was a prelude to investigations planned to investigate the effects of 
LTrPs on muscle activation patterns during scapular plane elevation of the 
arm. 
 
 
3.2 Subjects and Methods 
 
Upon gaining approval from the RMIT University Human Research Ethics 
Committee, 154 university staff and students volunteered to be assessed for 
joint and muscle dysfunction of the upper back, neck and shoulders. Subjects 
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were excluded if they had less than 160° of arm elevation, had a positive 
apprehension test (glenohumeral instability), positive upper limb tension test 
(neurological dysfunction) or significantly increased thoracic kyphosis (judged 
by clinical observation). Subjects were also excluded if they reported any 
pain in the back, neck or either upper limb any time in the week prior to the 
examination. After this assessment, the scapular positioning muscles of the 
137 remaining subjects were examined bilaterally for the clinical 
characteristics of LTrPs. The muscles examined were the pectoralis minor 
and serratus anterior (examined lying supine), all parts of the trapezius and 
rhomboids and the levator scapulae (examined lying prone). All examinations 
were carried out by the same trained and experienced (12 years) 
Myotherapist using procedures explained by Simons, Travell and Simons 
(Simons, D., Travell & Simons 1999) and employed by Lew and colleagues 
(Lew, Lewis & Story 1997) in their reliability study and briefly described as 
follows: The subject lay on an examination table in a warm and relaxed state 
with the upper body disrobed. The subject was then positioned to lengthen 
the muscle being examined to the point of a perceptible increase in 
resistance to movement. In this position, the normal muscle fibers are still 
slack but the fibers of any taut bands are placed under additional tension, 
rendering them more easily distinguishable. Next, cross-fiber palpation was 
used to identify any taut bands (Fig. 3.1), using “flat palpation” (trapping the 
LTrP between the examiner’s fingertips and underlying bone) for all muscles 
except the upper trapezius, which was examined using “pincer palpation” 
(trapping the LTrP between the examiner’s thumb and fingers). If a taut band 
was identified, the examiner then palpated along the taut band searching for 
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a slightly enlarged point or the ‘focus’ of the contraction. When the examiner 
had identified this point, the subject was asked if the point was tender when 
compressed manually. In the event of an affirmative response, the PPT of the 
point was measured with an algometer (Activator Methods Inc., Phoenix, 
Arizona, USA) (Fig. 3.2) using the procedure validated by Fisher (1987b). If 
the PPT was less than that of ‘normal’ muscle tissue (Table 1), the tender 
point was defined as a LTrP and its position documented on an enlarged 
body diagram. Pressure-pain threshold measurements were repeated three 
times and the mean recorded to improve reliability. All PPT measures were 
taken in quick succession (within approximately 30 seconds) due to the fact 
that LTrPs can be inactivated by sustained pressure (Hou, C. R. et al. 2002). 
The order of muscle assessment was randomised for each subject. This 
LTrP examination process was found to have high intra-examiner reliability 
(Kappa statistics= 0.71 to 1 muscle dependent; Intra-class correlation 
coefficient (ICC) for PPTs = .92) using a test/retest protocol with 30 minutes 
between examinations for the clinician who conducted all of the examinations 
(see Appendix C). Subjects were also asked if the pain was referred 
elsewhere before snapping palpation was applied in an attempt to elicit a 
LTR. When referred pain or a LTR was elicited, the event was documented, 
and used as additional confirmation of the presence of a LTrP. On the basis 
of Fischer’s work (1987a, 1987b) and other previously cited studies (Gerwin, 
R. D. et al. 1997; Hong, C. Z. 1996; Lew, Lewis & Story 1997; Sciotti et al. 
2001), the definition used to identify a LTrP in the current study became: 
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A tender point within a palpable taut band of skeletal muscle that had 
a PPT of less than that expected in normal muscle, with or without 
referred pain or an LTR. 
 
Table 3.1: Lowest PPT (kg/cm2) at which a muscle can be considered 
'normal' (Fischer, AA 1987b). 
 Males 
(kg/cm2) 
Females 
(kg/cm2) 
Upper trapezius 2.9 2.0 
Scapular muscles 3.6 2.7 
 
 
Finally, side dominance was determined by asking subjects with which hand 
they normally wrote. 
 
 
Figure 3.1: Palpation perpendicular to the direction of the muscle fibers 
to identify the taut band. 
 126 
 
 
Figure 3.2: Using the pressure algometer to measure the PPT of a 
tender point. 
 
 
3.3 Statistical Analysis 
 
The number of LTrPs identified and the muscles in which they occurred were 
tabulated and the means and the percentage of subjects with at least one 
LTrP determined. Relationships between variables were examined using 
either Pearson’s ‘r’ (number of LTrPs, age, muscles containing LTrPs) or 
Point biserial correlations (number of LTrPs, gender, staff member or student 
and side dominance). Differences between the number of LTrPs in the 
various muscles were determined using ANOVA. All calculations were made 
using the Statistical Package for the Social Sciences version 13 and 
significance was set as p<0.05 for all measurements. 
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3.4 Results 
 
General characteristics of the sample are presented in Table 3.2. Of the 137 
subjects examined (mean age = 34.0 ± 13.2 years; range = 18-60 years), 
89.8 percent had at least one LTrP in the scapular positioning muscles 
(mean=10.65 ± 6.8, range=1-27). Of the subjects with LTrPs, 62 percent had 
more LTrPs on the dominant side, 25 percent had more LTrPs on the non-
dominant side and 13 percent had the same number of LTrPs on both sides 
of the body.  
 
Table 3.2: Demographic data of the sample 
 LTrPs 
N=123 (89.8% of all subjects) 
No LTrPs 
N=14 (10.2% of all subjects) 
 Female 
N=63  
Male 
N=60 
Female 
N=7 
Male 
N=7 
Age 33.0 ±13.5 34.8 ± 13.7 37.4 ± 8.7 33.7 ± 9.2 
N staff (% ) 28 (44%) 32 (53%) 5 (71%) 4 (57%) 
N students (%) 35 (56%) 28 (47%) 2 (29%) 3 (43%) 
N R-handed (%) 59 (94%) 54 (90%) 7 (100%) 5 (71%) 
N L-handed (%) 4 (6%) 6 (10%) 0 (0%) 2 (29%) 
N=number of subjects; R-handed=right hand dominant; L-handed=left 
hand dominant. 
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Figure 3.3 shows the percentage of subjects who had at least one LTrP in 
any of the muscles examined. The upper trapezius (78.8 percent), pectoralis 
minor (77.3 percent), serratus anterior (71.5 percent), lower trapezius (70.4 
percent), levator scapulae (68.9 percent) and rhomboids (major and minor 
together) (65.9 percent) were more likely to have a LTrP than to not have one 
while middle trapezius was the least likely to have a LTrP (40.7 percent).  
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Figure 3.3: Percentage (%) of subjects with LTrPs by muscle. Dark 
columns are the % with at least 1 LTrP in that muscle. Light columns 
are the % with no LTrPs. Pectoralis minor (PM), serratus anterior (SA), 
upper trapezius (UT), middle trapezius (MT), lower trapezius (LT), 
rhomboids major and minor combined (RH), levator scapulae (LS). 
 
For the subjects who had LTrPs, Table 3.3 displays the mean number for 
females and males and compares the dominant and non-dominant sides. 
Because there were no significant differences between the genders for LTrPs 
(numbers, muscle and side), the table also shows the combined data. The 
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number of LTrPs was significantly higher (p<0.01) on the dominant side of 
the body for each muscle investigated. 
 
Table 3.3: Mean number of LTrPs (± SD) for females, males, muscles 
and dominant side of the body (LTrP absent subjects are not included) 
 Female Male Whole sample 
No. LTrPs total 11.10 ± 5.1 12.37 ± 5.4 11.72 ± 6.2 
Serr ant D 1.27 ± 1.0 1.38 ± 1.1 1.33 ± 1.1 
Serr ant ND 1.08 ±  1.0 1.18 ± 0.9 1.13 ± 0.9 
Upp trap D 1.06 ± 1.2 1.33 ± 0.6 1.2 ± 0.7 
Upp trap ND 1 ± 1.3 1.33 ± 0.7 1.16 ± 0.8 
Pec min D 1.02 ± 0.7 0.93 ± 0.8 0.98 ± 0.7 
Pec min ND 0.73 ± 0.7 0.77 ± 0.7 0.75 ± 0.7 
Rhoms D 0.89 ± 0.9 0.95 ± 0.9 0.92 ± 0.9 
Rhoms ND 0.68 ± 0.9 0.78 ± 0.8 0.73 ± 0.8 
Lev scap D 0.9 ± 1.0 0.88 ± 0.7 0.89 ± 0.7 
Lev scap ND 0.62 ± 1.1 0.68 ± 0.7 0.65 ± 0.6 
Lwr trap D 0.89 ± 0.6 0.85 ± 0.7 0.87 ± 0.7 
Lwr trap ND 0.52 ± 1.1 0.52 ± 0.6 0.52 ± 0.6 
Mid trap D 0.27 ± 1.1 0.47 ± 0.5 0.36 ± 0.5 
Mid trap ND 0.16 ± 1.4 0.30 ± 0.5 0.24 ± 0.4 
D=dominant side; ND=non-dominant side; Serr ant=serratus anterior; Upp 
traps=upper trapezius; Pec min=pectoralis minor; Rhoms=rhomboids major and 
minor; Lev scap=levator scapulae; Lwr traps=lower trapezius; Mid traps=middle 
trapezius. 
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No significant differences were found between gender, age or occupation 
and number of LTrPs. However, significant differences were identified 
between the mean number of LTrPs and the muscles in which they occurred 
(Table 3.4). The results revealed that the serratus anterior and upper 
trapezius were equally prone to have LTrPs (p>0.05) but had significantly 
more LTrPs than any of the other muscles (all p<0.01). Likewise pectoralis 
minor, rhomboids, levator scapulae and lower trapezius harboured a similar 
number of LTrPs (p>0.05) but all had more than middle trapezius (all 
p<0.01).  
 
 
Table 3.4: Differences in the number of LTrPs by muscle (mean ± SD) 
 
 
Significantly 
< 
(p<0.001) 
No significant 
differences in 
no. LTrPs 
Significantly 
< 
(0.001>p<0.01) 
No significant 
differences in 
no. LTrPs 
Middle 
trapezius 
(0.59 ± 0.8) 
< Pectoralis 
minor 
(1.72 ± 1.3) 
< Serratus 
anterior 
(2.46 ± 1.8) 
  Rhomboids 
(1.65 ± 1.4) 
 Upper 
trapezius 
(2.36 ± 1.3) 
  Levator 
scapulae 
(1.54 ± 1.2) 
  
  Lower 
trapezius 
(1.39 ± 1.0) 
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Two weak but significant point biserial correlations (p<0.01) were found 
between number of LTrPs and dominant side (r= 0.14) and between the 
number of LTrPs and staff member (r= 0.16). A further significant positive 
correlation (p<0.01) was identified using Pearson’s ‘r’ between the number of 
LTrPs and age (r= 0.18), suggesting that older subjects were more likely to 
have more LTrPs. No relationship was found between number of LTrPs and 
gender (p>0.05). 
 
 
3.5 Discussion of Results 
 
Although a number of studies have investigated the inter-examiner reliability 
of identifying both ATrPs and LTrPs in specific muscles (Gerwin, R. D. et al. 
1997; Lew, Lewis & Story 1997) and the inter-examiner precision in locating 
LTrPs (Sciotti et al. 2001), there have been no previous studies that have 
specifically examined the frequency with which LTrPs occur in the scapular 
positioning muscles. 
 
The objective of the present study was to determine how commonly LTrPs 
occur within the scapular positioning muscles of ordinary, healthy, pain-free 
adults. The results confirmed the popular clinical opinion that LTrPs are a 
common phenomenon with nearly 90 percent of 137 subjects harbouring at 
least one and often multiple LTrPs in this group of muscles (mean 11.72 for 
subjects that had LTrPs). In related early work Sola and co-workers (Sola, 
Rodenberger & Gettys 1955) investigated what they described as the 
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occurrence of “hypersensitive spots” in the posterior shoulder muscles of 200 
healthy, young military recruits. It was later suggested by Simons (Simons, D. 
1997) that the “hypersensitive spots” identified in 50 percent of this sample 
were probably LTrPs. The large discrepancy in occurrence of LTrPs between 
Sola’s findings (50 percent) and the present study (89.8 percent) may be due 
to the different populations investigated (active young military recruits 
compared with university staff and students in the current investigation). In 
the present study with subjects aged between 18 and 60 years, the 
correlation between age and the number of LTrPs was weak but significant 
(r= 0.18; p<0.01). This may have contributed to a higher occurrence of 
LTrPs, given subjects in the current study were older (18-60 years versus 18-
35 years) and likely to have spent more time in static postures (computer 
use, desk work and studying), which are thought to predispose to MTrP 
development (Simons, D., Travell & Simons 1999). Another explanation for 
the incongruence may lie in the improvement in trigger point examination 
techniques that have evolved, particularly in the last ten years. It should be 
emphasised that comparisons between the two studies can at best be 
speculative given the “suggested” presence of LTrPs in Sola’s study. Some 
of the same difficulties in comparing the current work with past reports is also 
evident when considering a more recent study in which Cimbiz et al. (Cimbiz, 
Beydemir & Mainisaligil 2006) studied 114 university students (mean age = 
22.2 years) divided into Myofascial Pain Syndrome (MPS) sufferers and 
controls for the presence of trigger points in a range of muscles between the 
occipital and knee regions. The description of trigger points detected in their 
control group (most comparable with the asymptomatic subjects of the 
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current study, N=60 range 18-30 years; mean 20.7 years) as ‘taut bands and 
nodules with minimal or no pain’, suggests that these were actually LTrPs. 
They found at least one trigger point in approximately 57 percent of their 
control subjects with a maximum of five. The trapezius was the most likely 
muscle to harbour a LTrP (35 percent). Excluding staff members and all 
subjects over 30 years of age from the data set of the present study (N=70; 
mean age = 22.9 ± 3.8 years) to provide a better comparison between the 
two studies, actually resulted in a slight increase in prevalence of LTrPs in 
the scapular positioning muscles (92.5 percent) for the current sample. 
Hence, the disparity in the results increased. Perhaps the different diagnostic 
criteria used to identify a LTrP in the two studies partially explain the 
difference. In addition, though there were a number of muscles common to 
both studies, among them, only results for the trapezius were reported in the 
Cimbiz (2006) publication, making too direct a comparison between the two 
studies problematic.  
 
In two small clinical investigations dealing with aspects of migraine 
(Fernandez-de-Las-Penas, C. et al. 2006) and chronic tension-type 
headache (CTTH) (Fernandez-de-Las-Penas, C et al. 2006), LTrPs were 
also found in the muscles of the control group subjects. The first study 
(N=20, suboccipital, upper trapezius, temporalis sternocleidomastoid) found 
LTrPs in all control subjects (mean 1.7±0.9), while in the second (N=25; 
upper trapezius, temporalis sternocleidomastoid) the mean was 1.4 LTrPs. 
However, it was not possible from the data reported in the CTTH subjects to 
determine the percentage of LTrP occurrence, though it was at least 48 
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percent. Interestingly in both studies there was no difference between the 
controls and sufferers in numbers of LTrPs. Furthermore, LTrPs were most 
often found in the upper trapezius in agreement with both Cimbiz (2006) and 
the results of the present study. 
 
In terms of the individual muscles examined, pectoralis minor was more likely 
to have at least one LTrP than serratus anterior (77.3 percent versus 71.5 
percent respectively). The seemingly contradictory finding of a greater 
average number of LTrPs in serratus anterior versus pectoralis minor despite 
a lower percentage of occurrence, is probably explained by more occasions 
of multiple LTrPs in the former. The upper trapezius was most likely to 
contain a LTrP (78.8 percent) but had fewer on average than the serratus 
anterior (2.36±1.3 versus 2.46±1.8 respectively), probably for the same 
reason. For the remaining muscles, the percentage of subjects possessing at 
least one LTrP decreased in the following order: lower trapezius (70.4 
percent) levator scapulae (68.9 percent) rhomboids (65.9 percent) but 
changed when the mean number of LTrPs was considered (rhomboids1.65 ± 
1.4; levator scapulae 1.54 ± 1.2; lower trapezius 1.39 ± 1.0) The “multiple 
LTrP explanation” might also account for the change in order though it should 
be remembered that the differences were not significant. The middle 
trapezius was least likely to harbour LTrPs (40.7 percent) and where LTrPs 
were identified, in most cases there was only one (mean=0.59± 0.8).  
 
The largest numbers of LTrPs were found in the serratus anterior and upper 
trapezius, supporting the accepted clinical view (Simons, D., Travell & 
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Simons 1999) and available experimental findings (Cimbiz, Beydemir & 
Mainisaligil 2006; Fernandez-de-Las-Penas, C et al. 2006; Fernandez-de-
Las-Penas, C. et al. 2006; Sola, Rodenberger & Gettys 1955) that the upper 
trapezius frequently develops LTrPs. Simons and collaborators (Simons, D., 
Travell & Simons 1999) discussed likely structural and functional reasons for 
this phenomenon and many authors have discussed the significance of 
trapezius myalgia (Larsson, B. et al. 2000; Larsson, B. et al. 2001; Larsson, 
R., Oberg & Larsson 1999; Lindman et al. 1991), of which LTrPs may be an 
early sign (Hong, C. Z. & Simons 1998). The high occurrence in these two 
muscles (78.5 percent upper trapezius; 71.5 percent, serratus anterior) 
perhaps reflects the synergy between these two muscles in producing 
scapular upward rotation which demands precise timing of muscle activation 
if the movement is to be efficient (Wadsworth & Bullock-Saxton 1997). The 
reasons for the overall descending order of prevalence: serratus 
anterior/upper trapezius > pectoralis minor/rhomboids/levator scapulae/lower 
trapezius > middle trapezius, perhaps also reflects the order of demand 
placed upon these muscles by common activities which may also be 
reflected by muscle size or functional capacity.  
 
In all muscles examined for the presence of LTrPs in the current work, 
subjects were significantly more likely to have a greater number of LTrPs in 
muscles of the dominant side (p<0.05). According to many authors (Cimbiz, 
Beydemir & Mainisaligil 2006; Dommerholt 2005; Fernandez-de-las-Penas et 
al. 2006; Gerwin, R. D. 2005; Simons, D., Travell & Simons 1999), MTrPs 
can develop due to mechanical loading of the muscle by either a sudden, 
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sustained or repetitive overload. That there existed a dominant side 
“preference” for LTrPs seems logical given the greater use of the dominant 
limb and therefore a greater exposure to conditions that may predispose to 
their development (fatigue etc). 
 
The reasons for the large disparity in the number of LTrP found in the five 
studies cited (at least 48 percent (Fernandez-de-Las-Penas, C et al. 2006); 
50 percent (Sola, Rodenberger & Gettys 1955); 56.6 percent (Cimbiz, 
Beydemir & Mainisaligil 2006); 89.8 percent current study; 100 percent 
(Fernandez-de-Las-Penas, C. et al. 2006)), are multiple (as previously 
discussed), however, combined, these investigations lend strong support to 
the notion that LTrPs are common in otherwise healthy people. 
 
 
3.6 Conclusions 
 
From these results, of the current study it can be concluded that LTrPs in the 
scapular positioning muscles are common in a sample of normal, healthy 
adult university students and staff and therefore, likely so in the broader 
population. Given that LTrPs might develop into ATrPs, which are often 
identified as the source of pain in patients with pain complaints, it is important 
to investigate the effects of LTrPs in their own right and also whether 
treatment of LTrPs affects the future development of ATrPs.  
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CHAPTER 4 
 
 
THE EFFECTS OF LTrPs ON MUSCLE ACTIVATION PATTERNS DURING 
SCAPULAR PLANE ELEVATION  
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Overview of Chapter 
This chapter presents three related experiments designed to establish the 
effects of LTrPs on the activation patterns of selected scapular muscles and 
representatives of the rotator cuff group during elevation of the arm in the 
scapular plane. All were carried out on the same 42 subjects, a subset of the 
original 154 volunteers described in Chapter 3 who provided data on the 
prevalence of LTrPs in the scapular rotator muscles. In the first (section 4.1, 
page 142), MAPs obtained from LTrP-free subjects (Controls) were 
compared with those obtained from subjects with LTrPs (LTrP group) in the 
scapular rotator muscles during unloaded scapular plane elevation of the 
arm. In the second (section 4.2, page 162), the same protocols were followed 
but with the addition of a load in the form of hand-held weights. The third 
experiment (section 4.3, page 176) explored the combined affects of fatigue 
and LTrPs by carrying out scapular plane elevation after fatigue induced by 
repetition of the test movement while carrying a load. In a fourth experiment, 
the subject of Chapter five, LTrP subjects were subjected to either an 
established LTrP treatment (superficial dry needling followed by post-
isometric relaxation, see Chapter 2, pages 74-78) or placebo and all of the 
scapular plane elevation protocols repeated (unloaded, loaded, post-fatigue). 
In this way, comparisons with pre-treatment conditions and control group 
results obtained from each experimental condition could be used to both 
confirm the effects of LTrPs on the criterion measurements (muscle 
activation patterns (MAPs)) as well as test the efficacy of the treatment. To 
clarify the sequence of events, a flow diagram has been provided (Figure 
4.1.1)  
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Figure 4.1: Outline of the experimental sequence 
 
154 
volunteers 
Fatiguing protocol.  
Loaded repetition of the test movement 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane – loaded 
(hand-held weights) 
 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane – rested and 
unloaded 
Tests for presence of LTrPs – 
Prevalence Study (Chapter 3) 
14 
controls 
28 LTrP 
subjects 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane –post fatigue 
with load (hand-held weights) 
 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane –post fatigue, 
unloaded 
Control group subjects–end of experimental work. 
Random assignment of LTrP subjects to placebo or true 
treatment interventions. 
MAP investigations repeated for LTrP subjects post-
interventions 
Presented in 
Chapter 4 
Presented in 
Chapter 5 
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In summary, the following questions were addressed: 
1. Do LTrPs in the scapular rotator muscles alter their activation patterns 
(MAPs) during the performance of a common movement (scapular plane 
elevation of the arm)? 
2. What affect (if any), do they have on the activation patterns of muscles 
placed more distally in the kinetic chain of the upper limb? 
3. Does adding resistance to the criterion movement, affect the MAPs 
displayed by LTrP subjects? 
4. Does inducing fatigue in the affected muscles affect the MAPs displayed 
by LTrP subjects during production of the criterion movement? 
5. Does a commonly employed TrP treatment (superficial dry needling see 
page_) reverse any altered MAPs that might be attributable to the 
presence of LTrPs (questions 1 and 2. Presented in Chapter 5)? 
The current Chapter is divided into three sections, each dealing with one of 
the experimental conditions presented in Table 4.1.1 and each is more or 
less self-contained with its own introduction, description of methods, 
statistics, results, discussion and conclusions. Such an approach means 
some repetition of material presented in earlier Chapters however, it has the 
advantage of avoiding constant cross referencing.  
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Table 4.1.1: Experimental conditions investigated. 
Condition Section 
Rested and unloaded 4.1 The effect of LTrPs on MAPs during scapular 
plane elevation 
Rested and loaded 4.2 The effect of LTrPs on MAPs during loaded 
scapular plane elevation 
Post-fatigue, unloaded 4.3 The effect of LTrPs on MAPs post-fatigue 
during scapular plane elevation 
Post-fatigue, loaded 4.3 The effect of LTrPs on MAPs post-fatigue 
during loaded scapular plane elevation 
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4.1 The Effects of LTrPs in the Scapular Rotator Muscles on MAPs  
during Elevation in the Scapular Plane. 
 
 
4.1.1 Introduction 
 
Many clinicians suggest that it is useful to view the musculoskeletal system 
as a series of segments linking to form kinetic chains that transfer force in a 
coordinated manner to produce movement at more distal or proximal 
segments in any chain (so-called closed and open kinetic chain movements 
respectively) (Kibler, W. B. 1998b). Kibler (1998) suggested that deficiencies 
(due for example, to injury, overload, fatigue or TrPs), in proximal segments 
of such systems, could change the loading patterns in related distal 
segments and thereby compel changes in muscle recruitment patterns 
distally as the nervous system sought to preserve normal movement 
outcomes. If this be true, various musculoskeletal conditions (overload, 
inflammatory or degenerative) affecting structures in one segment of a kinetic 
chain, might predispose tissues in other segments to injury/dysfunction 
because of altered loading patterns (Kibler, W. B. 1998b). For the upper 
extremity, the scapula and the muscles attaching it to the vertebrae and ribs, 
(trapezius, serratus anterior, rhomboids, levator scapulae and pectoralis 
minor), can be considered to constitute the proximal segment linking the 
trunk to the upper limb (Burkhart, S. S., Morgan & Kibler 2003b, 2003a; 
Kibler, W. B. 1998b, 1998a; Van der Helm et al. 1992). In order for the 
scapula to be positioned and moved effectively in its role of force 
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transference to and from the upper limb, the scapular positioning muscles 
must be recruited in optimal patterns (MAPs). Hence, any disturbance to the 
normal pattern of recruitment could be transferred “downstream” promoting 
abnormal patterns distally, for example in the infraspinatus and rotator cuff, 
and in consequence, exacerbating the original problem or potentially 
developing a new problem. 
 
Scapular dyskinesis describes an alteration in the normal position or motion 
of the scapula during coupled scapulohumeral movements (Burkhart, S. S., 
Morgan & Kibler 2003b) that is commonly associated with compression of the 
contents of the subacromial space (subacromial impingement syndrome) 
which can lead to inflammatory or degenerative changes in these structures 
as well as to the appearance of TrPs due to overload in muscles attempting 
to cope with shoulder joint pathology (Brossmann et al. 1996; Burkhart, S.S. 
2006; Hebert et al. 2002; Sevinsky 2006). This relatively common upper 
extremity condition highlights the need to maintain normal scapular muscle 
control which may be lost if Kibler’s propositions are correct. For example, 
Wadsworth and Bullock-Saxton (1997) investigated the MAPs of the scapular 
upward rotator muscles of nine young elite male swimmers with unilateral 
chronic shoulder impingement syndrome and compared them to matched 
controls during elevation of the arm in the scapular plane. They found that 
chronic shoulder pain was associated with an increased variability in the 
timing of muscle activation in these muscles, however, they were unable to 
establish a cause and effect relationship since it was impossible to determine 
which condition (altered MAPs or impingement) occurred first. Importantly 
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with regard to the present focus on LTrPs, Sterling and colleagues (2001) 
suggested that changes in motor control could occur through a process of 
reflex inhibition secondary to non-painful sensory input (mechanoreceptors) 
which in turn could eventually lead to the development of pain. They felt that 
this phenomenon might explain the persistent weakness and atrophy 
observed in the quadriceps muscles after non painful knee damage without 
effusion (Hurley 1997; Sterling, Jull & Wright 2001). Latent myofascial trigger 
points (LTrPs) are pain-free neuromuscular lesions that are associated with 
muscle overload and decreased contractile efficiency (Simons, D., Travell & 
Simons 1999) and there is evidence that these lesions are common (Simons, 
D., Travell & Simons 1999) (see also Chapter 3), suggesting that they 
deserve investigation. The following section presents an investigation into the 
effects of LTrPs in the scapular rotator muscles on MAPs during scapular 
plane elevation of the arm in both the muscles harbouring them and those 
downstream in the upper extremity kinetic chain.  
 
 
4.1.2  Methods 
 
4.1.2.1 Subjects 
 
The subjects were a subset of those who were recruited for the prevalence 
study described in Chapter 3. Of the original 154 pain-free volunteers, 14 met 
the criteria for inclusion in this part of the investigation as “controls” that is, 
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they were the only subjects with healthy shoulders and no LTrPs (see 
Chapter 3). From the 140 LTrP sufferers, the first twenty-eight subjects who 
were assessed as having healthy shoulder girdles and at least one LTrP in 
the scapular positioning muscles on the dominant side, were invited to 
participate in the remaining components of the study and in due course, were 
randomly assigned to receive either treatment (N=14) or sham treatment 
(N=14) in the final investigations where the effects of superficial dry needling 
were tested (Chapter 5). Subjects were excluded if they had less than 160° 
of arm elevation, had a positive apprehension test (glenohumeral instability), 
positive upper limb tension test (neurological dysfunction) or significantly 
increased thoracic kyphosis (judged by clinical observation), reported any 
pain in the back, neck or either upper extremity any time in the week prior to 
the examination, or harboured LTrPs in the infraspinatus or middle deltoid 
muscles on the dominant side. Subjects were examined bilaterally for the 
clinical characteristics of LTrPs in the pectoralis minor, serratus anterior and 
middle deltoid (examined lying supine), all parts of the trapezius and 
rhomboids, the levator scapulae and the infraspinatus (examined lying 
prone). Examinations of infraspinatus and middle deltoid were carried out to 
ensure that they harboured no LTrPs which could have affected muscle 
activation patterns either intrinsically and/or in related muscles. All 
examinations were carried out by the same trained and experienced (12 
years) Myotherapist using procedures explained by Simons, Travell and 
Simons (Simons, D., Travell & Simons 1999) and employed by Lew and 
colleagues (Lew, Lewis & Story 1997) in their reliability study. A full 
description of the LTrP examination process was provided in Chapter 3 (page 
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122). For reasons detailed in Chapter 3 (page 124), the definition used to 
define a LTrP in the current study became: 
A tender point within a palpable taut band of skeletal muscle that had 
a PPT of less than that expected in normal muscle (see Table 4.1.2), 
with or without referred pain or an LTR. 
 
Table 4.1.2: Lowest PPT (kg/cm2) at which a muscle can be considered 
'normal' (Fischer, 1987). 
 Males (kg/cm2) Females (kg/cm2) 
Upper trapezius 2.9 2.0 
Scapular muscles 3.6 2.7 
 
All participants gave informed consent and all procedures were approved by 
the RMIT University Human Research Ethics Committee. Characteristics of 
the experimental groups are provided in Table 4.1.3. 
 
Table 4.1.3: Characteristics of experimental groups. 
Group No. LTrPs 
present 
Mean Age 
(yrs) 
No. of 
Females 
No. of 
Males 
Control 14 No 35.6 ±  8.6 7 7 
LTrP  28 Yes 33.86 ±  11.4 12 16 
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It should be recalled that nearly 90% of the original volunteers (Chapter 
three) had at least one LTrP (mean =10.65) in the muscles examined and for 
the present study, all 28 LTrP subjects had at least one LTrP in the scapular 
rotator muscle group of the dominant arm, however mean number and 
standard deviation (SD) of LTrPs are described for each scapular positioning 
muscle in Table 4.1.4. 
 
Table 4.1.4: Mean number and standard deviation of LTrPs by muscle in 
the LTrP group (N=28) in the dominant upper extremity. 
 
PM 
 
SA 
 
UT 
 
MT 
 
LT 
 
RH 
 
LS 
 
TOTAL 
SRM 
Mean 0.86 1.75 1.39 0.36 1.00 1.11 0.71 13.50 
SD 0.76 1.04 0.69 0.56 0.72 0.96 0.76 4.99 
% of subjects 64 82 93 32 79 64 56 100 
PM=pectoralis minor; SA=serratus anterior; UT=upper trapezius; MT=middle 
trapezius; LT=lower trapezius; Rh=rhomboids major and minor combined; 
LS=levator scapulae; Total SRM=total number of LTrPs in the scapular 
rotators as a group; SD=standard deviation. 
 
4.1.2.2 Time of onset of muscle activation 
 
Surface electromyography (sEMG) was used to measure time of onset of 
muscle activity for five muscles of the dominant arm, chosen on the basis of 
accessibility (for sEMG) and their known functions as either scapular rotators, 
muscles of the rotator cuff group or prime movers for glenohumeral 
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abduction. Specifically, the upper and lower trapezius and serratus anterior 
represented upward scapular rotators, the infraspinatus, the rotator cuff 
group and the middle deltoid, a prime glenohumeral abductor. The 
infraspinatus and deltoid belong to a functionally different muscle group than 
the scapular rotators and represent a more distal component of the upper 
extremity kinetic chain. Importantly, Laursen and colleagues (2003), on the 
basis of their biomechanical model, (which used predicted EMG activity to 
establish the roles of selected shoulder muscles), concluded that the 
glenohumeral stabilising role of the infraspinatus was more important than its 
role as an external rotator (Laursen, Sogaard & Sjogaard 2003). This factor 
and the muscle’s amenability to sEMG (compared with the specialised 
abducting role and deep position of supraspinatus), provided the rationale for 
its selection as a representative of the rotator cuff muscles in the current 
work. 
 
Bipolar Ag/AgCl electrodes (3M Red Dot) were used and were positioned 
according to Cram and colleagues (Cram, Kasman & Holtz 1998) using a two 
centimetre inter-electrode distance. The raw EMG signal from each muscle 
was collected using an eight channel data recording system (Powerlab, 
ADInstruments, Castle Hill, NSW). The EMG signal was amplified, filtered 
(low pass=500Hz, high pass 10Hz), rectified then smoothed using a root 
mean square (RMS) calculation. The sampling speed was 2000 samples/sec. 
A custom built microswitch was placed on the subject's thigh to align with the 
ventral forearm, immediately proximal to the wrist creases. When the forearm 
moved away from the body a voltage change was recorded, signifying the 
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start of the movement. This enabled the time of onset of muscle activity to be 
normalised to the start of the movement. The test movement was carried out 
according to the procedures reported by Wadsworth and Bullock-Saxton 
(1997). Plane of motion, standing posture, and postural sway were controlled 
by asking the subjects to look at a target approximately two metres ahead of 
them positioned at eye level and to lightly brush wooden movement guides 
(vertical wooden panels set at appropriate angles) while velocity of 
movement was controlled by asking subjects to move in time with a 
metronome set at 60 beats per minute, with four beats to raise and four beats 
to lower the arm, equivalent to 40 degrees per second (Figures 4.1.2 and 
4.1.3). 
 
Figure 4.1.2: Starting position of the test movement. 
Movement guides 
Microswitch 
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Figure 4.1.3: Performing elevation of the arm in the scapular plane. Note 
lateral aspect of the index finger remains in contact with the movement 
guide to restrict external rotation of the shoulder at the top of the 
movement. 
 
Elevation of the arms in the scapular plane was performed without allowing 
the subject to externally rotate at the end of the range (Figure 4.1.3). This 
was accomplished by instructing the subjects to maintain contact of the 
lateral surface of the index finger with the movement guides throughout the 
movement. This strategy restricted subjects to 160° of abduction but allowed 
the infraspinatus to act as a glenohumeral stabiliser rather than as a prime 
mover for external rotation. Prior to application of sEMG, subjects practised 
the velocity of movement in time with the metronome until they could reliably 
Microswitch 
Lateral surface of 
index fingers lightly 
brushing the 
movement guides 
limits elevation range 
to approximately 160° 
and restricts external 
rotation at the end of 
the range of motion 
Movement guides 
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reproduce the required velocity. After adequate rest (5 -10 minutes), subjects 
performed three trials of the movement in time with the metronome with a 
four second rest between trials to re-establish a stable electrical baseline. To 
identify the onset of muscle activity, the algorithm suggested by Hodges and 
Bui (1996) for a low-noise signal (10ms windows, 1 standard deviation above 
the baseline and 500hz low pass filter) was employed (Hodges, P. W. & Bui 
1996). The time of onset of muscle activity was defined as the time at the 
start of the first 10ms window whose mean was more than one standard 
deviation (SD) above the mean of the baseline. The accuracy of this process 
was confirmed by a visual inspection to ensure the time identified as the 
beginning of muscle activity was not associated with ECG or other artefact. 
 
4.1.2.3 Statistical Analysis 
 
An independent t-test was used to test for differences in the mean muscle 
activation times for the control and LTrP groups and the F statistic was used 
to identify significant differences in the variability of activation times between 
groups and was calculated by dividing the variance of one group (higher 
value variance) by the variance of the other group (lower value) and then 
compared to the appropriate critical value of F. The significance level was set 
at p<0.05 for all comparisons. 
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4.1.3  Results  
Group data are depicted in Table 4.1.5 and Figure 4.1.4 and show the mean 
(solid circles) and SD (bars) of activation times for each muscle for both 
groups. Examples of raw sEMG are provided in Figures 4.1.4 and 4.1.5. 
 
4.1.3.1 Control group MAP 
The control group displayed a relatively stable, sequential MAP with all 
subjects demonstrating the same order of muscle activation which consisted 
of the upper trapezius (UT) always activated first, on average 115ms prior to 
movement start. Immediately after the arm left the side of the body, the 
infraspinatus (Inf) (mean=75ms) and the middle deltoid (MD) (mean=201ms) 
were activated. The serratus anterior (SA) and lower trapezius (LT) were 
activated 433ms and 776ms after movement start respectively and displayed 
more variability in activation times than did the preceding three muscles as 
evidenced by the length of the SD bars in Figure 4.1.4.  
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Figure 4.1.4: Raw sEMG from an individual control group subject.
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4.1.3.2 LTrP group MAP 
 
In contrast to the control group, the only consistency in the order of muscle 
activation for the LTrP group was that Inf was activated first in 13 out of 14 
subjects (92.9%). Beyond this finding, the order of muscle activation was 
inconsistent across the group with the most common activation sequence 
being Inf activated prior to movement start, UT approximately as the arm 
began to move, then SA, MD and LT after movement start respectively (three 
out of 14 subjects, 21.4%). With regard to the mean activation pattern for the 
group, Inf was activated 153ms prior to movement start, followed by UT 
(27ms), MD (142ms), SA (212ms) and LT (477ms) after movement start 
respectively. 
 
 
 
 
 
Infraspinatus: -150ms 
Figure 4.1.5: Raw sEMG from an individual LTrP group subject 
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Significant differences (p<0.05) between groups for mean activation times 
were found for all muscles except the MD. In addition, the variability in 
muscle activation times was significantly greater for all muscles in the LTrP 
compared with the controls. 
 
Table 4.1.5: Mean muscle activation times for the control and LTrP 
groups in the rested state. 
 UT Inf MD SA LT 
Control -115 75 201 434 776 
LTrPs  27*# -153*# 142# 212*# 477*# 
* significant difference in activation times. # significant difference in the 
variability of activation times (p<0.05). UT=upper trapezius, Inf=infraspinatus, 
MD=middle deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 4.1.6: The effects of LTrPs on MAPs during scapular plane 
elevation (mean and SD displayed). Time ‘0’ is the time at which the arm 
left the side of the body as measured by the microswitch. 
 
 
4.1.4  Discussion of Results 
 
In this study the control group displayed a relatively stable and sequential 
MAP with the UT consistently activated before movement start. As shown by 
Bagg and Forrest (1986), the instantaneous centre of rotation (ICR) of the 
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scapula is located near the root of the spine of the scapula during the initial 
phase of elevation of the arm in the scapular plane (the first 60-90°), giving 
the UT an advantageous moment arm and length-tension relationship for 
elevating the lateral clavicle and acromion, perhaps to maintain/increase the 
subacromial space guarding against superior translation of the humeral head 
(Bagg & Forrest 1986; Graichen et al. 1999). The initial activity (at -115ms) in 
the UT was not enough to cause the arm to leave the side of the body and 
thus activate the microswitch, suggesting this initial UT activation was aimed 
specifically at elevating the acromion, rather than the entire arm. The Inf was 
activated 75ms after movement start (on average), perhaps in keeping with 
its primary roles in the early phase of scapular plane elevation: resisting 
superior and anterior translation of the humerus by compressing the head 
against the glenoid fossa (thereby preventing the excessive translations 
associated with subacromial impingement syndrome) and contributing to a 
force couple with the other rotator cuff muscles for abduction of the humerus 
(Halder et al. 2001; Sharkey & Marder 1995). Interestingly, the MD was not 
activated until some 200ms after the arm left the side of the body, adding 
support to the notion that other muscles such as the remaining members of 
the abduction force couple (Inf, supraspinatus and subscapularis), are 
responsible for initiating the movement of the arm from the side of the body 
(Michener, McClure & Karduna 2003). Although only five muscle activation 
times were analysed and no kinematic data were collected in this study, 
based on the movement speed of 40°/sec, it can be estimated that at 200ms 
post movement start (MD activation), the arm would be in the vicinity of 8° of 
abduction. In contrast, the Inf was activated on average within 75ms of 
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movement start, which places the arm within the first 3° of abduction at the 
time. According to Liu and colleagues (1997), the supraspinatus has its peak 
moment arm at approximately 30° of scapular plane elevation, suggesting 
that the supraspinatus might not be in a position to initiate arm movement on 
its own (Liu et al. 1997), however length/tension factors should also be 
considered. Given the importance of coordinated movement of the functional 
segments of the upper extremity to facilitate efficient scapular plane elevation 
(Kibler, W. B. 1998b), it appears most likely that the coordinated actions of 
the UT and rotator cuff combine to produce the first few degrees of arm 
elevation while acting to preserve the subacromial space, though onset data 
from other rotator cuff muscles would be useful to confirm this proposal. The 
early activations of UT and Inf immediately prior to and after movement start 
respectively, indicate that these muscles play important roles in initiating 
elevation of the arm in the scapular plane compared with the much later 
onsets for SA and LT (433ms and 776ms after movement start respectively). 
These data support an early report by Bagg and Forrest (1988) who found 
that SA and LT probably have their most favourable combination of moment 
arm (Bagg & Forrest 1986) and length/tension relationship (Neumann 2002) 
once the glenoid has rotated superiorly and the ICR of the scapula had 
migrated laterally (Bagg & Forrest 1988).  
 
A significantly different (p<0.05) temporal sequence of muscle activation was 
found in both the scapular rotators and shoulder muscles when LTrPs were 
present in the scapular rotator muscles, suggesting that LTrPs do indeed 
affect MAPs in the “parent” muscle group and functionally related muscles in 
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the upper extremity chain. This contention was further supported by the 
significantly greater variability in muscle activation times, indicative of less 
consistency in activation patterns, for all five muscles in the LTrP group. 
Interestingly, increased variability of MAPs is a feature that has often been 
associated with muscle fatigue (Chabran, Maton & Fourment 2002) and joint 
injury (Wadsworth & Bullock-Saxton 1997). This finding (greater variability in 
muscle activation times) indicates that LTrPs force an alteration in the 
strategy used by the CNS to elevate the arm and perhaps these patterns 
represent coping behaviours associated with decreased movement 
efficiency. In fact, the only “reliable” aspect of the LTrP group pattern was 
that the Inf was commonly activated first (92.9% of trials), and the UT just 
prior to or immediately after movement start (±90ms from movement start in 
57.1% of trials). Alternatively, perhaps the descending commands remain the 
same, but they meet motoneurons that are unable to respond appropriately 
due to inhibitory influences set in train by the presence of LTrPs with a 
resultant change in order of activation (Taylor, Butler & Gandevia 2000). 
Some of the potential mechanisms for these propositions are presented in 
Chapter 5, page 220. 
 
Given the high likelihood of LTrP group subjects having a LTrP in the UT 
(93% of 28 otherwise asymptomatic subjects, Table 4.1.4, page 147) it is 
important to note that when the UT contained a LTrP, the UT was activated 
at approximately the same time as the arm began to move from the side of 
the body, whereas when this muscle was LTrP-free (control group), it was 
clearly activated before the arm began to move. If one of the intentions of an 
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early activation of UT is to begin elevating the acromion via the AC joint to 
create increased subacromial space, then later or inefficient activation of this 
muscle during this movement may predispose an individual to impingement 
of structures between the humeral head and the inferior surface of the 
acromion. Furthermore, where LTrPs existed in the scapular positioning 
muscles, the Inf was activated 153ms before the arm left the body instead of 
immediately after movement start, as was the case in the control group. This 
implies that the Inf may be active for longer when LTrPs are present in the 
scapular rotator muscles, an interesting possibility given the high prevalence 
of rotator cuff overload and tendinitis in many countries (Netherlands (van der 
Windt et al. 1995), Britain (Ostor et al. 2005) and Australia (Green, 
Buchbinder & Hetrick 2003). Perhaps increased duration of activation of Inf 
along with an altered, and possibly less effective MAP overall, due to LTrPs, 
contributes to the occurrence of this phenomenon? 
 
Due to the fact that the human musculoskeletal system is a redundant 
system with more muscles involved in the generation of joint torque than the 
number of degrees of freedom of the joint (Bernstein 1967), humans can 
generate the same joint torque with numerous combinations of MAPs (Yao, 
Acosta & Dewald 2006). Therefore, individuals can use different MAPs to 
achieve the same motor task with varying degrees of efficiency. In the only 
other study to date to specifically measure MAPs in the scapular rotator 
muscles, Wadsworth and Bullock-Saxton (1997) investigated the temporal 
sequence of recruitment of the upward scapular rotator muscles in nine 
competitive young freestyle swimmers with unilateral shoulder pain including 
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signs of impingement and compared them to matched controls. In the control 
group, they found that UT was activated 217ms prior to movement start and 
the SA and LT were activated 53ms (approximately 2° of abduction based on 
movement speed) and 349ms (approximately 15° of abduction based on 
movement speed) after movement start respectively (Wadsworth & Bullock-
Saxton 1997). These authors reported control group mean activation times in 
their study that differed from those of the control group in the present study 
(UT -217 Vs -115; SA 53ms Vs 433ms and LT 349ms Vs 776ms), but the 
order of activation for the scapular rotator muscles was the same (UT prior to 
movement start, followed by SA, then LT after movement start). These 
differences may be due to the different populations investigated (young 
competitive male swimmers (mean age=19.3years) Vs female and male 
university staff or students (mean age=35.6years)) or the fact that the former 
study defined the muscle as ‘activated’ when the EMG trace was more than 
five percent higher than the baseline, whereas in the current study, a different 
algorithm was employed to determine onset (10ms ‘sliding window’ with 1SD 
above the baseline). In both studies visual verification of the trace was used 
to eliminate artifact. Interestingly, though the activation times differed 
between the respective control groups (Wadsworth and Bullock-Saxton and 
the current study), there were no significant differences in the variability of 
onset times (found by squaring the SD to calculate the variance, then dividing 
one group variance by the other to calculate the F statistic) for any of the 
muscles common to the two studies (Table 4.1.6). In addition, the 
experimental groups in both studies demonstrated significantly increased 
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variability in activation times when compared with their respective control 
groups. 
Table 4.1.6: Comparison of mean activation times (±SD) for the upward 
scapular rotator muscles during scapular plane elevation between the 
Wadsworth and Bullock-Saxton (1997) study and the current study. 
Studies and groups UT SA LT 
Wadsworth and Bullock-Saxton:  
control MAP (ms) 
-217 ± 110 53 ± 478 349 ± 340 
Current study: control MAP (ms) -115 ± 28 433 ± 93 776 ± 177 
Wadsworth and Bullock-Saxton:  
SIS MAP (ms) 
-138 182 498 
Current study: LTrP MAP (ms) 27 ± 132 212 ± 215 477 ± 401 
UT=upper trapezius, SA=serratus anterior, LT=lower trapezius, SIS=shoulder 
impingement syndrome, MAP=muscle activation pattern, (ms)=milliseconds. 
‘-‘ = muscle activated prior to the arm leaving the side of the body. Standard 
deviations for the SIS group of the Wadsworth and Bullock-Saxton (1997) 
study were not available. 
 
4.1.5  Conclusions 
 
The presence of LTrPs in the scapular rotator muscles was associated with 
changes in motor control patterns in the absence of pain, manifested as 
altered activation times and increased variability of muscle activation 
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patterns. Such changes may predispose individuals to increased risk of 
subacromial impingement, overuse of the infraspinatus due to earlier 
activation and decreased efficiency of movement with earlier onset of fatigue 
during scapular plane elevation. 
 
LTrPs in the scapular rotator muscles do alter the timing and decrease the 
consistency of the MAPs of this muscle group and functionally related 
muscles more distally placed in the upper extremity chain. These findings 
occurred in the absence of pain and may have implications for overuse 
syndromes (rotator cuff), shoulder impingement syndrome, and less effective 
motor control in “overhead” movement patterns in general.  
 
Having found evidence that LTrPs have significant effects on the timing and 
consistency of MAPs in unloaded motion, section 4.2 details an investigation 
into the effects of LTrPs in the scapular rotators during elevation of the arm in 
the scapular plane holding a light load, replicating a movement task that may 
be performed in many daily work and sporting activities. 
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4.2 The Effects of LTrPs in the Scapular Rotator Muscles on MAPs  
during Loaded Elevation in the Scapular Plane. 
 
 
4.2.1 Introduction 
 
While maximal external loads have been found to alter scapulohumeral 
rhythm during arm elevation in the scapular plane in healthy subjects 
(McQuade & Smidt 1998), two three-dimensional studies found that light 
loads of 0-3kg, (de Groot, van Woensel & van der Helm 1999) and 0-4kg 
(Pascoal et al. 2000) had no affect on clavicular or scapular kinematics 
during scapular plane elevation. However, none of these data shed light on 
what influence LTrPs might have on MAPs when light loads are lifted. Having 
found evidence that LTrPs have significant affects on the timing and 
consistency of MAPs in unloaded motion (section 4.1, page 152), the 
following study was carried out to test the proposition that light loads would 
increase the degree of dysfunction produced by LTrPs in the scapular 
rotators during execution of the same common movement pattern, elevation 
of the arm in the scapular plane. 
 
4.2.12.1 Questions addressed: 
 
1. Do loads commonly encountered in daily activities alter the 
MAPs of functionally related muscles during scapular plane 
elevation in ‘LTrP-free population’? 
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2. Do LTrPs in the scapular rotator muscles produce different 
MAPs during scapular plane elevation in response to the same 
light loads? 
 
 
4.2.2  Methods 
 
4.2.2.1 Subjects and Procedures 
 
For this experiment, the same subjects formed the control and LTrPs groups 
(Section 4.1) respectively and sEMG was recorded in the loaded 
experimental condition approximately five minutes after the unloaded data 
were collected, during which time the subjects rested with electrodes still in 
place. The procedures used in this experimental condition were almost 
identical to those reported in section 4.1 (page 144), with the exception that 
subjects were asked to hold one of two hand-weights (1.3kgs or 4kgs), while 
performing elevation in the scapular plane. The loads were chosen on the 
basis of subject feedback during pilot testing, when 1.3kg and 4kg hand-
weights were selected by most females and males respectively, when asked 
to choose a weight that they regularly lifted. Therefore these loads were 
considered to be representative of those that might be encountered in 
activities of daily living or work-related tasks for the subjects in the current 
study. To maintain scapular plane motion, this time, the end of the weight 
was brushed along the movement guides rather than the index finger (Figure 
4.2.5).  
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Figure 4.2.1: Loaded elevation in the scapular plane with hand-held 
weights gently brushing the movement guides to control plane of 
motion. 
 
4.2.2.2 Statistical Analysis 
 
To test for the effects of load on the MAPs during the test movement in both 
the control and LTrP groups, paired t-tests were employed and the 
comparison was made with the data collected in the first experiment (see 
section 4.1, page 151), where the same subjects (in control and LTrP groups) 
performed unloaded elevation in the scapular plane. To test for the effects of 
LTrPs on MAPs during loaded scapular plane elevation, an independent t-
test was employed to examine differences in the mean activation times of the 
control and LTrP groups for all muscles. F statistics were used to compare 
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the variability in the muscle activation times both within and between groups. 
The significance level was again set at p<0.05 for all comparisons. 
 
4.2.3  Results 
 
4.2.3.1 Control group MAPs (within group comparisons) 
The muscle activation patterns for the control group subjects under both 
unloaded and loaded conditions are displayed in Table 4.2.1 and Figure 
4.2.2. Paired t-tests indicated that although the order of muscle activation 
was the same under both conditions, the timing of activation was significantly 
different (p<0.05), with all five muscles activated earlier under load. In terms 
of the stability of the MAPs as indicated by comparisons of the standard 
deviations (via F statistics) for muscle onset times for each muscle under the 
two conditions, the UT was more variable, and the MD less variable under 
load (both p<0.05). There were no other significant differences for the effects 
of load in the control group. 
 
Table 4.2.1: Mean times of muscle activation for the control and LTrP 
groups for the unloaded and loaded conditions. 
MAPs UT Inf MD SA LT 
Control unloaded MAP -115 75 201 434 776 
Control loaded MAP -191 -57 -6 316 536 
LTrP unloaded MAP 27 -153 142 212 477 
LTrP loaded MAP -57 -244 25 91 343 
UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, SA=serratus anterior, 
LT=lower trapezius, ‘-‘=muscle activated prior to movement start.  
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Table 4.2.2: Differences in mean activation times between groups, 
comparing the unloaded and loaded conditions 
Differences in activation times UT Inf MD SA LT 
Difference control unloaded Vs loaded -76 -132 -207 -118 -240 
Difference LTrP unloaded Vs loaded -84 -91 -117 -121 -134 
Difference control Vs LTrP unloaded +142 -228 -59 -222 -299 
Difference control Vs LTrP loaded +134 -187 +31 -225 -193 
UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, SA=serratus 
anterior, LT=lower trapezius. ‘-‘=muscle activated earlier in the group named 
second (loaded condition or in the LTrP group compared with the control 
group respectively); ‘+‘=muscle activated later in the group named second 
(loaded condition or in the LTrP group compared with the control group 
respectively). 
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Figure 4.2.2: The effects of load on the MAP of the control group (mean 
and SD displayed). Time ‘0’ is the time at which the arm left the side of 
the body as measured by the microswitch. 
 
 
4.2.3.2 LTrP group MAPs (within group comparisons) 
 
The muscle activation patterns for the LTrP group under both unloaded and 
loaded conditions are displayed in Table 4.2.1 and Figure 4.2.3. Analyses 
failed to reveal any changes in the order or the timing of muscle activation in 
response to load (p>0.05). Though not statistically significant, all muscles 
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were activated earlier than in the unloaded condition: UT [27ms, -57ms, 
84ms]; Inf [-153ms, -244ms, 91ms]; MD [142ms, 25ms, 117ms]; SA [212ms, 
91ms, 121ms]; LT [477ms, 343ms, 134ms] (Table 4.2.2). The only significant 
difference identified was a reduction in the variability for the time at which LT 
was activated under the loaded condition (p<0.05). 
 
 
Figure 4.2.3: The effects of load on the MAP of the LTrP group (mean 
and SD displayed). Time ‘0’ is the time at which the arm left the side of 
the body as measured by the microswitch. 
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4.2.3.3 Controls Vs LTrP group under load (between group 
comparisons) 
 
It should be remembered that the two groups had already been compared for 
the unloaded condition (section 4.1), hence the results presented here relate 
only to comparisons between the groups when a load was applied. Results 
for activation patterns between the groups when lifting a light weight are 
presented in Tables 4.2.1 and 4.2.2 and Figure 4.2.4. Under this condition, 
independent t-tests revealed significant differences for all muscles with the 
exception of MD. As occurred in the unloaded situation, (see section 4.1.3, p. 
155), the LTrP group had a different order of muscle activation with the UT 
being activated significantly later and the Inf, SA and LT being activated 
significantly earlier. F statistics revealed significantly more variability for the 
UT, MD and SA in the LTrP group in the loaded condition, reminiscent of the 
findings for the unloaded situation (Figure 4.1.4, page 154). 
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Figure 4.2.4: The effects of LTrPs on MAPs during loaded scapular 
plane elevation (mean and SD displayed). Time ‘0’ is the time at which 
the arm left the side of the body as measured by the microswitch. 
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4.2.4 Discussion of Results 
 
This study investigated the effects of light loads on the MAPs of related 
shoulder girdle muscles during elevation in the scapular plane in healthy 
controls and subjects with LTrPs in the scapular rotator muscles. Loads were 
chosen to represent those that might be lifted during everyday tasks and did 
not cause subjects undue strain. Under load, the control group demonstrated 
the same order of muscle activation as they had without load however, all 
muscles were activated significantly earlier. The UT, Inf and MD were all 
activated prior to the start of the movement, whereas, only the UT was 
activated prior to movement start in the unloaded condition. In consequence, 
it was speculated that when even a light load is imposed, earlier activation is 
needed to preserve a predetermined movement strategy. The SA and LT 
were activated 118ms and 214ms earlier respectively in the loaded condition, 
suggesting that the controlled upward rotation these muscles provide the 
scapula during the early phases of elevation of the arm, is required earlier 
with greater external load. Alternatively, earlier activation of muscles in 
general might be a means of increasing muscle stiffness in anticipation of an 
applied load that would otherwise result in an unwanted change in scapula 
position (much in the way the muscles of the lower limb contract in 
anticipation of foot contact in walking, running or falling (Neumann 2002). In a 
study of 16 asymptomatic shoulders, Alpert and colleagues (2000) measured 
the degree of muscle activation, as opposed to the timing of muscle 
activation, of the deltoid and rotator cuff muscles in response to various 
external loads during scapular plane elevation. The authors found that EMG 
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activity of deltoid, supraspinatus and infraspinatus increased in the 0°-90° 
range, with peak activity for anterior and middle deltoid, supraspinatus and 
infraspinatus occurring between 30° and 60° of scapular plane elevation. 
Furthermore, the change in activity with increasing load was greater between 
0-25% and 25-50% of maximum load, than it was for heavier external loads 
(Alpert et al. 2000). These findings imply that lighter loads (< 50% of 
maximum) also require significant increases in muscle activation to perform 
scapular plane elevation, despite the fact that light loads (0-4kgs) have not 
been found to have any effect on clavicular and scapular kinematics (de 
Groot 1999; Pascoal et al. 2000), or scapulohumeral rhythm (Doody, 
Freedman & Waterland 1970; Michiels & Grevenstein 1995). These data and 
the findings for the control group in the current study, suggest that “healthy” 
individuals alter the timing and degree of activation of shoulder girdle 
muscles in order to maintain optimal kinematics and scapulohumeral rhythm 
when attempting to lift light loads during scapular plane elevation. 
 
The LTrP group demonstrated the same sequence of muscle activation 
whether the arm was loaded or not, that is Inf activated prior to movement 
start, the UT approximately as the arm left the side of the body, followed by 
the MD, SA and LT all after movement start. Reminiscent of the control group 
responses to load, all LTrP muscles were activated earlier when the arm was 
loaded, but none significantly so. Perhaps the failure to observe significant 
changes was due to the large variability in activation times displayed for all 
LTrP muscles both within and between subjects for both conditions. 
However, only the LT had a significant change in variability actually having a 
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more stable activation time under load, a result not likely explained by a 
learning effect since no other muscle responded in this way.  
 
When comparing the MAPs of the control and LTrP groups during loaded 
scapular plane elevation (Table 4.2.2), a number of significant timing 
changes were found: the Inf, SA and LT were activated earlier (187ms, 
225ms and 193ms respectively) in the LTrP group, while the UT was 
activated 134ms later and the MD at approximately the same time in the two 
groups. In fact, the differences in the activation times between groups were 
similar when the unloaded and loaded conditions were compared (Table 
4.2.2) suggesting that light loads make little difference to the sequence of 
muscle activation. However, loading was associated with a change in the 
temporal pattern of activation with all control muscles activated earlier and 
though not significant, a trend for the same phenomenon was observed in the 
LTrP group. Interestingly, though the variability between the groups for onset 
times was significantly greater in all LTrP muscles without load, under 
loading only three of the five muscles (UT, MD and SA muscle) demonstrated 
this phenomenon. It seems unlikely that this finding can be explained by 
increased stability of activation under loaded conditions in the LTrP subjects, 
but rather, by the fact that variability increased in the control group as well 
(only UT significantly so) (Figures 4.2.2 and 4.2.4 - see SD bars). As was the 
case in the unloaded condition, it appears that aside from the consistent early 
activation of the Inf in the LTrP subjects, the remainder of the MAP was so 
inconsistent that the addition of external load did not result in additional 
variability in activation times across the group. Rather than suggesting that 
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light loads do not adversely affect the MAPs of subjects with LTrPs in the 
scapular rotator muscles, the results may imply that the presence of LTrPs 
results in chaotic MAPs whether load is added or not. Supporting this 
concept, Wadsworth and Bullock-Saxton (1997) found greater variability of 
muscle activation times in patients with shoulder impingement syndrome 
compared with healthy controls (Wadsworth & Bullock-Saxton 1997).  
 
 
4.2.5 Conclusions 
 
In healthy individuals (no LTrPs), performing scapular plane elevation, the 
sequence of muscle activation in the scapular rotators and related muscles of 
the shoulder joint, remains relatively stable, but the muscles are activated 
earlier when light loads are imposed. The presence of LTrPs in the scapular 
rotator muscles is associated with changes in motor control during scapular 
plane elevation, but the addition of external loads does not amplify the 
changes seen in unloaded movement. To reiterate the conclusions of section 
4.1, these findings occurred in the absence of pain and clinically, may have 
implications for overuse syndromes (rotator cuff), shoulder impingement 
syndrome, and a generally less effective motor control in “overhead” 
movement.  
 
An additional situation regularly encountered through daily, work and sporting 
activities is repetitive elevation of the arms, which can bring about a level of 
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fatigue associated with decreased movement performance. Section 4.3 
describes an experiment which investigated the effects of LTrPs in the 
scapular rotator muscles on the MAP of related shoulder girdle muscles after 
fatiguing repetitive elevations of the arms in the scapular plane. 
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4.3 The effect of LTrPs in the scapular rotator muscles on MAPs 
during elevation in the scapular plane after fatigue. 
 
4.3.1 Introduction 
 
Muscle fatigue resulting from repetitive overload can lead to overuse injuries 
of the upper limb (Weldon & Richardson 2001) that may result in lost 
productivity and quality of life (Visser & van Dieen 2006). Initially, muscular 
fatigue is associated with decreased movement efficiency (Myers, J. B. et al. 
1999; Sterner, Pincivero & Lephart 1998) and efficient movement of the 
upper extremity obviously relies upon the effective coordination of the 
scapular and shoulder joint muscles to dynamically position the scapula and 
the arm.  
 
A search of the literature failed to find any investigations into the effects of 
fatigue on MAPs during scapular plane elevation in normal subjects nor those 
with LTrPs in the scapular rotator muscles. Given the ubiquity of overuse 
injuries in the shoulder (second only to low back pain (Langford 1994)), their 
common association with overhead motion (Blevins 1997; Scoville et al. 
1997; van der Hoeven & Kibler 2006) and the fact that LTrPs have the ability 
to disrupt MAPs (Sections 4.1 and 4.2, pages 152 and 165 respectively), a 
study was undertaken to elucidate the effects of fatigue on the activation 
patterns of key muscles of the shoulder girdle during scapular plane 
elevation. This work was also undertaken to build upon and add to the 
findings reported in previous sections of this Chapter that have provided 
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evidence that LTrPs induce significant effects on the timing of muscle 
contraction, effects that in themselves might be exacerbated or indeed 
contribute to, muscular fatigue. The results of the current section will be 
compared to findings reported in sections 4.1 and 4.2.  
 
4.3.1.1 Questions Addressed: 
 
1. Does fatiguing repetitive movement such as may occur 
commonly in daily activities, alter the normal activation patterns 
of functionally related muscles during scapular plane elevation? 
2. Considering that LTrPs have been shown to alter the timing of 
muscle activation compared with those who do not have LTrPs 
(Sections 4.1 and 4.2), will fatigue produce a different pattern of 
activation in the scapular rotator muscles as well as those more 
distally placed during scapular plane elevation?  
 
4.3.2  Methods  
 
4.3.2.1 Subjects and Procedures 
 
For this experiment, the same subjects formed the control and LTrPs groups 
respectively and the post-fatigue sEMG was recorded on the same day, after 
the unloaded and loaded experiments. The procedures used for this 
experimental condition were the same as described in section 4.1, but in 
addition, subjects underwent a fatiguing protocol, then performed three trials 
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of loaded scapular plane elevation followed by another three trials of this 
movement unloaded to establish the MAPs of each group after fatiguing 
movement.  
 
4.3.2.2 Fatiguing protocol 
 
In this experiment, control and LTrP subjects were asked to hold a hand-
weight (females 1.3kg and males 4kg), while performing scapular plane 
elevation in time with a metronome set at 60 beats per minute (subjects took 
four seconds to reach the top of the movement, that is, 160° of elevation 
moving at approximately 40° per second, and four seconds to return to the 
starting position), a speed judged to be attainable without resort to anaerobic 
metabolism (Ogita, Onodera & Tabata 1999). Fatigue was deemed to have 
occurred when subjects could no longer maintain the cadence. The same 
relatively light weights were used to duplicate the loaded movement tested 
earlier (section 4.2), but also to decrease the time taken to fatigue. Subjects 
were then allowed four seconds rest holding the weights in the starting 
position to obtain a stable baseline for sEMG and then performed six more 
trials representing the post-fatigue state, the first three with weights (post-
fatigue, loaded), the final three trials without (post-fatigue, unloaded). Again a 
four second rest was provided between trials (holding the weights for the 
‘loaded’ trials and without any load for the last three trials) to collect baseline 
sEMG signals (see Figure 4.3.1 for the experimental sequence of sEMG 
recordings).  
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Figure 4.3.1: Experimental sequence and timing of sEMG recordings to 
test the effects of fatigue on MAPs during scapular plane elevation 
Fatiguing repetitive elevations 
Weights, no rest, metronome at 60bpm; 
approximately 40°/sec for 160° of abduction 
Fatigue = perceived muscle burning and inability 
to maintain movement speed 
Post-fatigue condition 
Fatiguing arm elevations stopped 
4 seconds rest holding hand-weights, subjects 
asked to ‘relax the shoulders’ 
Baseline sEMG re-established 
3 trials with external load with 4 seconds rest 
between trials (post-fatigue, loaded) 
Hand-weights taken from subject during the last 4 
second rest after the third ‘loaded’ trial. 
Baseline sEMG re-established 
3 trials with no external loaded with 4 seconds rest 
between trials (post-fatigue, unloaded) 
Rested and loaded scapular plane elevation 
Section 4.2 
Rested and unloaded scapular plane elevation 
Section 4.1 
Subjects rest for approximately 5 minutes 
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4.3.2.3 Statistical Analysis 
 
To test for the effects of fatigue on the MAPs during the test movement in 
both the control and LTrP groups, paired t-tests were employed and the 
comparison was made with the data collected in the first two experiments 
(see sections 4.1: rested and unloaded, page 152 and 4.2: rested and loaded 
page 165), where the same subjects from the control and LTrP groups 
performed unloaded, then loaded elevation in the scapular plane 
respectively, prior to the fatiguing protocol. To test for the effects of LTrPs on 
MAPs during post-fatigue unloaded and loaded scapular plane elevation, 
independent t-tests were employed to test for differences in the mean 
activation times of the control and LTrP groups for all muscles. F statistics 
were once again used to compare the variability in the muscle activation 
times between conditions or groups and the significance level was set at 
p<0.05 for all comparisons. 
 
 
4.3.3  Results  
 
4.3.3.1 Control group MAPs (within group comparisons): unloaded 
motion 
The muscle activation patterns for the control group subjects under both 
rested and fatigued conditions without load are displayed in Table 4.3.1 and 
Figure 4.3.2. Though the order of muscle activation was preserved, except 
for the UT, paired t-tests revealed significant differences in all other muscle 
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activation times post fatigue as follows: UT was activated 30ms later and the 
Inf, MD, SA and LT were activated 95ms, 198ms, 190ms and 437ms earlier 
respectively (Table 4.3.2). In addition, activation times were significantly 
more variable for the UT, Inf and MD post-fatigue.  
 
Table 4.3.1: Mean times of muscle activation for the control and LTrP 
groups for the rested and fatigued conditions with or without load. 
MAPs UT Inf MD SA LT 
Control rested, unloaded -115 75 201 434 776 
Control fatigued, unloaded -85 -20 3 244 339 
Control rested, loaded -191 -57 -6 316 536 
Control fatigued, loaded -134 -54 -20 223 363 
LTrP rested, unloaded 27 -153 142 212 477 
LTrP fatigued, unloaded 30 -54 155 218 541 
LTrP rested, loaded -57 -244 25 91 343 
LTrP fatigued, loaded -41 -149 23 95 276 
UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, SA=serratus anterior, LT=lower 
trapezius; ‘-‘=muscle activation time prior to movement start. 
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Table 4.3.2: Differences in mean activation times between groups, 
comparing the rested and fatigued conditions, with or without external 
load. 
Differences in activation times UT Inf MD SA LT 
Difference control rested Vs fatigued, 
unloaded 
+30 -95 -198 -190 -437 
Difference control rested Vs fatigued, 
loaded 
+57 +3 -14 -93 -173 
Difference control fatigued, unloaded 
Vs loaded 
-49 -34 -17 -21 -24 
Difference LTrP rested Vs fatigued, 
unloaded 
+3 +99 +13 +6 +54 
Difference LTrP rested Vs fatigued, 
loaded 
+16 +95 -2 +4 -67 
Difference LTrP fatigued, unloaded Vs 
loaded 
-71 -95 -132 -123 -265 
Difference control Vs LTrP, fatigued, 
unloaded 
+115 -34 +152 -26 +202 
Difference control Vs LTrP, fatigued, 
loaded 
+93 -95 +43 -128 -87 
UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, SA=serratus anterior, 
LT=lower trapezius, ‘-‘=muscle activated earlier in the group named second 
(fatigued condition or in the LTrP group compared with the control group 
respectively); ‘+‘=muscle activated later in the group named second (fatigued 
condition or in the LTrP group compared with the control group respectively). 
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Figure 4.3.2: Normal MAP rested Vs fatigued with no load during 
scapular plane elevation (mean and SD displayed). Time ‘0’ is the time 
at which the arm left the side of the body as measured by the 
microswitch. 
 
4.3.3.2 Control group MAPs (within group comparisons): loaded motion 
 
When the load was added, subjects continued to recruit the muscles in the 
same order, but the UT was activated significantly later (57ms) and the SA 
(93ms) and LT (173ms) were both activated significantly earlier. The Inf and 
MD showed no difference in activation times post-fatigue. Variability in 
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activation times was unchanged by fatigue (Tables 4.3.1 and 4.3.2 and 
Figure 4.3.3). 
 
Figure 4.3.3: Normal MAP rested Vs fatigued during loaded scapular 
plane elevation (mean and SD displayed). Time ‘0’ is the time at which 
the arm left the side of the body as measured by the microswitch. 
 
 
4.3.3.3 LTrP group MAPs (within group comparisons): unloaded motion 
 
For the LTrP group, as was observed with controls under the same 
conditions, the order of activation was the same as the rested state (Inf, UT, 
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MD, SA, LT), however, the Inf was activated significantly later (99ms) though 
still prior to movement start (Table 4.3.1 and Figure 4.3.4). Variability of 
muscle activation times was not changed by fatigue when the movement was 
performed without load. 
 
 
Figure 4.3.4: LTrP MAP rested Vs fatigued with no load during scapular 
plane elevation (mean and SD displayed). Time ‘0’ is the time at which 
the arm left the side of the body as measured by the microswitch. 
 
4.3.3.4 LTrP group MAPs (within group comparisons): loaded motion 
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When loaded motion was performed post-fatigue, for LTrP subjects, the 
sequence of activation was the same as found in both the rested state and 
the post-fatigue unloaded trial. The only difference observed in sequencing 
was the later activation of Inf (95ms) in the fatigued state. Large standard 
deviations in activation times were observed under both conditions (rested 
and loaded compared with fatigued and loaded) for this group, but the 
differences were not significant. There was also some ‘condensation’ or 
‘compression’ of the MAP post-fatigue for the LTrP group with the whole 
sequence completed in a shorter time span (on average, 587ms rested with 
load Vs 425ms fatigued with load), that is the first muscle (Inf) was activated 
later (95ms) and the last muscle (LT) was activated earlier (67ms) for this 
group post-fatigue (Tables 4.3.1 and 4.3.2 and Figure 4.3.5). 
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Figure 4.3.5: LTrP MAP rested Vs fatigued during loaded scapular plane 
elevation (mean and SD displayed). Time ‘0’ is the time at which the arm 
left the side of the body as measured by the microswitch. 
 
4.3.3.5 Controls Vs LTrP group post-fatigue (between group 
comparisons): unloaded motion 
 
A comparison between the control and LTrP MAPs during unloaded scapular 
plane elevation revealed two different muscle activation sequences post-
fatigue. The control group sequence was UT then Inf both prior to movement 
start, MD as the movement started, then SA and LT after movement start, 
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whereas the LTrP group activated the Inf prior to movement start, the UT just 
after movement start, then the MD, SA and finally the LT (table 4.3.1 and 
Figure 4.3.6). With regard to the mean times of muscle activation between 
groups, the UT and MD muscles were activated significantly later in the LTrP 
group (115ms and 152ms respectively, Table 4.3.2) and only the SA was 
significantly more variable in activation time in the LTrP group. The control 
group MAP was more condensed than the LTrP group MAP (424ms Vs 
595ms; time taken for all muscles to become activated). 
 
 
Figure 4.3.6: Comparison of normal to LTrP MAPs post-fatigue with no 
load during scapular plane elevation (mean and SD displayed). Time ‘0’ 
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is the time at which the arm left the side of the body as measured by the 
microswitch. 
 
4.3.3.6 Controls Vs LTrP group post-fatigue (between group 
comparisons): loaded motion 
 
Comparisons between the control and LTrP groups for post-fatigue loaded 
scapular plane elevation revealed two different activation sequences. The 
control group sequence was UT then Inf then MD prior to movement start, 
then SA and LT after movement start, whereas the LTrP group activated the 
Inf then UT prior to movement start, the MD just after movement start, then 
the SA and finally the LT after movement start (Table 4.3.1 and Figure 4.3.7). 
With regard to the mean times of muscle activation, the UT was activated 
significantly later (93ms) and the Inf and SA muscles were activated 
significantly earlier (95ms and 128ms respectively, Table 4.3.2) in the LTrP 
group and only the MD (in LTrP group) showed significantly more variation in 
time of activation. The total time taken for all muscles to become active was 
similar for both groups in the loaded post-fatigued state (497ms Vs 425ms 
respectively).  
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Figure 4.3.7: Comparison of normal to LTrP post-fatigue during loaded 
scapular plane elevation (mean and SD displayed). Time ‘0’ is the time 
at which the arm left the side of the body as measured by the 
microswitch. 
 
 
4.3.4  Discussion of results  
 
This study investigated the effects of fatigue caused by repetitive loaded 
elevations in the scapular plane, on the MAPs of related shoulder girdle 
muscles during the same movement in healthy controls and subjects with 
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LTrPs in the scapular rotator muscles. Muscle activation patterns were 
recorded post-fatigue under two conditions: unloaded and loaded (females 
1.3kg and males 4kg), thought to represent loads that individuals might 
experience during home and work related tasks and similar to loads applied 
in previous kinematic studies (de Groot, van Woensel & van der Helm 1999; 
Pascoal et al. 2000) and studies investigating the effects of load on the 
scapulohumeral rhythm (McQuade & Smidt 1998). Fatigue was defined as an 
inability to maintain a cadence of 40°/second over a 160° range of elevation 
in the scapular plane (4 beats or seconds going up, then 4 beats/seconds 
coming down), and in all cases, was accompanied by subjective reports of 
varying degrees of a ‘muscle burning’ sensation. This definition of fatigue 
was associated with a decreased efficiency of movement rather than an 
inability to move at all, and was chosen to represent a level of fatigue that 
individuals might experience during common daily tasks.  
 
 
4.3.4.1 Effects of fatigue on MAPs of healthy subjects 
 
In the current study, the order of muscles activated post-fatigue in the control 
group was the same as in the rested state, however the timing of activation 
was condensed, that is, the UT was activated slightly later (not significant) 
and the remaining muscles were activated significantly earlier, perhaps in an 
attempt to increase scapulothoracic motions in relation to glenohumeral 
motions, in order to maintain the congruity of the glenohumeral joint and 
preserve the subacromial space, as supported by previous studies as 
 193 
follows. Two kinematic studies found that shoulder muscle fatigue resulted in 
increased upward rotation of the scapula, although one study found twice the 
increase in this motion (Ebaugh, McClure & Karduna 2006) as the other 
(McQuade, Dawson & Smidt 1998), possibly due to the former study 
employing a fatiguing protocol of longer duration than the latter. Conversely, 
two further studies reported decreased upward scapular rotation after 
shoulder muscle fatigue (McQuade, Hwa Wei & Smidt 1995; Tsai, McClure & 
Karduna 2003), though the different fatiguing protocols and small and 
different populations used, make direct comparisons problematic. External 
rotation of the scapula, defined in their work as the lateral border moving 
posteriorly, was increased in the Ebaugh et al. study (2006) but decreased in 
the Tsai et al. study (2003) after fatigue. Possible explanations for these 
contrary findings may lie in the specific fatiguing of the humeral external 
rotators by Tsai and colleagues, whereas Ebaugh et al. achieved generalised 
shoulder fatigue, suggesting that patterns of altered scapular kinematics may 
be dependent on the group or groups of muscles fatigued.  
 
As discussed in section 4.1 (page 154), it appeared that optimal timing of 
activation of the UT, Inf and MD muscles was important in the initiation of 
scapular plane elevation in healthy subjects. Post-fatigue, these three 
muscles had significantly more variability in their timing of action, implying 
that when fatigued, healthy subjects may have initiated elevation in the 
scapular plane with decreased efficiency, with possible implications for 
maintaining favourable subacromial space. Scapulothoracic kinematic 
changes such as increased upward and external rotation may be viewed as 
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an attempt to optimise the relationship between the glenoid fossa, 
coracoacromial arch and the humeral head to compensate for a decrease in 
external rotation of the humerus, preserving the subacromial space and 
decreasing pressure of the humeral head on the subacromial structures 
(Kibler, W. B. & McMullen 2003; Ludewig & Cook 2000). Ebaugh and 
colleagues (2006) proposed that increased scapulothoracic motions were a 
response to altered glenohumeral motion, believed to be a direct result of 
fatigue in the external rotator muscles of the humerus in their study (Ebaugh, 
McClure & Karduna 2006). Furthermore, when light external load was added 
by asking subjects to hold hand-weights in the current study, UT was 
activated significantly later and SA and LT were activated significantly earlier, 
resulting in an even more condensed MAP when healthy subjects were 
loaded and fatigued, though surprisingly, no differences were found in the 
variability of activation times in this state. One further factor complicating any 
comparisons between studies is the fact that in the present work, external 
rotation of the shoulder was eliminated by using the movement guides, hence 
the muscle roles may have been different where “uncontrolled” scapular 
plane elevation was carried out. 
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4.3.4.2 Neural mechanisms associated with fatigue in healthy subjects 
 
Since this was not a mechanistic study, the descriptions below have been 
necessarily brief and are meant to encourage discussion and further 
experimental work in this area. In an attempt to explain the neural 
mechanism(s) that may underpin the effects of fatiguing repetitive 
movements on MAPs of healthy subjects during elevation of the arm, an 
understanding of the motor control systems is provided. Recall that a motor 
command for movement is initiated at high levels of the CNS and this 
command is processed at progressively lower levels of the CNS and finally at 
segmental levels in the spinal cord, where it is resolved into the muscles and 
motor units that are recruited to action for the proposed movement. Output 
from the CNS occurs through the final common pathway (co-activation of the 
α and γ motoneurons) and determines the level of activation of individual 
muscles (Rothwell 1994). Feedback for the system occurs through muscle 
receptors and their afferent fibers, that is, muscle spindle Ia and II fibers, 
Golgi tendon organ (GTO) group Ib fibers, Group II non-spindle fibers (low 
threshold mechanoreceptors), group III and IV fibers (high threshold 
mechanoreceptors and nociceptors sensitive to algesic substances and 
ischemia) and in turn, these affect neuromuscular control and joint function 
(Myers, J. B. et al. 1999). As fatigue develops, extracellular metabolites 
accumulate and pH decreases in the contracting muscles (Fischer, M. & 
Schafer 2005; Windhorst et al. 1997). With regard to the effects of this tissue 
state, the proposal of Myers and colleagues (1999) and the thoughts of 
Mense (1997) might provide insight. In combination, these authors suggested 
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that when muscles fatigue, intramuscular afferents responsible for providing 
proprioceptive feedback (Myers, J. B. et al. 1999) and warning the CNS that 
where tissues may be approaching structural or functional limits (Mense 
1997), are stimulated and alter neuromuscular responses reflected in MAPs. 
Broadly speaking, this may occur through two neural mechanisms: one 
affecting central commands and generating “sub-optimal” descending signals 
and a second operating through spinal cord reflexes, as discussed below. 
 
4.3.4.3 Central and Sub-Optimal Descending Commands 
 
A number of authors have suggested that group III and IV muscle afferents 
from nociceptors are stimulated secondary to fatigue and might act 
supraspinally to impair voluntary descending drive, inhibiting activation of 
affected α-motoneurons, though the mechanism by which this occurs has not 
been proven as yet (Gandevia 2001; Taylor et al. 1996; Taylor, Todd & 
Gandevia 2006). In addition, Renshaw cells may play a role in this process. 
These neurons are stimulated by collateral branches from the axons of α-
motoneurons and inhibit “their own” α-motoneurons, (“recurrent inhibition”) as 
well as other α-motoneurons. However, they also receive direct supraspinal 
input that facilitates their inhibitory actions (Gandevia 2001) and through their 
wider projections, Renshaw cells have the capacity to influence the α and γ 
motoneurons of homonymous and heteronymous muscles, the Ia inhibitory 
interneuron and other Renshaw cells (Rothwell 1994). Because of these 
connections, supraspinal input to Renshaw cells, may provide a mechanism 
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through which group III and IV inputs can influence MAPs and motor control 
during muscle fatigue. 
 
4.3.4.4 Spinal cord reflexes 
 
(i) Facilitation of α-motoneurons secondary to group III and IV 
stimulation of fusimotor drive 
 
In the event that central commands and descending signals remain unaltered 
from the proposed motor program initiated at higher CNS centres, these 
commands can arrive at the appropriate spinal segment where group III and 
IV afferent input has increased motoneuron excitability, possibly via the 
following mechanism/pathway (Gandevia 2001). As muscle fatigues, 
nociceptors are activated by the fatigue-induced accumulation of metabolites 
as well as increased acidity leading to group III and IV afferent discharge. 
These afferents synapse with γ-motoneurons and excite predominantly static 
gamma efferents that cause contraction of spindle intrafusal fibres and 
increased spindle primary (Ia) and secondary (II) afferent firing, resulting in 
facilitation of both α and γ motoneurons (Appelberg et al. 1982, 1983; 
Djupsjobacka, Johansson & Bergenheim 1994; Djupsjobacka, M et al. 1995; 
Djupsjobacka, M. et al. 1995; Fischer, M. & Schafer 2005) (Figure 4.3.8). 
Accordingly, the Ia excitatory input to the homonymous and heteromonymous 
α-motoneurons results in facilitation of agonist and synergist muscles. The 
stimulation of the homonymous and heteromonymous γ-motoneurons by Ia 
and II spindle discharge feeds back in to the fusimotor system and drives the 
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continued facilitation of motoneurons supplying these muscles.(Gladden, 
Jankowska & Czarkowska-Bauch 1998). As Rothwell (1994) explains, the 
degree of γ activation dictates the degree of ‘stiffness’ of the muscle spindle 
and therefore its mechanical sensitivity and subsequent level of spindle 
afferent input into the CNS. In addition, the spindle Ia fiber synapses with the 
Ia inhibitory interneuron, which results in inhibition of the antagonist muscle 
as the agonist is contracting (Rothwell 1994) and acts to facilitate movement. 
With regard to the MAPs for healthy subjects in the current study, in the 
unloaded condition, all muscles were activated significantly earlier aside from 
the UT, however, in the loaded state only SA and LT activation was earlier 
than when subjects were rested. Although the level of muscle activation 
(signalled by sEMG amplitude) is obviously different from the timing of 
muscle activation, these phenomena could have affected each other due to 
the criteria used to identify the time of muscle activation in the current study. 
For example, an increased α-motoneuron firing rate (due to increased 
fusimotor drive secondary to group III and IV afferent input) may have 
resulted in a sEMG amplitude that was large enough to reach one SD greater 
than the baseline mean amplitude more quickly, potentially resulting in the 
muscle being identified as ‘active’ sooner (e.g. Inf, MD, SA and LT in the 
unloaded, post-fatigue state in the current study). Conversely, a decrease in 
α-motoneuron firing rate (for example, due to recurrent inhibition by Renshaw 
cells) would probably necessitate both increased temporal and spatial 
summation to reach a certain force output, potentially increasing the time 
needed to activate motor units and producing an apparent delay in the 
activation times (e.g. UT in the unloaded, post-fatigue state in the current 
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study). Furthermore, different muscles may have fatigued at different rates 
leading to varying amounts of interstitial concentrations of nociceptor 
activating substances present at any given moment resulting in varying 
amounts of fusimotor drive to α-motoneurons and producing the increased 
variability of muscle activation seen in control group subjects post-fatigue. 
 
 
 
Figure: 4.3.8: Gamma motor positive feedback loops. Reproduced from 
Knutson (2000). 
 
 
(ii) Inhibition of α-motoneurons secondary to group III and IV 
afferent discharge 
 
As outlined above, group III and IV muscle afferent input can lead to reflex 
activation of γ-motoneurons (Djupsjobacka, Johansson & Bergenheim 1994; 
Djupsjobacka, M. et al. 1995), producing fusimotor drive that facilitates and 
provides ongoing support for contraction of the agonist and synergistic 
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muscles and inhibits the antagonist(s) (Hagbarth et al. 1986; Rothwell 1994; 
Sjolander & Johansson 1995). However, it has been suggested that muscle 
activation is often inhibited secondary to fatigue and/or pain, when group III 
and IV nociceptors have become sensitised rather than just activated due to 
short-term exposure to metabolites). Evidence for this phenomenon was 
demonstrated by Rossi and colleagues (1999) who chemically induced tonic 
muscle nociceptive discharge from the extensor digitorum brevis muscle and 
produced a decrease in the size of the monosynaptic Ia excitatory post-
synaptic potentials of soleus motoneurons (Rossi, Decchi & Ginanneschi 
1999). In an attempt to explain this result, Thunberg and co-workers (2002), 
suggested that the process may occur via presynaptic inhibition of the Ia 
terminals in association with group III and IV afferent input, implying that 
where fusimotor drive or other reflex effects had enhanced the excitability of 
α-motoneurons, the effectiveness of the connection between the primary 
spindle afferent and α-motoneurons could be reduced, ultimately resulting in 
decreased α-motoneuron discharge (Thunberg et al. 2002). However, 
Rossi’s group did not establish whether the presynaptic inhibition occurred 
via segmental or supraspinal pathways nor whether the muscle nociceptive 
volley directly facilitated these presynaptic pathways or removed some tonic 
inhibition of them (Rossi, Decchi & Ginanneschi 1999). In relation to the 
current study, this process may have contributed to findings of delayed or 
variable muscle activation which were observed in the UT (significantly 
delayed activation when fatigued with external load) and the UT, Inf and MD 
(significantly more variable in activation time post-fatigue) in healthy subjects.  
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In addition to the potential for pre-synaptic inhibition of the Ia terminals to 
inhibit motoneurons, the intrinsic properties of the α-motoneurons 
themselves can also been modulated by group III and IV input secondary to 
fatigue. Windhorst and co-workers (1997) substantiated this phenomenon in 
a study on decerebrate and “mostly” spinalised cats exposed to intra-arterial 
injections of BK and 5-HT (serotonin). They found that group III and IV 
afferent reflex action on afterhyperpolarisation (AHP) of motoneurons (an 
intrinsic property of motoneurons associated with inhibition) may occur 
through “classical transmitters” altering motoneuron inputs or by altering α-
motoneuron responsiveness through modulation of intrinsic properties, 
including AHP or altering ionic conductance via neurotransmitters, 
neuromodulators or “neuro-active peptides” (Windhorst et al. 1997). With 
regard to the control group subjects affected by fatigue in the current study, 
the UT was activated later, possibly indicating inhibition of this muscle, in 
both the unloaded (non-significant) and loaded states. Given more muscles 
in the control group responded with earlier activation, this may suggest that 
with relatively low levels of fatigue (defined in this study as an inability to 
perform arm elevations at a required speed as opposed to neuromuscular 
fatigue), the initial neural response may be one of facilitation of motoneurons. 
Perhaps because UT was the first muscle active in the sequence of muscle 
activation, it fatigued more (being active for more of the movement with  less 
opportunity for dispersal of metabolic products) (Taylor, Butler & Gandevia 
2000). It was the only muscle that showed signs of inhibition (if that is what 
can be interpreted from the responses), perhaps demonstrating that as 
fatigue increases in dynamic movements, inhibition of motoneurons may 
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begin to occur. It should be emphasized that duration of muscle activation 
was not measured in the current study so such an explanation would require 
further analysis of the signals. 
 
It should be recalled that the current study was not designed to investigate 
mechanisms underpinning fatigue, hence the previous section was prepared 
as a brief review of this topic to allow some speculation on the findings of the 
control group post-fatigue. In fact, according to Taylor and co-workers (2000), 
mechanisms that result in the alteration of motoneuron firing associated with 
fatigue can apparently, be contributed to by any of the following processes:  
• Presynaptic inhibition of Ia muscle spindle afferent discharge. 
• Changing patterns of transmission from afferents to motoneurons 
reflex.  
• Inhibition or disfacilitation in response to altered afferent input. 
• Changes in the descending drive to the motoneuron pool. 
• Changes to the intrinsic properties of the motoneurons. 
• Recurrent (Renshaw cell) inhibition.  
However, the complex interactions and exact involvement of each of these 
elements in any given circumstance remains a topic for ongoing investigation 
(Taylor, Butler & Gandevia 2000). In a concluding remark, Taylor and 
colleagues (2000) suggested that although group III and IV afferents are 
activated and sensitised in fatigued and ischemic muscle, other afferents, 
from Golgi tendon organs or those group III and non-spindle group II 
afferents which respond when muscles contract, could be used to moderate 
voluntary drive to respond to variations in force output from the muscle 
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(Taylor, Butler & Gandevia 2000), These supraspinal effects represent yet 
another aspect of fatigue relevant to explaining the mechanisms by which 
healthy subjects alter their MAPs in response to fatigue. 
 
 
In summary, the work cited suggests that changes to muscle afferent 
discharge in response to fatigue may alter α-motorneuron activity directly (via 
spinal cord reflexes at the relevant spinal segmental level) or indirectly at 
supraspinal sites, altering both the descending command to α-motoneurons 
and their intrinsic properties in healthy subjects. The next section discusses 
the MAPs of the LTrP group post-fatigue and the potential effects and 
underpinning mechanisms. 
 
 
4.3.4.5 Effects of fatigue on MAPs of LTrP subjects 
 
For the LTrP group, fatiguing arm elevations in the scapular plane caused 
only a minor alteration in the MAPs compared with the pre-fatigue trials, 
regardless of whether the movement was performed unloaded or loaded, that 
is, the Inf muscle was activated significantly later post-fatigue. There were no 
significant differences in the variability of muscle activation times induced by 
fatigue, perhaps due to the already large standard deviations (representing 
variability), of activation times that existed in the rested states associated 
with the very inconsistent order of muscle activation these subjects employed 
in either state. When unloaded and compared with the control group, the 
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LTrP subjects activated the UT (115ms) and the MD (152ms) later when 
fatigued, potentially compromising the subacromial space and placing the 
subacromial structures at increased risk of compression, inflammation or 
ultimately, degeneration over time. Perhaps in an adaptive role aimed at 
minimising subacromial compression (due to the delayed activation of UT) 
and helping to initiate abduction (due to the late activation of MD), the Inf was 
activated earlier in LTrP subjects (compared with controls) in fatigue (non-
significant compared with controls), though not as early as at rest where the 
difference in activation time was significantly earlier compared to both the 
control group at rest and their own results post-fatigue. It appears that 
fatiguing activity altered the strategy used by the LTrP group at rest, where 
the earlier activation of Inf may have been in an attempt to optimise 
glenohumeral joint mechanics. If the acromion was not elevated early in the 
movement and the glenohumeral kinematics are altered, when fatigued the 
Inf was perhaps less capable of performing this role (indicated by its later 
activation in fatigue in LTrP subjects). As discussed above in relation to 
healthy subjects, the earlier activation of Inf might be explained by reference 
to fatigue-induced inhibitory responses mediated by group III and IV afferents 
via several avenues: sub-optimal descending commands; recurrent inhibition 
via facilitation of Renshaw cells; pre-synaptic inhibition of spindle Ia afferent 
terminals or altered intrinsic properties of the affected motoneurons (Bigland-
Ritchie, B. R. et al. 1986; Garland 1991; Woods, Furbush & Bigland-Ritchie 
1987). With the addition of light loads, though the mean times of activation 
were generally earlier (as was the case when subjects were rested and 
loaded, Section 4.2, Pages 168-171), the order of activation remained the 
 205 
same as the rested state for both the control and LTrP groups. This result 
suggests that  the overall strategies (perhaps preserving subacromial space 
in the control group (optimal)) or reacting to sub-optimal 
glenohumeral/scapulothoracic kinematic interactions in the LTrP) employed 
prior to fatigue remained in force, but muscles were activated earlier to 
generate the increased force required to lift the added mass (Neumann 
2002). 
 
Interestingly, the only significant change brought about by repetitive fatiguing 
arm elevations for the LTrP group (within group comparison) was that Inf was 
activated later than when rested (but still earlier than in the control group 
fatigued). Given that Inf was LTrP-free, its delayed activation post-fatigue 
was most likely due to a decreased ability to adapt to the inefficient 
glenohumeral joint mechanics suggested to exist in LTrP subjects or an 
inhibitory effect of LTrPs located in functionally related muscles (Eg: UT, SA 
or LT). The relatively repeatable responses of the LTrP-containing muscles 
(UT, SA and LT) whether at rest or post-fatigue, suggests that either fatigue 
has less effect on the MAPs of subjects with LTrPs in the scapular rotator 
muscles or that LTrPs produce a fatigue-like MAP in the rested state that 
fatigue does not appreciably alter. The results of Chapter five (Section 5.3, 
page 246) will elucidate which of these two suggestions represents the more 
feasible explanation. 
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4.3.5 Conclusions 
1. For healthy subjects, fatigue is associated with a ‘condensing’ of the 
MAP where the muscles activated subsequent to the UT were 
activated earlier and increased variability of activation times compared 
with the rested state.  
 
2. Fatigue induces very little change to the MAP of LTrP-sufferers 
beyond those generated during “rested movement”. 
 
 
As described in Sections 4.1, 4.2 and 4.3, the presence of LTrPs in the 
scapular rotator muscles was associated with a number of effects on MAPs 
during scapular plane elevation under conditions that occur commonly in 
daily life. In an attempt to establish a cause and effect relationship between 
LTrPs and altered MAPs, the next chapter reports on the effects of ‘removing’ 
LTrPs from the scapular rotator muscles on MAPs recorded under the same 
experimental conditions (unloaded, loaded, fatigued). 
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CHAPTER 5 
 
 
THE EFFECTS OF TREATING LTrPs ON MAPS DURING SCAPULAR 
PLANE ELEVATION 
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Overview of Chapter 
 
This chapter presents and discusses the MAPs derived from the test muscles 
of LTrP subjects during scapular plane elevation under each of the conditions 
previously described (unloaded, loaded, fatigued) but after either LTrP 
treatment or no treatment (sham treatment). The experiment was designed to 
establish what happens to the MAPs of the muscles under investigation, 
when LTrPs are “removed” from affected muscles and thereby strengthen 
any conclusions drawn about their effects on motor control. To revise the 
experimental sequence, a flow diagram from Chapter four is again presented 
below (Figure 5.1.1) and briefly described next. All MAP data were derived 
from the same 42 subjects who participated in the studies presented in 
Chapter four, where the 14 members of the control group had undergone 
sEMG of the scapular upward rotators and related shoulder muscles as 
previously described (Chapter 4), and in so doing, provided normative MAPs 
for these muscles during scapular plane elevation under unloaded, loaded 
and fatigued conditions. The LTrP group (N=28) underwent the same 
protocols as the control subjects (Chapter 4) so that comparisons of their 
MAPs with controls could be made. The current chapter describes the results 
of the same protocols performed on the LTrP subjects after random 
assignment to one of two interventions: ‘treatment’ of LTrPs represented by 
superficial dry needling (SDN) followed by post-isometric relaxation (PIR) 
stretching applied to all muscles in which LTrPs had been identified (n=14), 
or “placebo treatment” in which sham ultrasound was employed leaving 
LTrPs ‘intact’ (N=14). It should be emphasised that the entire experimental 
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program for any given subject (experiments described in chapters 3 – 5) was 
carried out on the same day, including the initial screening for ‘normal’ 
shoulder girdles; examination for LTrPs, sEMG for the various conditions of 
scapular plane elevation (unloaded, loaded, fatigued) and subsequently the 
interventions for LTrP subjects (treatment or sham) followed by a repetition of 
the various shoulder elevation protocols. The entire process took 
approximately 90 minutes per subject. 
 
The effects of “removing” LTrPs on MAPs were determined by a number of 
comparisons:  
1. MAPs in treated versus untreated LTrP subjects under each of the 
scapular plane elevation conditions. 
2. MAPs in treated LTrP subjects versus controls (Chapter 4)  
It was hypothesised that “removing” LTrPs (using a recognised treatment) 
would change the timing of muscle activation in these subjects towards the 
patterns observed in “normals” thereby providing strong evidence that the 
MAPs observed in these subjects were indeed the result of LTrPs. The 
format of this chapter is the same as used in Chapter four with regard to the 
three experimental conditions under which MAPs were investigated, that is 
unloaded (Section 5.1), with external load in the hand (Section 5.2) and after 
fatiguing arm elevations (Section 5.3). As in Chapter four, each section has 
its own introduction, description of methods, results, discussion and 
conclusions to minimise the need for constant cross referencing. 
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Figure 5.1.1: Outline of the experimental sequence. The contents of 
Chapter 5 begin from the treatment interventions (coloured blue). 
154 
Volunteers 
Fatiguing protocol.  
Loaded repetition of the test movement 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane – loaded 
(hand-held weights) (Section 5.2) 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane – rested and 
unloaded (Section 5.1) 
Tests for presence of LTrPs – 
Prevalence Study (Chapter 3) 
First 14 LTrP-free 
volunteers=control group 
First 28 LTrP volunteers=LTrP 
group 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane –post fatigue 
with load (Section 5.3) 
 
Comparisons of the MAPs of selected muscles during 
shoulder elevation in the scapular plane –post fatigue, 
unloaded (Section 5.3) 
Control group – end of experimental work. 
Random assignment of LTrP subjects to placebo or true 
treatment interventions. 
All MAP investigations repeated for LTrP subjects post-
interventions (chapter 5). 
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5.1 The Effects of Removing LTrPs from the Scapular Rotator 
Muscles on MAPs during Scapular Plane Elevation 
 
 
5.1.1 Introduction 
 
Though the presence of pain has been shown to be capable of altering 
patterns of neuromuscular activation , there is also some evidence that non-
painful stimuli can have similar effects (Sterling, Jull & Wright 2001) for 
example where the quadriceps muscles can be inhibited secondary to non-
painful knee joint effusion (Shakespeare et al. 1985; Stokes & Young 1984). 
Latent TrPs are pain-free at rest or during movement, but do elicit pain when 
compressed (Simons, D., Travell & Simons 1999), presumably due to the 
presence of increased interstitial concentrations of nociceptor sensitising 
substances resulting from the presence of LTrPs. Greater concentrations of 
such substances at the sites of ATrPs are thought to explain the different 
pain responses in these two forms of trigger point (Shah, J. P. et al. 2005). In 
Chapter four it was established that LTrPs in the scapular rotator muscles are 
associated with altered MAPs during scapular plane elevation of the arm 
under unloaded, loaded and fatigued conditions, when compared with 
healthy subjects (control group). It is possible that such altered MAPs could 
lead to scapular dyskinesis (Kibler, W. B. & McMullen 2003) and thereby 
predispose to rotator cuff problems or overuse (Weldon & Richardson 2001) 
and/or subacromial impingement syndrome (Lewis, Wright & Green 2005; 
Michener, McClure & Karduna 2003). In contrast, identification of a mal-
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adaptive MAP or associated scapular dyskinesis, prior to the development of 
a painful shoulder condition, could provide an opportunity to prevent 
progression to a painful injury and optimise movement performance of the 
upper extremity (Kibler, W. B. 1998b).  
 
Because this chapter describes what happens to MAPs after the treatment of 
LTrPs, a very brief rationale for the chosen treatment is now provided – the 
reader is referred to Chapter two (page 66) and Appendix F (page 289) for 
further information on this topic. There are many TrP treatment modalities 
that work through a variety of mechanisms with varying degrees of efficacy, 
however, based upon the limited experimental data available, SDN (which 
requires the application of stretching after needle removal for best results 
(Edwards & Knowles 2003)) provided the most feasible approach due to its 
proven effectiveness (Cummings & White 2001; Sandberg et al. 2005), and 
provision of a relatively localised stimulus with little involvement of 
neighbouring tissues (Simons, D., Travell & Simons 1999). This is an 
important consideration given that any mechanical, thermal or chemical 
stimulus produces input to the CNS with the potential to influence motor 
output reflected in MAPs (Gandevia, McCloskey & Burke 1992). Furthermore, 
this technique requires no injectable and no need for medically qualified 
personnel. Section 5.1 which follows, describes the work carried out to 
answer the first two questions presented in the introductory pages of this 
Chapter, namely: 
1. Does removing LTrPs (absence of the clinical signs of LTrPs) from the 
scapular rotator muscles alter the activation patterns (MAPs) of these 
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muscles during the performance of a common movement (scapular plane 
elevation of the arm)? 
2. What affect (if any), does removing LTrPs have on the activation patterns 
of muscles placed more distally in the kinetic chain of the upper 
extremity? 
 
 
5.1.2  Methods  
 
5.1.2.1 Subjects and procedures 
 
As stated in the chapter overview, the experiments described below were 
carried out on the same 42 subjects described in Chapter four (14 control 
and 28 LTrP subjects). However, this time the LTrP subjects were randomly 
assigned to receive either treatment (N=14) or sham treatment (N=14) 
followed by determination of MAPs during scapular plane elevation under the 
same conditions as described elsewhere (unloaded, loaded, post-fatigue). 
Table 5.1.1 presents the relevant characteristics of each group. 
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Table 5.1.1: Characteristics of experimental groups. 
Group No. LTrPs 
present 
Mean Age 
(yrs) 
No. of 
Females 
No. of 
Males 
Control 14 No 35.6 ±  8.6 7 7 
LTrP placebo 14 Yes 31.7 ±  9.9 6 8 
LTrP treatment 14 Yes 36.0 ± 13.1 4 10 
 
5.1.2 Treatment group protocol 
 
After completing the sEMG protocols described in Chapter 4, the LTrP 
treatment subjects then received superficial dry needling (SDN) using 30mm 
long, 0.30mm gauge acupuncture needles (Hwato Ultraclean, Acuneeds, 
Camberwell, Victoria, Australia) followed by passive muscle stretch to 
remove LTrPs (a validated LTrP treatment: (Chen, J. T. et al. 2001; 
Cummings & White 2001; Lewit & Simons 1984; Sandberg et al. 2005)). 
Surface EMG electrodes were left in situ following the completion of the 
previous protocol (fatigue affects) wherever this didn’t interfere with the 
respective interventions. However on the rare occasions where removal was 
necessary, electrode positions were marked to allow new electrodes to be 
placed as near as possible to the original position.  
 
The treatment protocol is described in detail as follows. 
1. With the subject lying prone, Superficial dry needling, which consisted of 
cleaning the skin with an antiseptic wipe (70% alcohol, 30% water), then 
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inserting the acupuncture needle to a depth of 5-10mm at LTrP sites. With 
the subject lying prone, SDN was performed on any LTrPs in the lower 
trapezius (LT), middle trapezius (MT), rhomboids (Rh), levator scapulae 
(LS) and upper trapezius (UT), first on the right, then the left side of the 
body.  
2. With the subject lying supine, SDN (as described above) was performed 
on LTrPs located in the pectoralis minor (PM), serratus anterior (SA) and 
UT (if the LTrPs was in the more anterior fibers of the muscle).  
3. Following SDN, PIR stretching was performed for the PM and SA (usually 
with the subject supine), the LT, MT and Rh (usually with the subject in a 
side-lying position) and the LT and UT (usually with the subject in a seated 
position), as recommended by Lewit (personal communication, 2000)  
4. After the completion of the SDN and PIR, subjects stood and the following 
active movements were performed gently, to full range three times each: 
neck rotations, shoulder shrugs, arm circles (forwards and back, with the 
elbows flexed) and horizontal flexion and extension to encourage the 
treated muscles to move through a full range of motion as suggested by 
Simons and colleagues (1999). 
5. The subjects were then re-examined for LTrPs in all the scapular rotator 
muscles, the infraspinatus and the middle deltoid. Where the clinical signs 
of LTrPs were still present, or the PPT as measured with an algometer 
was still less than that expected for normal muscle tissue (see Table 3.1, 
page 125), LTrPs were re-treated (two of 14 subjects) until all muscles of 
interest were considered to be LTrP-free. Because PPTs increased 
despite extra LTrP treatment (two subjects), such additional treatment was 
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not expected to have adversely affected them or their subsequent 
performances in the tests.  
All treated subjects then repeated the scapular plane elevation protocols 
(unloaded, loaded and post-fatigue) that had been undertaken earlier and 
described in Chapter four.  
 
5.1.3 Sham treatment group protocol 
 
After completing the sEMG investigations described in Chapter 4 (scapular 
plane elevation unloaded, loaded and following fatigue) the ‘LTrP placebo’ 
subjects received a sham ultrasound treatment which had no effect on their 
LTrPs. This was confirmed by the presence of the clinical signs of LTrPs and 
PPTs indicative of abnormal muscle tissue (Table 3.1, page 125) following 
placebo “treatment”. An ultrasound machine commonly used to treat muscles 
was plugged into a fake power outlet on the wall and a false power switch 
turned on. The front of the ultrasound machine was turned away from the 
subject to conceal the fact that there was no indication of activity. Subjects 
were told ‘pulsed’ ultrasound was being used and were allowed to believe 
that the aim of the experiment was to investigate two different treatment 
interventions (SDN with PIR and pulsed ultrasound). Because of the aim of 
sham treatment, very light pressure was applied with a very slow stroking 
motion of the ultrasound transducer across the skin surface. The sham 
ultrasound protocol is described in detail as follows. 
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1. Ultrasound conducting gel was applied to all identified LTrPs and the 
ultrasound head was applied to the area over the LTrP for a period of 
three minutes. The PM and SA were ‘treated’ supine, then the subjects 
moved to a prone position and the UT, LS, MT, Rh and LT were ‘treated’. 
The only functioning part of the ultrasound machine was a bell that rang to 
indicate that the three minutes of treatment had concluded. The sham 
nature of the treatment was revealed to subjects at the end of the 
experiment (that is, after the various scapular plane elevation protocols) 
and all indicated that they had believed that the treatment was real. 
2. At the conclusion of the sham ultrasound treatment, the clinical signs 
indicating the presence of LTrPs remained in all subjects and there was 
no significant difference between the PPTs of these subjects pre or post 
sham ultrasound treatment, indicating that LTrPs remained.  
 
5.1.4 Surface EMG protocols 
 
After treatment, ‘actual’ or ‘sham’, all LTrP subjects repeated the sEMG 
protocols (unloaded, loaded, unloaded-post fatigue, loaded post fatigue) as 
described in detail in Chapter 4 (page 144) and depicted in Figure 5.1.1 
(page 208). For each subject, the “treatments” (actual or sham) took 
approximately 20 minutes and the “post treatment” sEMG recordings of 
scapular plane elevation under the various conditions, occurred 
approximately 30 minutes after the pre-treatment sEMG evaluation finished 
during which time, all subjects were ostensibly resting.  
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5.1.5 Statistical analysis 
 
Paired t-tests were employed to compare the mean times of muscle 
activation of the LTrPs subjects pre and post “treatment” while an 
independent t-test was used to compare the MAPs of treated LTrP subjects 
(LTrPs removed) with the control group. Again, F statistics were used to 
compare the variability of activation times for each muscle between the LTrP 
subjects in their various states and the control group as appropriate. The 
significance level was set at p<0.05 for all comparisons. 
 
 
5.1.3  Results  
 
5.1.3.1 LTrP subjects pre and post treatment (within group 
comparisons): unloaded motion 
 
Group data are depicted in Table 5.1.2 and Figure 5.1.2 below and show the 
mean activation times (solid circles) and SD of activation times (bars) for 
each muscle for unloaded scapular plane elevation. The LTrP group 
receiving sham treatment, had the same order of muscle activation before 
and after sham treatment with no significant differences occurring for the 
timing of any muscle as follows: Inf activated prior to movement start, the UT 
immediately as the arm moves, then the MD, SA and LT after movement 
start respectively. In contrast, the LTrP group who received SDN and PIR 
stretching to remove LTrPs, displayed a ‘normalised’ order of muscle 
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activation, that is, UT prior to movement start, followed by Inf, MD, SA and LT 
activated sequentially after movement start. In these subjects, the UT was 
activated significantly earlier and the Inf, SA and LT were activated 
significantly later. Finally, the variability in activation times for the group 
receiving actual treatment decreased significantly post treatment for all 
muscles except the Inf and SA. 
 
Table 5.1.2: Mean muscle activation times for the LTrP subjects prior to 
and after placebo and treatment interventions in the rested state. 
 UT Inf MD SA LT 
LTrP present 27 -153 142 212 477 
LTrP placebo 28 -110 89 254 547 
LTrP treatment -105*# 91* 167# 429* 771*# 
* significant difference in activation time between LTrPs present compared with LTrPs 
absent. # significant difference in the variability of activation times between LTrPs present 
compared with LTrPs absent (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle 
deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 5.1.2 Mean muscle activation times for the LTrP subjects prior to 
and after placebo and treatment interventions in the rested state (mean 
and SD displayed). 
 
 
5.1.3.2 Control Vs LTrPs removed (between group comparisons): 
unloaded motion 
 
Table 5.1.3 and Figure 5.1.3 display the mean activation times for the 
unloaded condition for the control group and the post-treatment LTrP 
subjects (LTrPs removed). As can be seen, there were no significant 
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differences between groups for activation times for any muscle and only the 
Inf was more variable in the post-treatment group.  
 
Table 5.1.3: Mean muscle activation times for the control group 
compared with the LTrP subjects who had their LTrPs removed in the 
unloaded state. 
 UT Inf MD SA LT 
Control -115 75 201 434 776 
LTrPs absent -105 71# 167 429 771 
* significant difference in activation times. # significant difference in the variability of 
activation times (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, 
SA=serratus anterior, LT=lower trapezius. 
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Figure 5.1.3: Mean muscle activation times for the control group 
compared with the LTrP subjects that had their LTrPs removed in the 
unloaded state (mean and SD displayed). 
 
 
5.1.4 Discussion of Results 
 
The results confirm that LTrPs in the scapular rotator muscles alter their 
activation patterns and also those of functionally related muscles, 
(infraspinatus, middle deltoid), by altering mean activation times and 
increasing their variability. This finding supports the proposal of Sterling and 
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colleagues (2001) who hypothesised that reflex inhibition of motoneurons 
secondary to some kind of afferent input not perceived as painful, could 
cause changes in neuromuscular control in humans (Shakespeare et al. 
1985; Sterling, Jull & Wright 2001; Stokes & Young 1984). In addition, these 
findings support Kibler’s hypothesis that dysfunction in a proximal segment of 
a kinetic chain (LTrPs in the scapular muscles in this instance), can affect the 
function of related segments (infraspinatus of the rotator cuff, middle deltoid 
as an abductor of the arm) in order to move the most distal segment, in this 
case, the hand (Kibler, W. B. 1998b) . 
 
With regard to motor control, Neilson (1993) suggested that the CNS 
contains circuitry able to judge and adapt the accuracy of motor commands 
by comparison between the command signals (internal movement model) 
despatched and their consequences (through sensory feedback). In this 
model, if the inputs show good correlation with the internal reference, the 
established motor program can ‘play out’ without alteration by the CNS 
(Neilson 1993). For the control group in the present study, though timing 
varied slightly, the same order of muscle activation occurred in all subjects, 
that is, UT immediately prior to movement start, Inf and MD immediately after 
movement start, then SA and LT respectively, suggesting that sensory inputs 
in control subjects were well correlated with the internal model for elevation 
of the arm in the scapular plane with a consistent MAP resulting. Later, 
Neilson (2005) also hypothesised that the adaptive CNS circuitry was able to 
independently extract varying sensory and motor signals and continually alter 
motor commands in a feedforward process designed to replicate the pre-
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planned movement as closely as possible (Neilson & Neilson 2005). In a 
more recent review, van Vliet and Heneghan (2006) stated that feedforward 
control incorporates inputs occurring immediately prior to the beginning of a 
movement and is an ongoing process during the movement (van Vliet & 
Heneghan 2006). For the LTrP group, the UT was the muscle most likely to 
contain a LTrP (93% of 28 subjects) and in contrast to the control group 
where it was always activated first, the UT was never activated first in the 
LTrP group. Many authors have reported on the specific purpose of the UT 
as an initiator of elevation of the acromion early in scapular plane elevation of 
the arm (Bagg & Forrest 1986, 1988; Ludewig & Cook 2000; Ludewig, Cook 
& Nawoczenski 1996; Matias & Pascoal 2006; Wadsworth & Bullock-Saxton 
1997). Accepting that UT plays a specific role and is therefore activated early 
in scapular plane elevation as part of an optimal activation pattern, where 
some factor (LTrPs) interferes with this timing, feedforward processing may 
have altered the rest of the MAP in an attempt to sustain the overall 
movement. Support for what might be referred to as a “compromised 
movement pattern” generated through feedforward processing in the face of 
pain has previously been demonstrated in the “sub-optimal” MAPs recorded 
for low back pain patients (Hodges, P. W. 2001; Hodges, P. W. et al. 2003), 
chronic neck pain sufferers (Falla, D., Bilenkij & Jull 2004), patients with long 
standing groin pain (Cowan et al. 2004) and those with patellofemoral pain 
(Cowan et al. 2003), but to the author’s knowledge, has not yet been 
demonstrated in a LTrP population, who feel pain when their LTrPs are 
directly compressed but are pain-free during movement. Given the possibility 
that an optimal MAP for scapular plane elevation depends upon early 
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activation of UT, understanding how the presence of a LTrP can delay its 
activation seems crucial to restoring optimal kinematics.  
 
With regard to comprehending how LTrPs may affect muscle activation, Shah 
and colleagues (2005) found increased interstitial concentrations of 
nociceptor activating substances, specifically substance P (SP) and 
calcitonin gene-related peptide (CGRP) in UT muscles containing both active 
and latent TrPs compared to TrP-free muscles (active>latent>normals; N=3 
in each group; p<0.02)). Given that ATrPs are spontaneously painful, the 
presence of pain-associated neuropeptides might be expected. However, the 
presence of these endogenous substances, usually produced in response to 
fatigue, pain or inflammation, at LTrP sites in greater concentrations than in 
normal tissue, implies that group III and IV afferent input could occur at rest 
and stimulate neural pathways similar to those expected where muscle is 
fatigued, painful or inflamed. These pathways were described in Chapter 4 
(page 193) as neural mechanisms that underpin fatigue in healthy subjects 
but are presented again below in point form for ease of reading (for 
underpinning references, see Chapter 4, page 193).  
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5.1.4.1 Facilitation of α-motoneurons secondary to group III and IV 
stimulation of fusimotor drive 
 
• Nociceptors are exposed to activating algesic substances and 
stimulate increased group III and IV afferent discharge. This leads to 
excitation of γ-motoneurons, especially static γ-motoneurons, which 
produces increased static (predominantly) and dynamic sensitivity to 
stretch. The increased spindle Ia and II input facilitates homonymous 
and heteromonymous α and γ motoneurons and Ia inhibitory 
interneurons resulting in activation of agonist and synergist muscles 
and inhibition of antagonist muscle(s). 
 
5.1.4.2 Inhibition of α-motoneurons secondary to group III and IV 
afferent input 
 
• Where fusimotor drive secondary to group III and IV afferent discharge 
facilitates agonist and synergist muscles and inhibits antagonists via 
the pathway outlined immediately above, the addition of pre-synaptic 
inhibition of the Ia fiber terminal results in a reduced excitatory input to 
the α and γ motoneurons and resultant relative depression of muscles 
usually activated or inhibited via this pathway.  
• Secondly, group III and IV afferent input may act at supraspinal sites, 
resulting in sub-optimal descending excitation of α-motoneurons or 
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may cause recurrent inhibition of multiple motoneurons by facilitating 
the inhibitory affects of Renshaw cells. 
 
A neural process not explored in Chapter four involves the potential effects of 
increased tension of the muscle fibers forming a LTrP taut band on the 
fusimotor system. Underpinning evidence comes from an earlier study 
performed by Macefield and colleagues (1991). In this study, subjects 
performed a low intensity (30% of MVC) isometric contraction for one minute 
while muscle spindle afferent discharge was measured. Interestingly, the 
authors found a significant decrease in spindle output that occurred 
approximately 10 seconds into the sustained contraction which further 
decreased to half the initial discharge rate by one minute (Macefield et al. 
1991). Although the current study used isotonic muscle contractions when 
measuring MAPs during the test movement, the nature of a LTrP taut band 
may somewhat replicate a low intensity isometric contraction of the involved 
fibers when the muscle is at rest. Thus, muscle spindles situated in parallel or 
in close association with a LTrP taut band while the muscle is at rest may 
produce a decreased afferent discharge into the CNS “disfacilitating 
motoneurons” as in Macefield and colleagues (1991) study. Likewise, the 
presence of LTrPs, with their associated nociceptor activating substances 
resulting in group III and IV afferent firing and taut band with contracted 
sarcomeres secondary to increased ACh acting on the exposed muscle cell 
membrane (see Chapter 2, pages 23-28; 50), potentially replicates a low 
intensity sustained isometric contraction of the muscle fibers forming the taut 
band at rest. If this concept is accurate, muscle fibers forming the LTrP taut 
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band might be associated with decreased spindle afferent discharge with the 
muscle at rest, resulting in disfacilitation of motoneurons and a decreased 
ability to activate agonist and synergistic muscles or inhibit antagonists. 
Speculating further, this may be one mechanism that potentially results in 
altered or variable MAPs when performing isotonic contractions in 
association with a low intensity isometric contraction of part of the muscle 
(taut band) and this potential disfacilitation of motoneurons might explain the 
variable timing of muscle activation in the current study.  
 
In addition to the effects of the tension of the taut band, Rothwell (1994) 
reported that muscle spindles are approximately 10mm in length, indicating 
that one spindle receptor would span approximately 3,700 sarcomeres, 
where sarcomeres were at optimal length (2.69µm according to (Zuurbier et 
al. 1995)). Rothwell (1994) also reported that spindle function was affected 
by their position within the muscle. Given they are preferentially sensitive to 
small increases in stretch (Matthews & Stein 1969; Poppele & Bowman 
1970) (for example, a 50µm stretch in a decerebrate cat soleus muscle 
significantly increased spindle afferent discharge (Rothwell 1994)), it follows 
that they may be activated by the lengthening of sarcomeres that occurs in 
parts of muscle fibers adjacent to LTrP contraction knots. Conversely, 
spindles in the endplate zone that may be situated over sections of a muscle 
fiber that remain shortened in the presence of a LTrP contraction knot, could 
be “unloaded” and decrease their afferent output. If so, decreased spindle 
afferent output from these muscle spindles, with associated disfacilitation of 
gamma and synergistic α-motoneurons, may decrease α-motoneuron drive 
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to homonymous and heteromonymous muscles, ultimately reducing the 
excitatory drive for activation of these muscles. Interestingly, according to 
these potential responses, it might be expected that where LTrPs exist, 
muscle spindle output would be decreased from spindles within the LTrP 
region (due to the decreased lengthening ability assumed in this part of the 
muscle fiber), with the opposite response away from the LTrP. Such 
“opposing” outputs have the potential to “compromise” the proprioceptive 
feedback provided from multiple spindles in LTrP-affected muscles with 
affects on the timing of that muscle’s activation. The possibility that spindles 
can be adapted to muscle fiber length by the fusimotor system (or by 
intrafusal creep of the dynamic bag sensory region) might not mean that any 
proprioceptive disturbance would be transient since even if the affected 
intrafusal fibres are adapted to the length change of their muscle fibers, their 
output would not be consistent with the length of the unaffected fibres. In 
addition since the muscle fibers from different motor units mix within any 
volume of muscle, it is possible that any influence these “dysfunctional” 
spindles have, could play upon motoneurons controlling different motor units 
and therefore affect a broader cross section of the motoneuron pool. Though 
these notions are nothing more than conjecture at this stage, they might 
provide a basis for further investigation into the effects of muscle spindle 
input from LTrP affected muscles and ultimately, motor control and 
movement performance. In addition to neural mechanisms that may alter 
MAPs, intrinsic properties of LTrP-affected muscle fibers may also contribute 
to the efficacy of muscle activation. An attempt to explain these potential 
interactions forms the next section of this discussion. 
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5.1.4.3 The intrinsic properties of LTrP-affected muscles 
 
As suggested above, in addition to neural mechanisms, the intrinsic 
properties (length/tension relationship of individual muscle fibers and their 
sarcomeres, contractile efficiency etc) of a specific muscle may contribute to 
its ability to contract (Gandevia, 2001). A LTrP contraction knot consists of 
multiple shortened sarcomeres in closely related muscle fibers, which force 
adjacent sarcomeres within the LTrP-involved muscle fibers to increase in 
length in an attempt to preserve the normal length of the entire fibre (Simons, 
D., Travell & Simons 1999). Muscle fiber configuration of this type could 
result in mechanical failure or disruption of normal contraction of the 
contractile elements due to loss of overlap of actin and myosin in the 
lengthened sarcomeres and active insufficiency of the shortened 
sarcomeres, which when occurring in multiple muscle fibers simultaneously, 
may reduce the force generating capacity of the entire muscle (Denoth et al. 
2002). It has been known for some time that sarcomere lengths within normal 
muscle fibres are not homogeneous, leading to differing length/tension 
conditions throughout a fibre (Telley, Denoth & Ranatunga 2003). However, 
the effects of LTrPs just described could be expected to increase this 
heterogeneity with unknown effects on force production and perhaps on 
recruitment. As an additional consideration, sarcomeres that remain 
shortened would be expected to have altered cross bridge 
attachments/detachments mechanics, which may affect the relaxation time of 
the contractile elements of affected muscle fibers. There are also increase in 
the static tension (as evidenced by the taut band) of the muscle fiber and this 
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possibly alters the stiffness of affected fibers. A decreased relaxation rate 
(increased time taken for cross bridge detachment) is thought to increase 
muscle twitch duration and ultimately decrease the contractile speed in 
sustained isometric contractions (Bigland-Ritchie, B. et al. 1983; Bigland-
Ritchie, B. & Woods 1984). However, no information could be found 
regarding the specific effects of decreased contractile speed during 
contractions of changing length. Reduced contractile capacity via either 
mechanism (loss of contractile efficiency due to severely shortened and 
consequently lengthened sarcomeres or reduced contractile speed 
secondary to altered cross bridge mechanics) could result in an initially 
reduced sEMG amplitude until additional motor units are activated, possibly 
delaying the time identified as the onset of muscle activation (defined as one 
SD above the mean baseline amplitude in the current study). Though these 
thoughts are speculative and further investigation is necessary, this possible 
mechanism (if it exists) could have contributed to the later activation of the 
UT in LTrP subjects demonstrated in the present study. 
 
Importantly, Mense (1997) pointed out that the goal of nociceptor activation 
was to provide timely feedback to the CNS regarding the structural or 
functional limits of tissues (Mense 1997). As described above, nociceptive 
input from muscles affects muscle spindles (Knutson 2000) and probably 
descending central commands (Taylor, Todd & Gandevia 2006), providing 
multiple neural processes that could result in either excitation or inhibition of 
muscle activation and alteration of the associated MAP (Bigland-Ritchie, B. 
R. et al. 1986; Garland 1991; Woods, Furbush & Bigland-Ritchie 1987). 
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Though nociceptive activating substances at greater concentrations than 
found in normal tissue have been found at LTrPs (SP and CGRP in a sample 
of three) and LTrP-affected muscle tissue has a pressure-pain threshold 
lower than would be expected in normal muscle (see Chapter 3, page ? and 
(Hong, C. Z. et al. 1997)), it is difficult to determine whether interstitial 
concentrations of nociceptor activating substances associated with low levels 
of fatigue (see discussion Section 4.3, page 190) or LTrPs, can also invoke 
reflex inhibition of motoneurons. To provide insight into the effects of the 
concentration of nociceptor activating substances a study performed by 
Farina and colleagues (2004) may be helpful. These authors stimulated 
nociceptive afferents by injection of hypertonic saline into the muscles of 
humans subjects, thus experimentally activating group III and IV afferent 
fibers, and found decreased motoneuron firing rates when subjects produced 
a contraction that was 10% of MVC (low intensity sustained isometric 
contraction). Furthermore, the decrease was inversely correlated with both 
the amount of nociceptive input (as judged by the concentration of hypertonic 
saline injected) and the subjectively scored pain intensity (Farina, D. et al. 
2004). Combining the results of Shah’s group (2005) with the findings of 
Farina’s (2004) suggests that with low intensity sustained isometric 
contraction, (perhaps similar to the situation created by a LTrP taut band), 
lower concentrations of nociceptor activating substances (LTrPs) produce 
less decrease in motoneuron discharge while greater concentrations (ATrPs) 
are associated with greater disfacilitation of motoneurons. Therefore, it is 
reasonable to posit that the interstitial concentrations of nociceptor activating 
chemicals affect the amount of motoneuron disfacilitation and that the 
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concentrations associated with LTrPs, can produce this phenomenon in the 
absence of spontaneous pain. 
 
 
In summary, although no literature could be found specifically dealing with 
the motor effects of LTrPs, it has been a popular belief of clinicians that these 
neuromuscular lesions are indeed capable of motor effects (Hong, C. Z. 
2004; Simons, D. G. 2005). The ‘normalisation’ of the MAP once LTrPs had 
been removed (clinical signs absent) greatly strengthens the conclusions 
stated in Chapter 4 (pages 160;174; 204), that LTrPs in the scapular rotator 
muscles affect the timing of muscle activation in this group and though this 
study was not intended to investigate the processes that may have produced 
these results, the presentation of ideas in the previous sections is meant to 
promote further discussion regarding the motor effects of LTrP-containing 
muscles and act as a spur for further debate and investigation. 
 
 
5.1.4.4 Adaptive role of infraspinatus 
 
Where LTrPs existed in the scapular rotator muscles, the only consistency in 
the MAP was that the Inf was activated first (occurred in 92% of trials). 
Infraspinatus plays an integral role in the early phase of elevation of the arm 
in the scapular plane by pulling on the greater tubercle of the humerus to 
cause slight external rotation, depression and posterior translation of the 
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humeral head in the glenoid fossa as the humerus begins to abduct, which 
along with the remaining rotator cuff muscles results in a compressive force 
to promote the dynamic stability of the glenohumeral joint (Neumann 2002; 
Payne et al. 1997; Reddy et al. 2000; Sharkey & Marder 1995). According to 
Kibler (1998), the muscles that connect the scapula to the vertebrae and ribs 
(all parts of the trapezius and rhomboids, serratus anterior, levator scapular 
and pectoralis minor), act to optimally position the scapula during upper 
extremity motion to best accommodate the rotating humeral head, 
contributing to a stable and functional glenohumeral joint. He argued that 
where the glenoid was not optimally positioned during arm movements, the 
muscles that positioned the humeral head may be predisposed to altered 
function in order to preserve the movement (Kibler, W. B. 1998b). He further 
suggested that where adaptation of function was ineffective or insufficient, 
the tissues attempting to compensate for the proximal dysfunction may be 
subjected to overload and injury. In the current study, except for the 
significantly earlier activation of the Inf, the MAP of the LTrP group was 
inconsistent with many different sequences of muscle activation occurring 
within the group, which might suggest that the early activation of the Inf was 
an attempt to adapt to sub-optimal glenoid positioning created by an 
inefficient MAP of the upward scapular rotator muscles, potentially exposing 
the compensating muscle to increased loads and ultimately injury. 
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5.1.5 Conclusions 
 
Based on the results of this study, it can be concluded that: 
1. The presence of LTrPs in the scapular rotator muscles is associated 
with changes in MAPs in the absence of pain, manifested as altered 
activation times and increased variability of muscle activation patterns.  
2. Non-painful afferent input can influence neuromuscular activation 
patterns in support of the proposal of Sterling and colleagues (2001). 
3. A pain-free neuromuscular dysfunction (LTrPs) in a proximal segment 
of the upper extremity kinetic chain can affect the function (MAPs) of 
structures in related segments in support of Kibler’s, theory (Kibler 
1998)  
4. Such changes may predispose individuals to increased risk of 
subacromial impingement, overuse of the infraspinatus due to earlier 
activation and decreased efficiency of movement with resultant earlier 
onset of fatigue during scapular plane elevation. 
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5.2 The Effects of Removing LTrPs on MAPs during Loaded Scapular  
Plane Elevation 
 
 
5.2.1 Introduction 
 
Latent TrPs located in the scapular rotator muscles were found to alter MAPs 
during elevation of the arm in the scapular plane while holding hand-weights 
selected to represent loads that may be lifted during commonly performed 
tasks (males 4kg, females, 1.3kg). These findings and the related 
methodologies were reported in Chapter 4, Section 4.2 (page 162) and were 
used for comparison with the MAPs recorded for the LTrP subjects after the 
LTrPs had been removed, in the current section. 
 
5.2.1.1 Question addressed: 
 
Does the removal of LTrPs from the scapular rotator muscles change the 
MAP of these muscles or functionally related shoulder girdle muscles 
employed to elevate a load commonly encountered in daily activities during 
scapular plane elevation? 
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5.2.2   Methods 
 
5.2.2.1 Subjects and Procedures 
 
After the LTrP treatment interventions had been completed and the first 
sEMG investigations (unloaded state, section 5.1) had concluded, subjects 
repeated the ‘Loaded’ trials with the same hand-weights used in previous 
loaded trials (Section 4.2). Once again each subject completed three loaded 
arm elevations as described previously (section 4.2) with four seconds rest 
between each trial to allow the sEMG to return to a baseline level. 
 
5.2.2.2 Statistical analysis 
 
Paired t-tests were employed to compare the mean times of muscle 
activation of the LTrPs subjects pre and post their respective interventions. 
An independent t-test was used to compare the LTrP subjects who had their 
LTrPs removed to the control group. Again, F statistics were used to 
compare the variability of activation times for each muscle between the 
LTrPs subjects in their various states and the control group as appropriate. 
All significance levels were set at p<0.05. 
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5.2.3  Results 
 
As there were no significant difference between the MAPs of the LTrP 
subjects who went on to have treatment compared with those who had sham 
treatment prior to any interventions, the mean MAPs displayed through this 
Chapter for LTrP subjects prior to treatment were pooled (N=28) and each 
sub-group (treatment and sham treatment) were compared to the pooled 
data. 
 
5.2.3.1 LTrP subjects pre and post treatment (within group 
comparisons): loaded motion 
 
Table 5.2.1 and Figure 5.2.1 compare the mean activation times for the LTrP 
subjects prior to intervention with their post-intervention results. The LTrP 
group post-placebo showed no significant differences from the activation 
pattern prior to placebo intervention. In contrast, the paired t-test comparing 
the LTrP subjects prior to treatment with their “treated” LTrP group (LTrPs 
removed using SDN and PIR stretches), displayed a significant difference in 
mean activation times from the pre-intervention condition where the UT was 
activated significantly earlier and the Inf significantly later. In addition, the 
variability in activation times significantly decreased post treatment for the 
UT, Inf and MD.  
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Table 5.2.1: Mean muscle activation times for the LTrP subjects prior to 
and after placebo and treatment interventions in the loaded state. 
 UT Inf MD SA LT 
LTrP -57 -244 25 91 343 
LTrP placebo -47 -264 19 86 371 
LTrP treatment -182*# -50*# -7# 280 486 
significant difference in activation time between LTrPs present compared with LTrPs 
absent. # significant difference in the variability of activation times between LTrPs 
present compared with LTrPs absent (p<0.05). UT=upper trapezius, 
Inf=infraspinatus, MD=middle deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 5.2.1: Mean muscle activation times for the LTrP subjects prior 
to and after placebo and treatment interventions in the loaded state 
(mean and SD displayed). 
 
5.2.3.2 Control Vs LTrPs removed (between group comparisons): 
loaded motion 
 
Table 5.2.2 and Figure 5.2.2 display the comparisons between the control 
group and the LTrP treatment group (LTrPs removed). There were no 
significant differences between groups (mean activation times, variability of 
activation times) for any muscle after LTrPs were treated. 
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Table 5.2.2: Mean muscle activation times for the Control group 
compared with the LTrP after treatment in the loaded state. 
 UT Inf MD SA LT 
Control -191 -57 -6 316 536 
LTrPs absent -182 -50 -7 280 486 
* significant difference in activation times. # significant difference in the variability of 
activation times (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, 
SA=serratus anterior, LT=lower trapezius. 
 
 
Figure 5.2.2: Mean muscle activation times for the Control group 
compared with the LTrP after treatment in the loaded state (mean and 
SD displayed). 
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5.2.4  Discussion of Results 
 
Chapter four reported on and discussed the results of an investigation into 
the effects of light loads on the MAPs of related shoulder girdle muscles 
during elevation in the scapular plane in healthy controls and subjects with 
LTrPs in the scapular rotator muscles. Under similar conditions (light loads) 
the protocols were repeated after LTrPs were removed from half the LTrP 
subjects thereby more accurately establishing the effects of LTrPs on MAPs 
under these conditions (loaded). The results virtually duplicated those found 
in the preceding Section (5.1, page 216), when scapular plane elevation was 
carried out without load in treated and untreated (sham) LTrP subjects. 
Hence it is logical to suggest that the same processes/mechanisms operated 
under each condition (unloaded and loaded) and are summarised as follows. 
 
In the presence of LTrPs (pre-treatment condition), the only consistent aspect 
of the MAP was the early activation of the Inf. Placebo intervention, where 
LTrPs remained in the scapular rotator muscles, resulted in no change of the 
MAP from the pre-intervention state, but in contrast, where LTrPs were 
removed with treatment, the MAP ‘normalised’, showing no difference from 
that of the control group in the loaded state. The lack of change in MAPs 
after sham treatment in contrast to the “normalising” effect of the SDN 
treatment (same MAPs as controls under the same conditions), provides 
strong evidence that this treatment works and that LTrPs are indeed 
responsible for the altered MAPs in the scapular rotators and related 
muscles. In addition, the results add weight to the argument that LTrPs 
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should be treated because they do have what can be presumed as 
deleterious effects on MAPs in shoulder girdle muscles. It should be 
remembered that these data shed no light on the duration of the changes 
produced by treating LTrPs, however, while MAPs are “normal”, the risks of 
developing rotator cuff overuse or dysfunction, subacromial impingement or 
inefficient movement patterns is likely to be reduced. It is presumed that the 
same mechanisms underlying the way that LTrPs produce altered MAPs, 
continue to operate under load and may involve any of the combination of 
neural pathways (Type III and IV muscle afferents, fusimotor effects etc) 
discussed previously. 
 
 
5.2.5  Conclusions 
 
Based on the results of this study, it can be concluded that: 
1. The addition of light external load does not reduce the capacity of the 
MAPs to normalise once LTrPs had been removed, implying that a 
positive outcome can be expected to hold for situations that require 
raising light weights overhead.  
2. The findings of this study support both the views of Sterling and 
colleagues (2001) who suggested that non-painful afferent input could 
influence neuromuscular activation patterns and Kibler’s theory 
(1998), that dysfunction of a proximal kinetic chain segment affects the 
function of related segments. 
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3. Superficial dry needling followed by PIR stretching removes the 
clinical signs associated with the presence of LTrPs and the effects of 
the LTrPs themselves. 
 
These outcomes may not hold in situations where repetitive arm 
elevations are required, an activity associated with the development or 
exacerbation of LTrPs (Simons, D., Travell & Simons 1999) and the 
subject of the following section of this chapter. 
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5.3 The Effects of Removing LTrPs on MAPs Post-fatiguing 
Movement during Scapular Plane Elevation 
 
 
5.3.1 Introduction 
 
In this final section of the experimental program, the effects of fatigue on the 
target muscles were examined following either SDN plus stretching or sham 
treatment of LTrPs. The protocols were the same as previously described: 
unloaded and loaded scapular plane elevation following fatigue induced by 
repetition of the same movement (Section 4.3, page 178) while holding hand-
weights. Fatiguing activity was specifically “targeted” because of previous 
suggestions that fatigue is associated with the development or exacerbation 
of LTrPs (Simons, D., Travell & Simons 1999). 
 
 
5.3.1.1 Question addressed: 
 
1. Does the removal of LTrPs from the scapular rotator muscles change 
the MAP of this group or functionally related shoulder girdle muscles 
after fatiguing repetitive arm elevations during both unloaded and 
loaded scapular plane elevation? 
2. Does fatigue alter the outcome of a LTrP treatment already shown to 
“normalize” MAPs in response to non-fatiguing exercise? 
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5.3.2  Methods 
 
5.3.2.1 Subjects and Procedures 
 
After the LTrP treatment interventions had been completed and the first two 
sEMG investigations (rested state, section 5.1 then loaded state, Section 5.2) 
had concluded, subjects were asked to again perform the fatiguing protocol 
as described in Chapter four (page 178), immediately followed by three trials 
of loaded scapular plane elevation, then three trials of the movement without 
load as outlined in Figure 5.3.1. 
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Figure 5.3.1: Experimental procedure to test the effects of fatigue on 
MAPs during scapular plane elevation 
Fatiguing repetitive elevations 
Weights, no rest, metronome at 60bpm; 
approximately 40°/sec for 160° of abduction 
Fatigue = perceived muscle burning and inability 
to maintain movement speed 
Post-fatigue condition 
Fatiguing arm elevations stopped 
4 seconds rest holding hand-weights, subjects 
asked to ‘relax the shoulders’ 
Baseline sEMG re-established 
3 trials with external load with 4 seconds rest 
between trials (post-fatigue, loaded) 
Hand-weights taken from subject during the last 4 
second rest after the third ‘loaded’ trial. 
Baseline sEMG re-established 
3 trials with no external loaded with 4 seconds rest 
between trials (post-fatigue, unloaded) 
Rested and loaded scapular plane elevation 
Section 5.2 
Rested and unloaded scapular plane elevation 
Section 5.1 
Subjects rest for approximately 5 minutes 
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5.3.2.2 Statistical analysis 
 
Paired t-tests were employed to compare the mean times of muscle 
activation of the LTrP subjects pre and post intervention (treatment or sham). 
An independent t-test was used to compare MAPs of the treated LTrP 
subjects with those of the control group under the same conditions. An 
additional independent t-test was employed to compare the mean activation 
times of the treated LTrP subjects post-fatigue with those of the control group 
in the rested state. Again, F statistics were used to compare the variability of 
activation times for each muscle between both LTrPs groups (treated and 
sham) and the control group as appropriate. Significance was again set at 
p<0.05 for all tests. 
 
 
5.3.3  Results 
 
5.3.3.1 LTrP subjects pre and post treatment post-fatigue (within group 
comparisons): unloaded motion 
 
Table 5.3.1 and Figure 5.3.2 compare the mean activation times for the LTrP 
subjects prior to intervention with their post-intervention post-fatigue and 
unloaded trials. The LTrP group post-placebo showed no significant 
differences from the activation pattern determined prior to sham intervention. 
In contrast, the LTrP group after LTrPs were removed using SDN and PIR 
stretching, displayed a significant difference (p<0.05) in mean activation 
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times from the pre-intervention condition for the UT (activated earlier) and Inf 
and SA (both activated later). The variability in activation times significantly 
(p<0.05) decreased post treatment for the muscles that had formerly 
contained LTrPs (UT, SA and LT). 
 
Table 5.3.1: Mean muscle activation times for the LTrP subjects prior to 
and after placebo and treatment interventions in the fatigued but 
unloaded state. 
 UT Inf MD SA LT 
LTrP 30 -54 155 218 541 
LTrP placebo 2 -49 142 200 596 
LTrP treatment -101# 112* 216 433*# 745*# 
* significant difference in activation time between LTrPs present compared with LTrPs 
absent. # significant difference in the variability of activation times between LTrPs present 
compared with LTrPs absent (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle 
deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 5.3.2: MAPs for the LTrP subjects prior to and after placebo and 
treatment interventions post-fatigue and unloaded (mean and SD 
displayed). 
 
 
5.3.3.2 Control Vs Treated LTrP group (between group comparisons): 
unloaded motion 
 
Table 5.3.2 and Figure 5.3.3 display the comparisons between the control 
group and the LTrP treatment group (LTrPs removed) in the post-fatigue but 
unloaded condition. In treated subjects, all muscles except the UT, were 
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activated significantly later (p<0.05) than in the controls. In addition, both the 
UT and LT muscles demonstrated significantly less variability of activation 
times versus controls after treatment.  
 
Table 5.3.2: Mean muscle activation times for the Control group 
compared with the LTrP after treatment in the fatigued but unloaded 
state. 
 UT Inf MD SA LT 
Control -85 -20 3 244 339 
LTrPs absent -112# 75* 202* 434* 776*# 
* significant difference in activation times. # significant difference in the variability of 
activation times (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, 
SA=serratus anterior, LT=lower trapezius. 
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Figure 5.3.3: MAPs comparing the control group to the LTrP subjects 
after the removal of LTrPs, post-fatigue and during unloaded scapular 
plane elevation (mean and SD displayed). 
 
 
5.3.3.3 Treated LTrPs subjects post-fatigue Vs Control group rested 
(between group comparisons): unloaded motion 
 
Table 5.3.3 and Figure 5.3.4 display the comparisons between the treated 
LTrP group (LTrPs removed) in the post-fatigue but unloaded condition and 
the control group in the rested and unloaded condition (i.e. controls before 
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exposure to fatiguing exercise). No significant differences in mean activation 
times were found between the treated LTrP subjects in the fatigued and 
unloaded condition and the control group in the rested and unloaded 
condition. However, rested, unfatigued controls demonstrated significantly 
less variability in their activation times when performing scapular plane 
elevation without load (unloaded) and unfatigued. 
 
Table 5.3.3: Mean muscle activation times comparing the control group 
(fatigued), the LTrP subjects once the LTrP had been removed 
(fatigued) and the control group (rested) during unloaded scapular 
plane elevation. 
 UT Inf MD SA LT 
Control fatigued -85 -20 3 244 339 
LTrPs absent -110 71 196 428 765 
Control rested -115 75 201 434 776 
* significant difference in activation time between control fatigued compared with LTrPs 
absent. # significant difference in the variability of activation times between control fatigued 
compared with LTrPs absent (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle 
deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 5.3.4: MAPs comparing the control group (fatigued) the LTrP 
subjects after the removal of LTrPs (fatigued) and the control group 
(rested), during unloaded scapular plane elevation (mean and SD 
displayed). No significant differences in the timing of muscle activation 
exist between the LTrP subjects once the LTrP have been removed 
(fatigued) and the control group (rested), however the Inf and MD of the 
LTrP treatment group display greater variability in their activation times 
than does the control group in the rested state. 
 
 
 255 
5.3.3.4 LTrP subjects (within group comparisons): loaded motion 
 
Table 5.3.4 and Figure 5.3.5 display the mean activation times for the LTrP 
subjects prior to intervention with their post-intervention states in the post-
fatigue and loaded condition. The LTrP group post-placebo treatment, 
showed no significant differences from the activation pattern found prior to 
placebo intervention. In contrast, the treated LTrP group displayed significant 
differences in mean activation times after intervention: the UT was activated 
significantly earlier and the Inf, SA and LT all activated significantly later. 
Furthermore, their activation time variability significantly decreased post 
treatment in all muscles except the LT  
 
Table 5.3.4: Mean muscle activation times for the LTrP subjects prior to 
and after placebo and treatment interventions in the fatigued and 
loaded state. 
 UT Inf MD SA LT 
LTrP -41 -149 23 95 276 
LTrP placebo -27 -140 47 72 290 
LTrP treatment -182*# -63*# -21# 290*# 511* 
* significant difference in activation time between LTrPs present compared with LTrPs 
absent. # significant difference in the variability of activation times between LTrPs present 
compared with LTrPs absent (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle 
deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 5.3.5: MAPs for the LTrP subjects prior to and after placebo and 
treatment interventions post-fatigue and loaded (mean and SD 
displayed). 
 
 
5.3.3.5 Control Vs treated LTrPs (between group comparisons): loaded 
motion 
 
Table 5.3.5 and Figure 5.3.6 display the comparisons between the control 
group and the treated LTrP subjects (LTrPs removed) in the fatigued and 
loaded condition. The UT was activated significantly earlier and the SA and 
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LT significantly later after LTrPs had been treated. In addition, the UT was 
significantly less variable in its activation time after LTrPs had been removed. 
 
Table 5.3.5: Mean muscle activation times for the control group 
compared with the LTrP after treatment in the fatigued and loaded state. 
 UT Inf MD SA LT 
Control -134 -54 -20 223 363 
LTrPs absent -195*# -53 -1 294* 553* 
* significant difference in activation times. # significant difference in the variability of 
activation times (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle deltoid, 
SA=serratus anterior, LT=lower trapezius. 
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Figure 5.3.6: MAPs comparing the control group to the LTrP subjects 
after the removal of LTrPs, post-fatigue and during loaded scapular 
plane elevation (mean and SD displayed). 
 
 
5.3.3.6 Treated LTrPs subjects post-fatigue Vs Control group rested 
(between group comparisons): loaded motion 
 
Table 5.3.6 and Figure 5.3.7 display the comparisons between the LTrP 
treated group (LTrPs removed) in the post-fatigue and loaded condition and 
the control group in the rested and loaded condition (i.e. controls performing 
loaded scapular plane elevation prior to undergoing fatiguing exercise). No 
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significant differences in mean activation times were found between the 
treated LTrP subjects (fatigued and loaded) compared with the control group 
performing loaded scapular plane elevation in the rested condition. However, 
controls (rested and loaded) had significantly less variability in activation 
times compared with the treated LTrPs subjects (fatigued and loaded 
condition). 
 
Table 5.3.6: Mean muscle activation times comparing the control group 
(fatigued), the LTrP subjects once the LTrP had been removed 
(fatigued) and the control group (rested) during loaded scapular plane 
elevation. 
 UT Inf MD SA LT 
Control fatigued -134 -54 -20 223 363 
LTrPs absent -195 -53 -1 294 553 
Control rested -191 -57 -6 316 536 
* significant difference in activation time between control fatigued compared with LTrPs 
absent. # significant difference in the variability of activation times between control fatigued 
compared with LTrPs absent (p<0.05). UT=upper trapezius, Inf=infraspinatus, MD=middle 
deltoid, SA=serratus anterior, LT=lower trapezius. 
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Figure 5.3.7: MAPs comparing the control group (fatigued) the LTrP 
subjects after the removal of LTrPs (fatigued) and the control group 
(rested), during loaded scapular plane elevation (mean and SD 
displayed). No significant differences in the timing of muscle activation 
exist between the LTrP subjects once the LTrP have been removed 
(fatigued) and the control group (rested). 
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5.3.4  Discussion of Results 
 
Instead of discussing mean muscle activation times of specific muscles in 
various experimental states, this discussion will focus on the overall pattern 
that was exhibited in both the unloaded and loaded MAPs of subjects when 
LTrPs had been treated and removed. The fact that placebo treatment 
intervention, where LTrPs remained in the scapular rotator muscles, did not 
change the MAP of these subjects post-fatigue from the pre-intervention 
pattern, confirms the efficacy of the SDN plus stretching intervention by ruling 
out any placebo effect. The most significant result of this study was the 
finding that removing LTrPs from the scapular rotator muscles ‘normalised’ 
the MAP - they were most similar to those recorded from controls in the 
rested state (loaded and unloaded). Surprisingly, the treated LTrP results, 
post-fatigue were not the same as those produced by the controls under the 
same conditions (fatigued loaded and unloaded). It could be speculated that 
perhaps the treated LTrP subjects were not adequately fatigued, though they 
met the set criteria (inability to maintain the 400/sec cadence and 1600 range 
of shoulder abduction in both eccentric and concentric phases accompanied 
by “muscle burning” sensations). Assuming that they were on the basis of 
these criteria, an alternate explanation may be that they recovered from the 
fatiguing exercise more rapidly than did the control subjects, who were LTrP-
free but had not received SDN or PIR stretching. In the current study, 
subjects had four seconds to relax their muscles after the fatiguing protocol 
which had the purpose of re-establishing a baseline sEMG signal before the 
test trials for loaded motion began. These three trials took eight seconds 
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each, with four seconds rest between trials, and were immediately followed 
by the three trials for unloaded elevations post-fatigue. This amounted to 36 
seconds between the last repetition of the fatiguing protocol and the 
conclusion of the loaded motion trials, with the unloaded motion trials 
beginning 40 seconds and concluding 72 seconds after the last fatigue 
protocol repetition. It is possible that treating LTrPs rendered these muscles 
more able to disperse the metabolic products produced during the fatiguing 
exercise, leading to a decreased likelihood of producing sub-optimal MAPs 
secondary to changes to motoneuron excitability moderated by group III and 
IV afferent discharge. However, recall that the treatment for LTrPs included 
both stretching and light range of motion exercises (see page 212) which 
could increase blood flow. Furthermore, there is some evidence that SDN 
itself increases blood flow (see later). Since the control group received no 
treatment, a discussion of the mechanisms by which the employed treatment 
may affect neuromuscular function may help clarify whether treating LTrPs 
facilitates recovery from repetitive movements. 
 
 
5.3.4.1 LTrP treatment interventions 
 
Perhaps another approach to understanding how LTrPs affect MAPs post-
fatigue (or indeed, any of their effects) is by determining the mechanisms by 
which the treatments work. An insight is provided through recent work by 
Langevin (Langevin, Bouffard et al. 2006; Langevin et al. 2005; Langevin et 
al. 2007; Langevin, Churchill & Cipolla 2001; Langevin, Storch et al. 2006), 
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whose results suggest there may be a mechanism of mechanotransduction 
occurring in the connective tissue secondary to needle movement. Though 
these investigations have been performed to investigate the mechanisms that 
underpin acupuncture, with further studies, the results may eventually help 
explain the effectiveness of SDN. Baldry (2005) has published a theoretical 
explanation of the mechanism by which SDN works, described briefly as 
follows. Superficial dry needling stimulates A-delta fiber mechanoreceptive 
nociceptors (fast conducting pain pathway), which project to the superficial 
zone (Lamina I) of the dorsal horn in the spinal cord. Between lamina I and II, 
‘stalked’ cells receive direct input from A-delta fibers and have the effect of 
releasing the inhibitory opioid peptide enkephalin, which in turn inhibits 
activity in the substantia gelatinosa cells to which small, unmyelinated 
sensory afferents, including group IV nociceptors, project. This action can act 
to block noxious information conducted by group IV afferents, possibly 
stimulated by LTrPs. In addition, activity in the serotonergic descending 
inhibitory system and in the descending noradrenergic system, including the 
associated inhibitory effect of wide dynamic range transmission neurons, 
blocks the intra-dorsal horn passage of noxious information, all actions that 
can be initiated by needle stimulation of A-delta receptors in the skin (Baldry, 
PE. 2005). Confusingly, subjects receiving SDN often do not report feeling 
the ‘needle prick’, something expected if needling stimulates A-delta skin 
receptors. This phenomenon suggests that other factors may be in play. 
Assuming that Baldry’s theory is valid, it provides an explanation for the 
increased PPTs following treatment that were observed in the current 
investigation, though it fails to explain the disappearance of the taut band. 
 264 
This was the reason PIR was employed after SDN to encourage the muscle 
fibers containing contracted sarcomeres to fully lengthen, removing the taut 
band (Lewit & Simons 1984). Although PIR has been demonstrated to 
increase range of motion of TrP-affected muscles, the mechanism(s) 
underpinning the change in stretch perception or tolerance are not known, 
although alterations in muscle spindle afferent output (Rothwell 1994) and 
pain modulation have been proposed (Sharman, Cresswell & Riek 2006). 
Because of the limited information available to explain the mechanisms via 
which this treatment intervention removed the clinical signs of LTrPs, it may 
be speculated that the stimulation of A-delta mechanoreceptive nociceptors 
produced responses that inhibit the processing of nociceptive information at 
the dorsal horn, creating an opportunity to “re-educate” the muscle fibers to 
an increased length by PIR stretching (lengthening the contracted 
sarcomeres via some mechanism), resulting in an improved local circulation 
and the removal of metabolites that had previously stimulated the group III 
and IV nociceptors. With this noxious afferent activity discontinued or 
reduced, its effects on spinal cord reflexes and at supraspinal sites potentially 
resulting in sub-optimal descending commands would be reversed. Thus, 
removal of the clinical signs of LTrPs (principally pain on external pressure of 
a tender point within a taut band) normalised and possibly led to improved 
ability of the muscle to cope with fatigue-related noxious stimuli as well as 
affecting intrinsic muscle properties (e.g. reducing the heterogeneity of 
sarcomere length and improving cross bridge mechanics).  
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5.3.5  Conclusions 
 
On the basis of the results, it can be concluded that: 
1. Superficial dry needling followed by PIR stretching removes the 
clinical signs of LTrPs from the scapular rotator muscles and 
normalises the MAP of LTrP subjects post-fatigue with respect to the 
control group MAP in a rested state.  
2. Treating LTrPs in proximal muscle groups affects the recruitment of 
functionally related muscles placed more distally in the kinetic chain of 
the upper extremity, especially where daily activities involve repetitive 
overhead tasks.  
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CHAPTER 6 
 
 
CONCLUSIONS, LIMITATIONS AND FUTURE DIRECTIONS 
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6.1 Thesis Summary and Conclusions 
 
With regard to LTrPs, despite a paucity of experimental evidence, current 
clinical opinion holds that though these neuromuscular entities allow pain-
free movement, they are primarily associated with motor effects and occur 
commonly in ‘healthy’ muscles. In contrast, evidence exists to support the 
fact that ATrPs are prevalent and a common cause of pain in patients with 
musculoskeletal pain and have significant effects, including augmentation or 
inhibition of sensation and because of pain, movement adaptations. The 
primary aim of this study was to investigate the effects of LTrPs on the MAPs 
of key shoulder girdle muscles during scapular plane elevation of the arm, 
the results of which were presented in Chapters four and five. In connection 
with the main aim, a preliminary study was carried out to examine the 
frequency with which LTrPs occur in the scapular positioning muscles in a 
group of normal subjects, which was presented in Chapter three and 
summarised in the following paragraph.  
 
The objective of the study presented in Chapter three was to determine how 
commonly LTrPs occur within the scapular positioning muscles of 
asymptomatic adults by examining healthy pain-free individuals represented 
by a sample of university staff and students. One hundred and fifty four 
healthy subjects volunteered to undergo a physical examination for the 
presence of LTrPs in the trapezius, rhomboids, levator scapulae, serratus 
anterior and the pectoralis minor muscles bilaterally. Of these subjects, 
89.8% had at least one LTrP in the scapular positioning muscles 
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(mean=10.65 ± 6.8, range=1-27), with serratus anterior and upper trapezius 
harbouring the most LTrPs on average (2.46 ± 1.8 and 2.36 ± 1.3 
respectively). Consistent with clinical opinion, this study found a high 
occurrence of LTrPs in the scapular positioning muscles. Having established 
that the presence of LTrPs in the scapular positioning muscles occurred 
commonly; the clinical significance of their presence and the question of 
whether they affect muscle activation patterns when raising the arm under a 
number of commonly occurring situations were investigated, the results of 
which were presented in Chapters four and five.  
 
Chapter four presents the results of a comparative study that used sEMG to 
investigate MAPs in functionally related shoulder girdle muscles during 
elevation in the scapular plane under a number of commonly occurring 
conditions, including unresisted movement (unloaded), carrying a light hand-
weight (loaded) and after fatiguing repetitive arm elevations both with and 
without external load (fatigued). The resultant MAPs of a sample that had 
LTrPs in the scapular rotator muscles, but not the Inf or MD, were compared 
with a control group who were LTrP-free. Irrespective of the experimental 
condition, there were a number of MAP features of the respective groups that 
were common and are described as follows: 
 
The control group had a relatively stable and sequential order of muscle 
activation that consisted of the UT, Inf, MD, SA than LT. The time at which 
the arm began moving with respect to the times at which muscles were 
activated differed for different experimental conditions. For example, when 
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external load was added, the entire MAP shifted (earlier) so that UT, Inf and 
MD were all activated prior to movement of the arm (as opposed to only the 
UT in the unloaded state), a phenomenon thought possibly designed to allow 
extra motor units to be recruited to generate the extra force needed to cope 
with the increased external load. After fatigue, LTrP-free individuals activated 
the muscles in the same order but the MAP was ‘condensed’, (the muscles 
were generally activated in a shorter time period) and with increased 
variability. These findings indicate that when fatigued, although the order of 
activation is maintained, LTrP-free individuals display a more variable, less 
consistent MAP than when rested, again consistent with fatigue-related 
movement performance in sports or repetitive work tasks.  
 
For healthy subjects, the neural pathways that are associated with fatigue (as 
well as the accompanying accumulation of metabolites, decreased pH and 
their resultant effects on muscle activation and movement) have been quite 
extensively investigated and are summarised briefly as follows as they are 
hypothesised to pertain to the current work: 
Group III and IV nociceptors are activated by fatigue-induced substances 
leading to: 
• Sub-optimal descending signals to the motoneuron pool, potentially 
inhibiting motoneurons directly or through recurrent inhibition via 
Renshaw cells, resulting in decreased excitability of motoneurons and 
muscle activation. 
• Increased fusimotor drive, facilitating motoneurons and muscle 
activation.  
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• Pre-synaptic inhibition of the Ia spindle fiber, depressing the 
monosynaptic excitatory synapse with motoneurons and inhibiting 
muscle activation. 
• Changes in motoneuron intrinsic properties, such as changing their 
activation thresholds through hyperpolarisation and changing ionic 
conductance secondary to changes induced by fatigue in 
neurotranmitters, neuromodulators and neuropeptides. 
 
 
The most significant finding for the LTrP group in all experimental conditions 
was that the only consistent aspect of their MAP was that Inf was activated 
first in most trials and conditions. Beyond this finding, the order of muscle 
activation was not consistent within or between LTrP-affected subjects. 
Based on evidence describing the role of the Inf during elevation of the arm 
in the scapular plane, it was hypothesised that early activation in this 
movement was aimed at compensating for sub-optimal positioning of the 
scapula by LTrP-affected muscles in order to minimise compression of 
subacromial structures. In addition to an inconsistent order of muscle 
activation, generally speaking, the variability of activations times, most 
commonly of the UT, SA and LT (LTrP-containing muscles), but also of the 
functionally related muscles (Inf and MD) in some conditions, was increased 
in the LTrP group. These findings were not significantly worsened either by 
adding light external loads or performing repetitive arm elevations in the 
scapular plane, suggesting that the mechanisms via which LTrPs affect 
MAPs were not exacerbated by these variables. The findings stimulated a 
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discussion of the mechanisms that may underpin changes in muscle 
activation in LTrP-affected muscles (UT, SA and LT in the present study). 
Briefly, these included: 
• Changes to motoneuron excitability secondary to group III and IV 
afferent discharge secondary to nociceptor activation based on the 
fact that SP and CGRP have been identified in increased 
concentrations at LTrP sites in UT muscles previously. 
• Decreased fusimotor drive to motoneurons secondary to unloading of 
muscle spindles positioned on sections of muscle fibers where 
sarcomeres are contracted (LTrP contraction knot). Conversely, where 
spindles were positioned on sections of muscle fibers where 
sarcomeres lengthen consequent to the development of a LTrP 
contraction knot, increased spindle discharge might be expected given 
their ability to respond to very small changes in fiber length. In 
combination, mis-matched spindle feedback from both within a LTrP 
affected muscle fiber and between spindles in the taut band region as 
opposed to ‘normal’ fibers may contribute to changes in activation of 
affected muscles and functionally related muscles via CNS pathways. 
• Altered intrinsic properties of LTrP-affected muscle fibers including, 
mechanical failure due to loss of overlap of actin and myosin in 
lengthened sarcomeres, active insufficiency of sarcomeres under 
contracture, (both affecting contractile capacity) and alterations to 
cross bridge attachment/detachment mechanics affecting contractile 
speeds. 
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Given that MAPs of LTrP subjects were found to be different from those who 
were LTrP-free, the next step was to remove the LTrPs from half the LTrP 
subjects by treating them with SDN and PIR stretching to test the affects of 
treating LTrPs on MAPs. These data were presented in Chapter five as 
described next. 
 
 
Chapter five involved randomly assigning half the LTrP subjects to treatment 
consisting of SDN and PIR stretching and half to a sham treatment 
(representing placebo intervention) that consisted of sham ultrasound 
therapy. After treatment (true or sham), half the subjects had no LTrPs and 
the remaining half did. All ‘treated’ subjects then repeated all sEMG 
investigations performed in Chapter four. The significant findings are outlined 
as follows: 
• Sham ultrasound treatment produced no difference from the pre-
interventions MAPs. 
• SDN and PIR stretching resulted in MAPs that were not significantly 
different from the control group in the unloaded and loaded 
experimental conditions, confirming the high likelihood that the 
presence of LTrPs in the upward scapular rotators produced the 
different (compared with healthy subjects) MAPs. 
• In the unloaded and loaded conditions, treating LTrPs ‘normalised’ 
and presumably optimized MAPs at the time of treatment, however it 
is not known how long this affect remains since no follow up testing 
was performed. 
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• When fatigued, treated LTrP subjects had the same order of muscle 
activation as the control group post-fatigue, however some differences 
in mean activation times and variability of these activation times 
remained, suggesting there are differences in the way these 
populations responded to fatigue-inducing repetitive movements. 
• Treating LTrPs results in activation patterns post-fatigue no different to 
those produced by healthy subjects in a rested state, implying that 
treatment of LTrPs may result in an increased ability to maintain an 
optimal MAP when exposed to fatigue. 
 
 
In conclusion, based on the results of the current work, LTrPs commonly 
occur in scapular positioning muscles and do have deleterious effects on 
MAPs and thus affect motor control mechanisms. Treating LTrPs with SDN 
and PIR stretching increases PPTs and removes associated taut bands and 
“normalises” the MAP during scapular plane elevation in commonly occurring 
conditions, at least transiently. 
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6.2 Limitations 
 
The results of the three closely linked studies must be considered in light of a 
number of limitations. 
 
6.2.1 The Prevalence of Latent Trigger Points (LTrPs) in the Scapular 
Rotator Muscles in Healthy Subjects 
 
(i) The 154 subjects were all volunteers from one environment (university 
campus) as opposed to randomly selected from a larger population. 
(ii) For this study to be considered an epidemiological study, the sample 
size was small and thus would limit the external validity of the results. 
(iii) Data collections stopped once 14 LTrP-free subjects were identified 
that could act as the control group in the remainder of the 
experimental program. Therefore, the sample size of this study was 
not pre-determined but was determined by the duration of time 
required to identify 14 LTrP-free subjects. 
 
6.2.2 The effects of LTrPs on muscle activation patterns during scapular 
plane elevation (Chapter 4) and The effects of treating LTrPs on MAPs 
during scapular plane elevation (Chapter 5) 
 
(i) No blinding was employed in this study, that is, the same 
investigator performed the LTrP examination, the sEMG 
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evaluations, the LTrP treatment interventions, the re-examination 
fro LTrPs and the repeated sEMG evaluations post-treatment. The 
aspect of the experimental procedures where no blinding had the 
greatest potential to affect the results was at the second LTrP 
examination after the respective interventions (treatment and sham 
treatment). The fact that an algometer was used to measure PPTs 
prior to and post-treatment interventions made the LTrP 
examinations more objective and helped to minimise the lack of 
examiner blinding. 
 
(ii) A power analysis resulted in the number of each final group being 
calculated as 14. The LTrP groups (N=14 treatment group; N=14 
placebo treatment group) filled first, however it took 154 
examinations to find 14 volunteers to form the control group. In 
itself, this elucidates how uncommon it is to be LTrP-free in the 
scapular positioning muscles. 
 
 
(iii) Spectral analysis of the sEMG signals was not carried out to 
confirm the presence of fatigue, nor was the duration of muscle 
contraction extracted from the recordings. Though both of these 
analyses may have added additional information regarding muscle 
activation patterns during fatigue, they most likely do not weaken 
the findings of the analysis that was performed. 
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6.3 Future Directions 
 
The results of Chapters four and five demonstrated that LTrPs affect MAPs 
during elevation of the arm in the scapular plane in various commonly 
occurring conditions. The principle recommendation for future investigations 
to arise from this work are to investigate the mechanisms via which LTrPs 
may exert their effects on MAPs would provide a greater understanding of 
the effects of these “sub-clinical” entities and might lead to the development 
of interventions by which painful overload conditions that may develop 
secondary to LTrP-mediated sub-optimised motor control, could be 
prevented or better managed. Further microdialysis studies in the vein of 
Shah and colleagues (2005) to further illuminate the chemical compounds at 
TrP sites would be useful and may help clarify which pharmaceuticals might 
be a useful adjunct in treating or managing MPS. With a clear understanding 
of the biochemicals involved, studies investigating the neural pathways, 
presumably predominantly by group III and IV afferent fibers due to 
chemonociceptor stimulation, but also investigation into which other afferent 
fibers may fire in association with the presence of LTrPs. Studies, perhaps 
using similar methodologies to those performed by Gandevia and Taylor’s 
group on the neural mechanisms underpinning fatigue processes, might be 
useful to elucidate the sites within the CNS where LTrP-related input is being 
processed. Of particular interest are spinal cord reflexes, Renshaw cells and 
the fusimotor system and muscle spindle receptors and how these systems 
or cells may be affected by LTrP-related inputs and ultimately affect 
motoneuron firing. 
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Another area of focus may be the muscle fibers forming the LTrP taut band. 
Aspects that might help shed light on LTrP effects on motor control are inter-
sarcomere dynamics, cross bridge attachment/detachment mechanics and 
the effects of the presence of a taut band on the rest of the muscle (possibly 
via the motor unit configurations) and how these elements affect the muscle’s 
ability to react to neural commands and generate force, especially in 
cooperation with other muscles and joints. 
 
Furthermore, since all the testing for the current study was performed in one 
day, follow up sEMG evaluations to test the duration of the effects of 
treatment of LTrPs on MAPs would provide further information regarding the 
nature of the LTrP effects on MAPs and provide insights into the efficacy of 
management programs. In addition, spectral analysis of sEMG would provide 
objective evidence of the degree of faigue associated with LTrPs and is 
recommended in future studies. 
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APPENDIX A 
Plain Language Statement Given to Participants 
 
 RESEARCH PROJECT INVOLVING HUMAN 
SUBJECTS 
 
 
 
 
1 / 12 /99 
 
 
Dear Participant, 
 
RE:  PARTICIPATION IN AN RMIT RESEARCH PROJECT 
 
 
Thanks for your interest in this project. My name is Karen Lucas and I am undertaking a PhD 
degree in the Department of Chiropractic, Osteopathy and Complementary Medicine at 
RMIT University. My research project is titled The effect of latent myofascial trigger points in 
the scapular rotator muscles on the recruitment pattern in the lower trapezius, serratus 
anterior and infraspinatus muscles during elevation of the arm in the scapular plane and 
aims to investigate muscle recruitment patterns of the shoulder girdle of individuals with and 
without knots in specific muscles to see if there are any differences. 
 
As a subject in this study, you will be invited to come to the Chiropractic research lab (room 
201.5.28). You will be assessed for latent trigger points, or knots in your muscles around 
your shoulder blades by feeling them for any painful spots. Immediately after this 
assessment, you will have 16 surface electrodes (adhesive patches) taped to your skin on 
your back and asked to perform some simple movements with your arms. These electrodes 
are attached to fully isolated amplifiers which will protect you from any possible power surge. 
This test will enable us to measure the electrical activity in your muscles.  
 
Next you will be given 20 minutes of muscle therapy, depending on what was found in your 
initial assessment. This therapy will be either myofascial dry needling, in which a very thin 
disposable acupuncture needle will be placed in your muscle for about 5 minutes. Most 
people experience no discomfort during or after this treatment, but it is possible to feel a 
mild, dull ache for 5 minutes up to 24 hours post treatment. All infection control procedures 
will be strictly adhered to. The other muscle therapy is gentle massage of the back and neck. 
You will not be able to choose which therapy you receive. 
 
Depending on what has been found in your muscles, you may have to have your muscle 
activity re-tested using the electrodes taped to your back. It would be expected that neither 
of these therapies should effect your health adversely. 
 
The entire process should take between 60 and 90 minutes, depending on what is found in 
the initial assessment. 
 
The data collected in this project may give us new knowledge on how the shoulder muscles 
function when raising the arm. It may also provide insight into how to prevent chronic 
shoulder pain. 
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Participation in this project is totally voluntary and you can withdraw, without prejudice, at 
any stage, including the withdrawal of any previously supplied unprocessed data. As a 
participant, you are invited to, and should, ask for clarification regarding any aspect of your 
participation that may be concerning you. Data from this project may be used in a 
presentation or a published article at a later date, but your personal information and any data 
collected from you will not be personally identified and your confidentiality will be protected at 
all times.  
 
 
 
Thank you for your interest in this project. 
 
 
 
 
 
 
Karen Lucas    Dr Barbara Polus Dr Peter Rich 
BAppSc(Human Movement)(Hons.) ApSci; MSc; PhD Dip PE; BSc; MSc; PhD 
AdDip (Myotherapy)    
Ph:  9925 7596    Ph:  9925 7714 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Any queries or complaints about your participation in this project may be directed to 
the Secretary, RMIT Human Research Ethics Committee, RMIT, GPO Box 2476V, 
Melbourne, 3001.  The telephone number is (03) 9925 1745. 
 
 
 
 281 
APPENDIX B 
Informed Consent Form 
 
 RESEARCH PROJECT INVOLVING HUMAN 
SUBJECTS 
 
Please note: This is a prescribed form.  It is a requirement of the RMIT Human Research 
Ethics Committee. 
 
 
DEPARTMENT OF CHIROPRACTIC, OSTEOPATHY AND 
COMPLEMENTARY MEDICINE 
 
FACULTY OF BIOMEDICAL AND HEALTH SCIENCES AND 
NURSING 
 
 
Prescribed Consent Form For Persons Participating In 
Research Projects Involving Tests and/or Procedures 
 
Name of participant:       
 
 
Project Title: 
The effect of latent myofascial trigger points in the scapular rotator muscles on the 
recruitment pattern of key shoulder girdle muscles during elevation of the arm in the scapular 
plane. 
 
Name of investigator(s): Karen Lucas  Tel: (BH)  9925 7655 (Hme) 9722 1199 
   Dr Barbara Polus Tel: (BH)  9925 7714 (Hme) 9484 8848 
 
 
1. I consent to participate in the above project, the particulars of which - including 
details of tests or procedures - have been explained to me and are appended 
hereto. 
 
2. I authorise the investigator or his or her assistant to use with me the tests or 
procedures referred to under (1) above. 
 
3. I acknowledge that: 
 
(a) the possible effects of the tests or procedures have been explained to me to 
my satisfaction; 
 
(b) I have been informed that I am free to withdraw from the project at any time 
and to withdraw any unprocessed data previously supplied; 
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2. 
 
 
(c) The project is for the purpose of research and/or teaching and not for 
treatment; 
 
(d) I have been informed that the confidentiality of the information I provide will 
be safeguarded. 
 
 
 
 
 
 
Signature: Date:    
(Participant)  
 
 
 
 
Signature:  Date:    
(Witness to signature) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participants should be given a photocopy of this consent form after it has been signed. 
 
Any queries or complaints about your participation in this project may be directed to 
the Secretary, RMIT Human Research Ethics Committee, RMIT, GPO Box 2476V, 
Melbourne, 3001.  The telephone number is (03) 9925 1745. 
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APPENDIX C 
 
INTRA-EXAMINER RELIABILITY IN LATENT MYOFASCIAL TRIGGER 
POINT EXAMINATION 
 
C.1 Introduction 
 
The aim of this study was to investigate the intra-examiner reliability of 
identifying latent trigger points (LTrPs) in the scapular rotator muscles of 
healthy adult subjects. Eight subjects (4 male, 4 female, aged 22-55 years, 
mean 38.2 years), who experienced no pain in their upper back, neck, 
shoulders or arms, had their scapular rotator muscles examined for the clinical 
characteristics of LTrPs. The muscles examined for LTrPs were the pectoralis 
minor, levator scapulae, serratus anterior and all parts of the trapezius, and 
rhomboids.  
 
Gerwin and colleagues (1997), in their interrater reliability of trigger point 
(TrP) examination study defined the clinical characteristics of TrPs as follows: 
taut bands (TB), a tender point (TE) within the TB, pain reproduction (Rep P), 
referred pain (Ref P) and local twitch response (LTR). Those definitions were 
also used in the present study except for the pain reproduction, as LTrPs do 
not elicit pain at rest. The term pressure-pain threshold (PPT) was used 
instead and defined as the number of kilograms per square centimetre that 
had to be exerted in a direction perpendicular to the skin surface before the 
sensation of pressure became the sensation of pain. The PPT was measured 
with an algometer (Activator Methods, Phoenix, AZ) using the procedure 
validated by Fischer (1986). A LTrP was defined as a TE within a TB that 
may or may not elicit a LTR or Ref P in response to snapping palpation or 
direct compression respectively and had a PPT of less that expected in 
normal muscle tissue. In this study, the palpation pressure used to elicit a 
pain response was standardized subjectively and defined as pressure that 
would not usually cause a pain response in normal muscle tissue, as judged 
by experienced examiners. In contrast, Hong and co-workers (1996) found 
that even when normal muscle tissue near a LTrP was compressed, 23% of 
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subjects reported a referred pain response if there was no limit placed on 
how much pressure could be employed. This finding suggests that it may be 
helpful to further objectify the amount of pressure used to identify a LTrP, in 
order to decrease the likelihood of false-positives. 
 
In earlier work, Fischer (1987) used pressure algometry to measure the 
pressure-pain threshold (PPT) of normal back and shoulder girdle muscles. A 
mathematical algorithm was used to calculate the PPT below which a muscle 
could be considered abnormal. Fischer noted that males and females had 
different PPT’s for the same muscles and that PPT’s decreased in a 
cephalad direction. On the basis of the cited studies, the definition used to 
identify a LTrP in this study became: 
A tender point within a palpable taut band of skeletal muscle that had 
a PPT of less than that expected in normal muscle tissue (see 
Fischer’s values, 1987 and table 1), with or without referred pain or a 
LTR. 
 
Table C.1: Lowest PPT (kg/cm2) at which a muscle can be considered 
'normal' Fischer, 1987). 
 Males 
(kg/cm2) 
Females 
(kg/cm2) 
Upper trapezius 2.9 2.0 
Scapular muscles 3.9 2.8 
 
 
C.2 Methods 
 
C.2.1 Subjects 
 
After gaining approval from the RMIT University Human Research Ethics 
Committee, 8 pain-free subjects (4 female, 4 male; mean age 38 ± 9.1 years) 
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who volunteered for the study had their scapular rotator muscles examined 
for the clinical characteristics of LTrPs. The muscles examined for LTrPs 
were the pectoralis minor and serratus anterior (examined lying supine), all 
parts of the trapezius and rhomboids and the levator scapulae (examined 
lying prone). Subjects were excluded if they reported any pain in the back, 
neck or either upper limb any time in the previous week. 
 
A therapist who had been trained and was experienced in LTrP examination 
used the identification procedures outlined by Simons et al (1999, p. 116-7) 
briefly described as follows. The subject was lying on a table in a warm and 
relaxed state with the upper body disrobed. The subject was then positioned 
to lengthen the muscle being examined to the point of a perceptible increase 
in resistance to movement. In this position, the normal muscle fibers are still 
slack but the fibers of any taut bands and placed under additional tension, 
which renders them most easily distinguishable from the normal fibers. Next, 
cross-fibre palpation was used to identify any taut bands (fig. 1). Fiber 
examination occurred via flat palpation for all muscles except the upper 
trapezius, which was examined using pincer palpation. If a taut band was 
identified, the examiner then palpated along the taut band searching for a 
slightly enlarged point or the ‘focus’ of the contraction. When the examiner 
had identified this point, the subject was asked if the point was tender when 
compressed. If the subject subjectively indicated a tender point, the PPT of 
the tender point was measured with an algometer (fig. 2) using the procedure 
validated by Fisher (1987). If the PPT was less than that of ‘normal’ muscle 
tissue (table 1), the tender point was defined as a LTrP and its position was 
documented on an enlarged body diagram. The subject was also asked if the 
pain referred elsewhere and the TE was stimulated with snapping palpation 
to attempt to elicit a LTR. Pressure-pain threshold measurements were 
repeated 3 times and a mean taken in order to ensure that the value was 
reliable. All three PPTs were taken in quick succession (within approximately 
60 seconds) due to the fact that LTrPs can be inactivated by sustained 
pressure (Hong, 1999).  
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Figure C.1: Palpation perpendicular to the direction of the muscle fibers 
to identify the taut band. 
 
 
 
 
Figure C.2: Using the algometer to measure the PPT of a subjectively 
painful nodule. 
 
Subjects were examined for LTrPs three times. The second examination was 
30 minutes after the first and the third examination was 24 hours after the first. 
All the clinical findings for each LTrP were recorded and the locations were 
described using anatomical landmarks and drawn on a body outline by the 
examiner for later analysis. The third examination 24 hours later served to 
decrease the examiner bias that may occur when the examiner remembers 
the area in which a LTrP was located previously. The time between 
examinations could not be too long as it is possible that the LTrP may be 
affected by the examination process itself or the activities in which the subject 
participated between examinations. The order of muscles assessment was 
random for each subject. 
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C.2.2 Statistical analysis 
 
To assess the agreement between the findings of each examination the kappa 
statistic, which reports pairwise judge agreement corrected for chance 
agreement (Cohen, 1960) was used. The kappa statistic is dependent upon 
the presence of two or more choices so when there is 100% agreement 
between examinations, the kappa value will be low (Hobart et al, 1996). When 
this occurs, the percentage agreement will be reported in the results. 
 
To assess the reliability between algometer scores for each trigger point in 
each examination, intraclass correlations (ICC) were performed. The ICC is a 
reliability coefficient that is calculated using variance estimates obtained 
through an analysis of variance, reflecting both the degree of correspondence 
and agreement among scores (Portney and Watkins, 1993). 
 
C.3 Results 
 
Kappa scores are displayed in Table 2 then classified in Table 3. Mean PPTs 
for each muscle are reported in Table 4 and the ICCs for the PPTs between 
examinations are reported in Table 5. 
 
Table C.2: Kappa Scores for each combination of examinations. 
 
Muscle Exam 
1 v 2 
Exam 
2 v 3 
Exam 
1 v 3 
Pectoralis minor 0.71 1 0.71 
Serratus anterior 1 0.6 0.6 
Upper trapezius 1 1 1 
Middle trapezius 1 0.5 0.5 
Lower trapezius 0.75 0.33 0.33 
Rhomboids (together) 1 1 1 
Levator scapulae 1 0.35 0.38 
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Portney and Waltkins (1993) reported that Landis and Koch suggested the 
following levels of agreement for kappa statistics: 
 >  0.8  =  excellent agreement 
 0.6-0.8 = substantial agreement 
 0.4-0.6 = moderate agreement 
 <  0.4  = poor to fair agreement 
 
Table C.3: The extent of agreement between examination findings for 
each muscle according to Portney and Waltkins (1993) definitions for 
kappa statistics. 
 
Muscle Exam 
1 v 2 
Exam 
2 v 3 
Exam 
1 v 3 
Pectoralis minor substantial excellent substantial 
Serratus anterior excellent substantial substantial 
Upper trapezius excellent excellent excellent 
Middle trapezius excellent moderate moderate 
Lower trapezius substantial poor poor 
Rhomboids (together) excellent excellent excellent 
Levator scapulae excellent poor poor 
 
Table C.4: Mean algometer scores where LTrPs had been identified 
(PPT) for each muscle and examination. 
 
Muscle Exam 1 Exam 2 Exam 3 
Pectoralis minor 3.3 3.1 2.4 
Serratus anterior 3.6 2.4 2.8 
Upper trapezius 2.8 3.0 2.7 
Middle trapezius 3.4 3.6 2.4 
Lower trapezius 3.6 3.4 3.0 
Rhomboids (together) 3.9 3.6 2.9 
Levator scapulae 3.5 3.7 2.2 
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Table C.5: ICCs for PPTs measured with the algometer (kg/cm2) between 
examinations for all muscles. 
ICC for PPTs 
Exam 
1 v 2 
Exam 
2 v 3 
Exam 
1 v 3 
 0.92 0.33 0.28 
 
C.4. Discussion and Conclusions 
 
For each muscle examined, the agreement was either “substantial” or 
“excellent” between examinations 1 and 2. That is, the point on the body 
identified as a LTrP in examination 1 was highly likely to also be identified as 
a LTrP in examination 2 by the same examiner. Additionally, if there was no 
LTrP identified in a muscle in examination 1, there was likely to be no LTrP 
found in that muscle in examination 2. With regard to PPTs, there was no 
significant difference in PPT scores between groups where LTrPs had been 
identified. There were however significant differences in PPTs between 
where there was no LTrP identified and where there was. In other words, the 
PPT is significantly higher in muscle where there are no clinical 
characteristics of LTrPs (taut band, tender point) when compared to the PPT 
of muscle where these signs have been identified. In addition, the ICC for the 
mean PPT for each muscle between examinations one and two was large 
(ICC of 0.5 or higher = “large”; ICC for examinations one and two=0.92). 
However, where ICCs were performed between examinations that occurred 
on different days, the ICCs did not produce good agreement, being classified 
as either moderate (ICC of 0.3-0.5) or small (ICC of 0.1-0.3). 
 
Based on these results, it was concluded that: 
1. Examinations performed on the same day for LTrPs in scapular 
positioning muscles, performed by the same examiner using the 
process described above was reliable. 
2. Where repeat examinations were performed more than 24 hours apart, 
PPTs decreased and the agreement (based on kappa scores) 
decreased to moderate or poor for the middle and lower trapezius and 
levator scapulae for this examiner.
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APPENDIX E 
Myofascial TrP Differential Diagnoses 
 
Myofascial TrPs can result from various mechanical and systemic causes 
that must be identified and treated specifically (Gerwin, R. 2004). For 
example, Simons and colleagues (Simons, D., Travell & Simons 1999) 
identified two conditions that often underpin MPS but are commonly 
overlooked: fibromyalgia and joint-mediated pain or dysfunction. They 
pointed out that these conditions often interact but require different diagnostic 
examination techniques and significantly different treatment approaches. 
More specifically, TrP pain can mimic specific pain conditions (eg 
radiculopathy, angina) from which they must be differentiated in order that 
the correct treatment be implemented. For a comprehensive list, readers are 
referred to table 2.5 in (Simons, D., Travell & Simons 1999). 
 
In a review on the differential diagnosis of TrPs, Gerwin (2004) outlined the 
following conditions that might require investigation and specific treatment 
when TrPs have been identified (Gerwin, R. 2004): 
1. Delayed onset muscle soreness (DOMS) which occurs secondary to 
unaccustomed exercise, usually involving eccentric contractions, and is 
the result of local muscle damage, inflammatory changes and nociceptor 
sensitisation (Proske & Morgan 2001). 
2. Hypermobility syndromes which produce multiple mechanical stresses 
secondary to ligamentous laxity causing poor joint stabilisation and 
resultant muscle overload. 
3. Forward head posture and the resulting muscular overload often 
associated with posterior displacement of the mandible, 
temporomandibular joint pain, headache and upper airway obstruction. 
4. Pelvic torsion-related pain caused by chronic anterior pelvic tilt. Pain 
arises from the muscular overload required to adjust to the pseudo-leg-
length inequality or pseudoscoliosis. 
5. Sacroiliac joint dysfunction or hypomobility can cause pelvic and spine 
dysfunction that results in painful widespread axial muscle TrPs. 
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6. Somatic dysfunction or muscle-joint dysfunction, a painful limitation of 
range of motion caused by muscular restriction of joint motion, seen 
commonly where a vertebral rotation or lateral displacement is sustained 
by persistent TrPs in paraspinal muscles. 
7. Static overload which occurs when mechanically stressful positions are 
held for prolonged periods of time causing overload and fatigue of the 
active muscles. This situation results from many common workplace and 
daily tasks which need to be specifically addressed. 
8. Nerve root compression can present with TrPs, treatment of which may 
bring transient relief of the muscle pain, but the TrPs will recur until the 
nerve root is decompressed. 
9. Muscle imbalance resulting from muscle weakness (from any cause) can 
produce a musculoskeletal imbalance leading to mechanical asymmetries 
and muscular overload of the compensating muscles. 
 
The following systemic illnesses have been associated with the presence of 
TrPs, although in most cases, causal relationships have not been confirmed: 
1. Autoimmune disorders including lupus, Sjogren’s and polymyalgia 
rheumatica. 
2. Infectious diseases such as Lyme disease or post-Lyme disease 
syndrome, mycoplasma pneumonia, Chlamydia pneumonia and 
parasitic disease. 
3. Allergies, when left untreated, may cause widespread myalgia that 
resolves when the allergies are treated. 
4. Viscero-somatic pain syndromes, in which internal organ dysfunction 
is associated with somatic segmental referred pain syndromes. 
Examples include endometriosis causing abdominal myofascial pain, 
interstitial cystitis and irritable bowel syndrome both associated with 
chronic pelvic pain syndromes and liver disease that causes local 
abdominal or referred shoulder regional pain. 
5. Brain tumour and base of skull pain may be caused by primary or 
secondary posterior fossa tumours with associated suboccipital or 
upper cervical TrPs that can be transiently de-activated. 
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APPENDIX F 
Myofascial TrP Injections and Other TrP Therapies 
 
F.1 Injection Therapy for TrPs 
 
As more is known about the biochemical milieu and pathoneurophysiology of 
MPS, clinicians and researchers are trialling new pharmacological 
substances in injection therapy to treat myofascial TrPs. As this aspect of TrP 
therapy falls outside the professional scope of this author, only a basic review 
of this literature has been performed. 
 
F.1.1 Botulinum Toxin A 
 
More trials or various natures are appearing in the medical literature testing 
the efficacy of injecting botulinum toxin A (BTX A) into myofascial TrPs, 
though no systematic review has been performed as yet. Investigators have 
had mixed results ranging from one prospective, randomized, double-blind, 
placebo-controlled, 12-week, multicentre study finding an efficacious affect 
beyond placebo (Gobel et al. 2006; Wheeler, Goolkasian & Gretz 1998) and 
one study finding a positive within-subject effect for BXT A injections but no 
improvement over saline. Conversely, more trials have found no difference to 
saline (Ferrante et al. 2005; Ojala, Arokoski & Partanen 2006; Porta & 
Maggioni 2004; Qerama et al. 2006). Although one trial did not find any 
benefit of BXT A above placebo, the authors suggested that due to many 
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subjects who received two BXT A injections becoming asymptomatic, that 
further investigations were warranted (Wheeler, Goolkasian & Gretz 1998). 
 
Graboski and co-workers (Graboski, Gray & Burnham 2005) found no 
difference in a trial comparing BTX A with bupivacaine in duration or 
magnitude of pain relief, function, satisfaction or cost of care cost of injectate 
excluded. They suggested that given the high cost of BTX A, bupivacaine 
would be a more cost-effective injectate for TrPs. 
 
In a trial comparing TrP injection with BTX A to dry needling and lidocaine 
injection, the authors considered lidocaine injection more practical due to the 
fact it caused fewer disturbances than dry needling and was more cost 
effective than BTX A injection. An additional recommendation was to use 
BTX A in TrP patients who were resistant to conventional treatments 
(Kamanli et al. 2005). 
 
F.1.2 Botulinum Toxin B 
 
A small uncontrolled, single-center, outpatient, open-label study (Lang 2004) 
to evaluate the clinical safety and efficacy of botulinum toxin type B 
(MYOBLOC) in reducing myofascial pain associated with piriformis syndrome 
suggested the possibility that botulinum toxin type B may be of potential 
benefit in the treatment of pain attributed to piriformis syndrome. 
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In summary, regarding the injection of botulinum toxin into TrPs, it the opinion 
of well respected researchers and clinicians that there are many other 
treatment modalities that are at least as effective as these injections (Simons, 
D. G. & Dommerholt 2006). 
 
F.1.3 Anti-inflammatory injectates 
 
In earlier times, injection of corticosteroids and non-steroidal anti-
inflammatory drugs (NSAIDs) into TrPs were more routinely performed, but 
once it was established there was no advantage over pain-killing substances 
such as lidocaine, these anti-inflammatory substances fell from favour. 
Recently, new injectable medications are being trialled that more directly 
target specific components of the pathophysiology of the TrP. As an 
example, one such study is outlined below. 
 
Muller and Stratz (Muller & Stratz 2004) performed a pilot study comparing 
the effect of 5-HT3 receptor antagonist (tropisetron) injections to analgesic 
(prioclaine) injections on visual analogue scales (VAS). They found a 
significant decrease in pain at three hours and subsequently at seven days 
on the VAS and a higher percentage of subjects that categorised themselves 
as “improved” at eight weeks in the tropisetron group compared with the 
prilocaine group. The authors indicated that the analgesic action of the 5-HT3 
receptor antagonist tropisetron manifested rapidly and lasted over a long 
duration (eight weeks) and probably had an anti-inflammatory effect which 
could be attributed to the inhibited release of substance P and other 
 297 
neuropeptides from the nociceptors and the blocked release of inflammatory 
substances from macrophages, and monocytes. 
 
F.1.4 Vitamin B12 
 
Although vitamin B12 deficiency is recognised as a condition that may 
promote or perpetuate MPS and that this deficiency must be rectified as part 
of the treatment program (Gerwin, R. D. 2005), some clinicians have 
employed injection of vitamin B12 directly into the TrPs itself. No RCTs on the 
injection of vitamin B12 into TrPs was found in the literature.  
 
 
F.2 Other Therapies Used For Treating TrPs 
 
A very brief overview of ‘other therapies’ for treating TrPs is presented.  
 
F.2.1 Laser Therapy 
 
Three types of lasers, Ga-As (Altan et al. 2005; Gur et al. 2004; Hakguder et 
al. 2003); He-Ne (Ilbuldu et al. 2004; Snyder-Mackler et al. 1989) and 
infrared diode (Ceccherelli et al. 1989) have been used to treat TrP pain. All 
but one study (Altan et al. 2005), showed at least short-term success in 
treating TrP pain. In two studies, a significant positive effect persisted at 
three months (Ceccherelli et al. 1989; Gur et al. 2004), but at six months no 
difference was noted when compared to the control group who received 
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placebo laser (Ilbuldu et al. 2004). It should be noted that Altan and co-
workers (2005) showed no advantage over placebo (Altan et al. 2005), 
however both the treatment and placebo groups participated in a concurrent 
program of isometric exercises and stretching, which the authors suggested 
may have confounded the conclusions. 
 
F.2.2 Electrotherapies 
 
Six types of electrotherapies have been reported in the MPS literature 
including transcutaneous electrical nerve stimulation (TENS), electrical 
muscle stimulation (EMS), high voltage galvanic stimulation (HVGS), 
frequency modulated neural stimulation (FREMS) and interferential current 
(IFC) (McMakin 2004; Rickards 2006).  
 
In a study judged as having poor internal validity (Rickards 2006), HVGS 
reduced pain scores at 15 days post-treatment but did not decrease 
analgesic use (Tanrikut et al. 2003). Interestingly, in a case series study 
using frequency-specific microcurrent to treat chronic low back myofascial 
pain (McMakin 2004), the author reported a statistically significant 3.8-fold 
improvement in pain reduction, suggesting a more thorough investigation 
was warranted on the basis of the results. Similarly, TENS has been shown 
to reduce TrP pain more effectively than EMS in two studies (Ardic, Sarhus & 
Topuz 2002; Hsueh et al. 1997) and has also been found to be superior to 
ultrasound in significantly reducing pain intensity (Hou, C. R. et al. 2002). The 
same study also revealed that when used in combination with other physical 
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therapy modalities or manual techniques both TENS and IFC produced a 
reduction in pain intensity. A frequency dependent effect was identified by 
Graff-Radford and colleagues (1989) who found superior pain reducing effect 
when TENS was used at 100 hertz (Hz), 250ms stimulation compared with 
2Hz, 250ms (Graff-Radford et al. 1989). In all these studies the findings were 
based upon immediate post-treatment effects, so that the medium or long-
term effects are not known. Related work by Smarnia and co-workers (2005) 
shed some light on the duration of the effects of TENS, finding an immediate 
pain relieving effect, however the effect did not persist at the one month 
follow up examination (Smania et al. 2005). Perhaps more positive were the 
results of the work performed by Farina and co-workers (2004), in which they 
evaluated TENS and Frequency Modulated Neural Stimulation (FREMS) for 
their ability to reduce TrP pain levels and alleviate the other clinical 
characteristics of TrPs. Both showed improvement at one month, but only the 
FREMS group maintained their improvement at 3 months (Farina, S. et al. 
2004). 
 
F.2.3 Ultrasound Therapy 
 
In a systematic review on non-invasive TrP treatments, Rickards (2006) 
reported that “standard” ultrasound applications had no effect on TrP pain 
beyond placebo in two studies (Gam et al. 1998; Majlesi & Unalan 2004). 
Similarly, Lee and colleagues (2002) demonstrated no significant difference 
between ultrasound and placebo ultrasound in TrP treatment (Lee, J. C., Lin 
& Hong 2002). In contrast, a trial that received a low validity score in 
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Rickard’s systematic review (Rickards 2006), high power pain threshold 
ultrasound (HPPT-US) significantly reduced TrP pain intensity compared with 
conventional ultrasound (Majlesi & Unalan 2004), though any adverse effects 
of this practice have not been fully investigated. 
 
F.2.4 Magnetic Therapy 
 
In recent investigations that show promise, in a small study (n=9 in each 
group), Smania and co-writers (2003) reported that repetitive magnetic 
stimulation (rMS) produced significantly better results than placebo in 
reducing TrP pain in the upper trapezius (Smania et al. 2003), while in a 
follow up and larger study (n=53 assigned to 3 groups) (Smania et al. 2005), 
the same authors found rMS produced significant positive changes in 
treatment outcomes up to three months following treatment when compared 
to TENS and placebo ultrasound.  
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APPENDIX G 
 
Electrode Positioning Procedure to Minimise Cross-Talk for the 
Infraspinatus, Lower trapezius and Serratus Anterior Muscles 
 
G.1 Aim 
 
To ensure the surface electromyographical (sEMG) signal recorded was valid 
for the infraspinatus (no cross-talk from posterior deltoid), lower trapezius (no 
cross-talk from latissimus dorsi) and the serratus anterior (no cross-talk from 
pectoralis major). 
 
 
G.2 Methods 
 
G.2.2 Subject Preparation 
 
Pre-gelled, silver-silver-chloride surface electrodes (Red Dot Paediatric 
surface electrodes, Melbourne) were placed over the following muscles: 
infraspinatus, posterior deltoid, teres minor, lower trapezius, latissimus dorsi, 
serratus anterior and pectoralis major. Prior to electrode application, the 
subjects’ skin was shaved, abraded and wiped with alcohol in order to reduce 
skin impedance. All electrodes were attached in the positions described in 
the table below with an inter-electrode distance of 20mm. The dominant-hand 
side was tested. 
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Table G.1: Testing position, electrode position and test action for all 
muscles with potential for cross-talk. 
MUSCLE 
ELECTRODE 
POSITION 
TESTING 
POSITION 
TEST ACTION 
Infraspinatus 4cm below the scapular 
spine, on the lateral 
aspect of the 
infraspinous fossa, 2cm 
apart and parallel to the 
scapular spine 
90° elbow flexion, 
no shoulder flexion. 
Possible slight 
abduction of arm. 
Resisted external 
rotation. Some arm 
abduction may also 
occur 
Posterior deltoid 2cm below the lateral 
aspect of the scapular 
spine, on an oblique 
angle in line with the 
fibres. 
Arm at side, elbow 
flexed to 90°. 
Resisted extension 
of the arm. 
Lower trapezius Two finger-breadths 
lateral to the spinous 
processes at the level of 
the inferior angle of the 
scapula, on an oblique 
angle in line with the 
fibres. 
Arm abducted to 
140° 
Hold against gravity. 
Latissimus dorsi Three finger-breadths 
distal to and along the 
posterior axillary fold, 
parallel to the lateral 
border of the scapula 
Elbow extended, 
arm abducted 30° in 
the coronal plane 
and internally 
rotated. 
Resisted extension 
and internal rotation 
Serratus 
anterior 
Below the axilla, anterior 
to the latissimus, placed 
vertically over ribs 4-6. 
Elbow flexed 45°, 
shoulder abducted 
75°and internally 
rotated 45°. 
Resisted scapular 
protraction 
Pectoralis major Horizontal placement 4 
finger-breadths below 
the clavicle, medial to 
the anterior axillary 
border. 
Elbow flexed 90°, 
shoulder abducted 
75°. 
Horizontal 
adduction (press 
palms together) 
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